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Peripheral Arterial Disease (PAD) is an increasingly prevalent long-term illness globally. The 
Ankle Brachial Pressure Index (ABPI) is a well-established, simple, relatively quick, inexpensive 
and non-invasive assessment useful in diagnosing and quantifying PAD. International 
guidelines have supported its use in both secondary and primary care, stating that it has a 
critical role in assessment and management of patients with PAD. Though many theoretical 
benefits exist, ABPIs are underutilised in general practice. No extensive literature has 
investigated its longitudinal usefulness in this setting.  
Aims 
The aims were to describe why and how ABPIs are being used at Mosgiel Health Centre (MHC) 
and to assess whether ABPI use is associated with a change in clinical management. The study 
also aimed to explore perspectives of health professionals on the role of the ABPI.  
Methods 
This study used quantitative and qualitative methods. The quantitative arm used ten years of 
electronic practice data from MHC. The qualitative arm analysed one-to-one interviews with 
health care professionals, mainly General Practitioners (GPs), on their experience and view of 
the usefulness of the ABPI in general practice.  
Results 
The quantitative arm assessed patients who had ABPIs at MHC between 2006 and 2015. This is 
the longest international retrospective study of ABPI patients followed-up in general practice. 
Of all 379 ABPIs, over half were completed to investigate patient eligibility for compression 
therapy for venous disease and just under half were completed to investigate perceived 
arterial-related symptoms. Between 21.6-24.5% of all ABPI values indicated PAD leading to 
23.2% of patients being reassured of having no PAD, 16.9% of patients managed as having 
PAD, and 17.7% requiring additional management or investigation. Approximately 73% of ABPI 
patients were not referred to secondary care. 
The qualitative arm showed that most GPs are aware of the main benefits of performing ABPIs 
in primary care; including to rule in or out PAD to aid management choices, to aid referral and 
for triage purposes. Many practical barriers to use were discussed, including cost, time and 
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low patient need. When considered together, barriers outweighed benefits for many GPs 
when determining whether ABPI was justified for use. However, both primary and secondary 
care health professionals agreed that there was a role for ABPI use in the community if 
barriers were overcome. Most interviewees agreed that having a ‘specialised’ professional to 
complete ABPIs would be most beneficial for patients in the community.  
Conclusions 
1. Common indications for ABPI use at MHC included to guide management of venous 
disease, and to investigate suspected arterial symptoms.  
2. Of the 379 patients having ABPIs tests, 26.39% were referred to the secondary care 
vascular department. ABPI use prevented inappropriate referrals in over 70% of cases. 
3. There was consensus among GPs that ABPI use is beneficial.  
4. Many GPs named similar, practical barriers for why ABPIs are not more commonly 
done. 
5. There is a role for ABPIs in primary care, although it may be more practical if it 
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Chapter 1: Introduction to Thesis 
The increasing health burden of long-term conditions is a well-established challenge the world 
is working to deal with.1-3 Patients may live with long-term conditions for decades, resulting in 
ongoing impairments and insults to the physical, emotional and spiritual aspects of their lives. 
Not only is this a large burden on themselves but also on the wider community and national 
health systems as a whole.  
Peripheral Arterial Disease (PAD) is an atherosclerotic long-term condition of public health 
importance, where in developed countries almost 20% of the population aged >75 years is 
afflicted.4 This number seems to be rising slowly over time with aging populations and 
improved treatment but PAD is often underdiagnosed and undertreated globally.5-8  The 
condition may manifest clinically as claudication, restricted mobility, or critical ischemia, and 
in some people results in limb amputation or death. Patients with PAD have an increased risk 
of fatal cardiovascular events, with myocardial infarction accounting for up to 60% of PAD-
related mortality.9  
In the USA, PAD alone accounted for 2.3% of total health spending in 2001 ($4.37 billion).10 In 
New Zealand (NZ) it accounted for approximately 5.2% of total cardiovascular health spending 
in 2011-12 ($26 million) excluding associated complications.11 Despite the many statistics 
regarding PAD, perhaps the most difficult fact to comprehend is that PAD is preventable, so 
for every person who dies because of a PAD-related cardiovascular event, preventable 
moments have been lost.  
The Ankle Brachial Pressure Index (ABPI) is a basic, relatively quick, reliable and safe 
investigative assessment that has been used extensively for decades in the diagnosis and 
monitoring of PAD in secondary care.4 It involves relatively little equipment and operators 
need little training to achieve competence. This makes the ABPI easy for health care 
professionals to use in many settings. Further, the ABPI allows clinicians to obtain an 
objectively measured numerical ratio, to measure severity of disease. The ABPI value obtained 
by the investigation may inform timely management changes which can lead to a limb or life 
saved.  
Nevertheless this investigative tool is not widely used in primary care, in particular general 
practices. In the literature, there is a lack of longitudinal studies of patients having undergone 
ABPIs in primary care. Therefore there is no long term data showing the likely benefits in 
general practice and so a lack of evidence to support its use. Further, potential practical 
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difficulties such as time or lacking the relevant skills has been alluded to in many papers but 
not extensively described in the literature. Therefore, there are knowledge gaps about how 
the ABPI can be used in general practice.   
This thesis reviews the body of literature which surrounds the ABPI since its inception in the 
1950s-60s and discusses two complementary arms of a mixed methods study aiming to 
expand knowledge and evidence regarding ABPI use in New Zealand general practice. The 
quantitative arm of the study examines the use of ABPI in one large Dunedin general practice 
over ten years by analysing descriptive data on all 379 ABPI tests completed at the practice 
during this time. The second qualitative arm analyses one-to-one interviews with health care 
professionals, mainly general practitioners (GPs), regarding their experience with, and view 
on, the usefulness of the ABPI in their workplaces. Both arms contribute to an overall 
assessment of how the ABPI has been used in general practice already, and provide the 
opportunity for comment on the suitability of its use in this setting.  Ultimately, the underlying 
question is whether testing patients’ ABPI in general practice can make a difference in 
preventing morbidity and mortality for the increasing number of patients living with PAD in 
New Zealand.   
Overarching Aims of this Research:  
1. To establish from the published literature if, why and how the ABPI has been and is 
being used already, in particular in general practice, and what the consequences of its 
uses have been.  
2. To describe characteristics of patients undergoing ABPI at the Mosgiel Health Centre 
(MHC) over the last ten years, and consider the influence of this test on their clinical 
management.   
3. To provide context by discussing the views, prior experience and opinions of local 




Chapter 2: Literature Review 
2.1 Introduction to Literature Review  
There is a substantial literature regarding both Peripheral Vascular Disease (PVD) and ABPIs 
dating back to the 1950s.12-15 Existing research has resulted in many published national 
guidelines and guidance documents pertaining to clinical assessment and management of the 
illness.16-20 However, no follow-up data on patients who have had an ABPI assessment could 
be identified in the literature. This chapter evaluates published research surrounding the ABPI 
in an attempt to understand its use and to determine what is known about its efficacy.  
 
2.2 Search Strategy, Search Scope  
The search strategy for the literature review comprised of two main tasks:  
The first task was to create a specific research question and literature review aims. Following 
an initial broad review of the literature and discussion with two supervisors, the following 
research question was developed: What is the usefulness of ABPIs in primary care? The 
literature review therefore aimed to investigate, review and summarise:  
(A) What is known about PVD, in specific PAD? (See Section 2.3 Peripheral Vascular Disease 
(PVD) and Peripheral Arterial Disease (PAD)) 
(B) What is already known about the ABPI, both in general and within primary care? (See 
Section 2.4 Ankle Brachial Pressure Index (ABPI))  
The second task was to systematically search for relevant studies. The following databases 
were used: Medline (Ovid), PubMed (National Library of Medicine), Web of Science Core 
Collection (Thomson Reuters), Scopus and Google Scholar. All the databases cover a wide 
variety of medical disciplines. Furthermore, the grey literature was searched (including clinical 
guidelines, guidance articles, reports, reviews and other articles not published in peer-
reviewed journals). Hand searching was included when recurring articles were referred to by 
the literature.  
The search terms used key words relating to three domains: (1) the ankle brachial pressure 
index itself, and covered terms including ‘ABPI’, ‘ankle brachial pressure index’, ‘ABI’, ‘ankle 
brachial index’, ‘ankle arm index’, ‘ankle brachial’; (2) key words relating to peripheral vascular 
disease, including ‘peripheral vascular disease’, ‘peripheral arterial occlusive disease’, 
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‘peripheral arterial disease’, ‘lower extremity arterial disease’ and corresponding acronyms 
(such as ‘PVD’, ‘PAOD’, ‘PAD’, ‘LEAD’’); and (3) key terms relating to primary care, such as 
‘primary care’, ‘primary health care’, ‘general practice’, ‘family practice’ and ‘ambulatory 
care’. The three domains were combined using Boolean operators to find literature pertaining 
to all three subject areas together. Supplementary key terms were added where more specific 
information regarding ABPIs was required, including ‘history’, ‘technique’, ‘effectiveness’, 
‘limitations’, ‘indications’, and ‘New Zealand’.  
The body of literature was narrowed in scope to include papers that were recent (the last ten 
years), older than ten years but cited often by later research, or papers specifically relating to 
a subtopic (e.g. historical papers first explaining ABPI).   
The boundaries of the literature search included content related to ABPI use and its 
applicability to PAD. Surrounding topics such as related cardiovascular and other conditions or 
events (e.g. diabetes, myocardial infarction) are discussed, but not in detail as they lie outside 
the scope of this literature review.   
The literature search was not restricted by language or publication descriptors. 
All searches were conducted between November 2014 and January 2015, and a final review of 
the more recent literature was conducted in September 2015.  
 
2.3 Peripheral Vascular Disease (PVD) and Peripheral Arterial 
Disease (PAD)  
2.3.1 Introduction and Definitions  
PVD is a broad term defined as any non-cardiac disease affecting the circulatory system.13 It 
encompasses multiple pathophysiological manifestations that affect many vessel types: 
arterial, venous and lymphatic.16 Aetiologies include: organic pathologies, structural 
pathologies, widespread systemic disease (e.g. systemic lupus erythematosus) as well as less-
specific functional changes (e.g. vessel spasms, Raynaud’s). The resultant pathway is a 
narrowing of peripheral vessels compromising blood (or lymph) circulation to and from 
extremities, bowel and other viscera.  
PVD can be specified further into PAD, which defines disease specific to non-coronary and 
non-carotid arterial vessels. The 2005 joint American College of Cardiology (ACC) and 
American Heart Association (AHA) guidelines define PAD as encompassing a “range of 
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noncoronary arterial syndromes which are caused by altered structure and function of the 
arteries that supply the brain, visceral organs and the limbs”.16  
Causes of PAD tend to be organic in nature, most commonly due to atherosclerosis or fatty 
build-up in the inner walls of arteries, explaining the synonymous term Peripheral Arterial 
Occlusive Disease (PAOD). PAD commonly affects the arteries of the legs (lower extremities).4  
Left untreated PAD can be limb-threatening, leading to gangrene and potentially the need for 
amputation. Lower extremity PAD is the third leading cause of atherosclerotic cardiovascular 
illness after stroke and coronary heart disease and greatly increases mortality risk from all 
major cardiovascular events.21  
Fortunately, as with other atherosclerotic diseases, progression of PAD is preventable.9  It can 
be diagnosed and monitored with thorough clinical history and examination and confirmed 
reliably using the ABPI (see Section 2.4 Ankle Brachial Pressure Index (ABPI)). PAD is still often 
underdiagnosed in clinical practice.22  
 
2.3.2 Epidemiology and Public Health Relevance 
Quantifying global and local burdens of disease for long-term conditions such as PAD provides 
insight into the scope of the issue. It also emphasises the increasing need for more effective 
solutions to management as countries face increasing PAD prevalence. The following section 
describes existing global and New Zealand knowledge regarding PAD prevalence.  
 
2.3.2.1 Global Data 
PAD affects 12-14% of the general population in many developed countries.4, 8, 23, 24  
The prevalence of PAD increases significantly with increasing age. In people aged >60 years in 
the UK, prevalence is around 10% of the general population.4 In people aged >75 years from 
the same population, prevalence reaches 20%.4 Similarly, a section of the German 
Epidemiology Trial on Ankle Brachial Index (getABI) study examined 6,880 participants aged 
>65 years demonstrated a 21% prevalence of PAD in this population.25  
A French study found that prevalence increased up to 38% among people who are considered 
at risk of PAD (see Section 2.3.6 Risk Factors).26    
There was no significant variation in total PAD prevalence between men and women.27, 28 
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Fowkes et al conducted a recent systematic review of 34 community-based studies to 
estimate global epidemiology of PAD.21 PAD was defined as an ABPI value <0.9 (the definition 
that most studies use).29 Approximately 202 million people globally were estimated to have 
PAD in 2010.30 It was determined that one in ten people aged ˃70 years and one in six people 
˃80 years have PAD, globally. 
The review covered populations in both high and low income countries. Of the 202 million, the 
majority (70%) were from low to middle income countries including 54.8 million in Southeast 
Asia and 45.9 million in the western Pacific Region.30 The Southeast Asia region had the largest 
number of people living with PAD of all World Health Organisation (WHO) regions in 2010. 21  
Fowkes et al also found that PAD was equally prevalent in men and women at all ages 
between 45 and 89 years in high income countries. However, there was some discordance in 
low to middle income countries where females were estimated to have higher PAD 
prevalence. This may be confounded by differing age and gender proportions in low to middle 
income countries. Tables 1 and 2 summarise prevalence of PAD for people in high and low to 
middle income countries respectively.  
Table 1:  Prevalence of PAD by Age and Sex in High Income Countries 30 
Prevalence  Male (%, confidence interval) Female (%, confidence interval) 
Young (45-49 years) 5.28% (3.38-8.17) 5.41% (3.41-8.49) 
Middle (60-64 years) 8.82% (6.85-11.28) 8.60% (6.65-11.05) 
Older (85-89 years) 18.83% (12.03-28.25) 18.38% (11.16-28.76 ) 
 
Table 2:  Prevalence of PAD by Age and Sex in Low to Middle Income Countries 30 
Prevalence  Male (%, confidence interval) Female (%, confidence interval) 
Young (45-49 years) 2.89% (2.04-4.07) 6.31% (4.86-8.15) 
Middle (60-64 years) 5.47% (4.40-6.48) 8.87% (7.53-10.41) 
Older (85-89 years) 14.94% (9.58-22.56) 15.22% (10.08-21.02) 
 
Further, in high income countries, people aged ˃55 years made up the largest proportion of 
people with PAD. Conversely, in low to middle income countries, PAD was more prevalent in 




When PAD prevalence in 2000 and 2010 were compared, a 23.5% increase was found. This has 
been described as a ‘global pandemic’.5 Of most striking difference was the increase in PAD in 
older age groups. In particular, an increase of over 35% occurred among people aged ˃80 
years between 2000 and 2010.30 The increasing life expectancy of people in low and middle 
income countries in the last decade probably influenced this finding.  
Despite the large prevalence changes, there is still likely to be an underestimation of the true 
prevalence of PAD because the majority of people living with PAD are asymptomatic and often 
are not diagnosed immediately, leading to underdiagnosis (see Section 2.3.5 Clinical Aspects). 
Additionally, many descriptive epidemiological studies have defined PAD based on ABPI values 
alone, without the use of other methods (such as toe pressures or duplex ultrasound). Relying 
on the ABPI assessment alone will mean that inherent limitations should be taken into 
consideration when interpreting prevalence findings (see Section 2.4.7 Limitations of the 
ABPI). Moreover, different methods of ABPI determination are possible, and this can 
profoundly influence prevalence patterns seen in different studies.31 More in depth 
surveillance strategies and research may be required to assess the disease prevalence more 
fully and accurately in the future.   
 
2.3.2.2 New Zealand  
The National Health Committee (NHC) provides routine analysis of health conditions in NZ. 
The NHC summarises data from several NZ surveillance data sets and studies to inform the 
government in making priorities to improve health outcomes and efficiency. The main sources 
of information used by the NHC include: the National Minimum Dataset of Hospital 
Separations, the New Zealand Burden of Disease Study, New Zealand population-based 
surveys and the New Zealand Health Tracker database (a New Zealand health census).11 The 
following summarises the most recent national epidemiological data about PVD from the NHC. 
In the 10 years to 2008, the New Zealand Health Tracker database showed the prevalence of 
PVD as being 416 per 100,000.11 This equals 17,000 individual cases per year. Prevalence was 
higher in males than in females (491 vs 347 per 100,000 respectively). Similar to global 
studies, prevalence increased with advancing age. Ethnicity data showed that prevalence was 
higher in non-Māori than in Māori (438 vs 269 per 100,000 respectively).  
Based on 2006 data, 1,300 Disability-Adjusted Life Years (DALYs) were attributed to PVD in NZ, 
making up 1% of overall DALYs in that year.11 There were more than 100 PVD-associated 
deaths in 2006, approximately 1% of the total all-cause mortality rate in NZ that year. The age 
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group ‘over 85 years’ contributed 22% of total DALYs attributed to PVD and over 50% of PVD 
related deaths.  
Health utilisation and cost analyses estimated that $26 million was spent on PVD in 2011-12. 
This was comprised of costs for 2,409 hospitalisations for 1,859 patients (1.3 hospitalisations 
per patient) lasting an average of 1.7 days. To put this in perspective, pulmonary embolism 
and venous thromboembolism accounted for $14 million of NZ expenditure together. A single 
hospitalised individual with PVD is estimated to cost the health system an average of $14,100.  
The NHC and the Ministry of Health (MoH) recognise the public health importance of 
cardiovascular diseases in general, acknowledging PAD as one of the contributors. One way 
the NHC and MoH have addressed cardiovascular disease management includes creating 
national health targets for heart checks (cardiovascular risk investigations). For example, a 
past national target included 90% of the eligible population having received a heart check by 
2014.11 Still, it seems that there is no national intervention targeted solely at PVD, and nothing 
currently being done to contain increasing prevalence trends. Investigation into the use of the 
ABPI in primary care could help to inform one possible method of ameliorating the problem.  
 
2.3.3 Pathophysiology  
Vascular disease is responsible for the highest proportion of all human diseases.32 The term 
‘vascular disease’ includes both central (cardiac) and peripheral vascular disease. PVD has a 
number of biological causes. To understand the pathological mechanisms behind the 
development of PVD, it is first necessary to understand the physiology of normal vessels, and 
their response to injury or damage.  
 
2.3.3.1 Arterial Vessel Anatomy and Pathophysiology 
A normal arterial vessel is made up of three layers: an ‘intima’ with an endothelial cell lining, a 
‘media’ primarily made of smooth muscle, and a connective tissue rich ‘adventitia’. Not all 
vessels in the body are the same however. They have different compositions to accommodate 
different functions. This means that different pathologies can occur in different vessels of the 
body.  
Arterial disease includes all pathologies that impede blood flow through mechanical 
obstruction or by causing abnormal vascular reactivity. These mechanisms cause ischemia due 
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to the reduced ability for tissue metabolism. An exclusive list of causes includes 
arteriosclerosis, atherosclerosis obliterans, atherothrombosis, functional vasoreactive arterial 
disorders, arteritic disorders, vasculitides and aneurysms. Degenerative disorders such as in 
Marfan syndrome can also cause arterial disease and PAD.32  Claudicating pain is caused by 
PAD due to a build-up of lactic acid in active muscles when there is a switch from aerobic to 
anaerobic metabolism as a consequence of lack of oxygen.  
Arteriosclerosis is the commonest arterial pathology (namely atherosclerosis). Arteriosclerosis 
means a “hardening of the arteries” reflecting abnormal wall hypertrophy and loss of elastic 
property. There are three patterns of arteriosclerosis: 
 Arteriolosclerosis- which affects small-sized arteries and arterioles, often caused by 
hypertensive damage and/or diabetes mellitus. 
 Mönckeberg medial calcific sclerosis- where muscular arteries are calcified 
(radiologically visible) but do not encroach into the lumen and so are not generally 
clinically significant. 
 Atherosclerosis- Greek for “gruel/hardening”, characterised by atheromatous lipid-
cholesterol plaques in the intima covered by fibrous caps protruding into the lumen. 
Atherosclerosis commonly affects large and medium sized arteries and is the most 
common type of arteriosclerosis (see Figure 1).  
PAD also increases thrombogenicity secondary to platelet activation, increasing the risk of 





Figure 1:  Normal and Atherosclerotic Peripheral Arteries. Source: National Heart, Lung, and 
Blood Institute; National Institutes of Health; U.S. Department of Health and 
Human Services, 2011. Released to the public domain, reproduced with 
permission.13 
 
PAD is often a polyvascular disease, meaning atherosclerotic disease is present in more than 
one vascular area. This means that diagnosing PAD is not only useful so that intervention can 
be implemented to treat the site affected, but intervention can be introduced to avoid other 
atherothrombotic cardiovascular events from occurring.  
The Reduction of Atherothrombosis for Continued Health (REACH) registry is the largest 
international PAD registry study conducted to date. The registry collected data from over 
67,800 patients from 44 countries to establish concordance of atherosclerotic risk factors and 
polyvascular disease.34 The study showed that atherothrombotic patients from around the 
world had similar risk factor profiles.34 Of those with symptomatic atherothrombosis, 15.9% 
had symptomatic polyvascular disease.34 Vidakovic et al studied 431 patients with known PAD 
using ultrasound measurements and revealed that only 29% had a single affected arterial 
territory as compared to 45%, 23% and 3% having two, three and four affected arterial 
territories respectively.35 In the subset of those with symptomatic PAD, 39% were found to 
have had at least one other territory affected other than that already known initially to the 
recruiters. These studies show that atherosclerotic PAD commonly affects multiple sites and 




2.3.3.2 Venous Vessel Anatomy and Pathophysiology  
Venous vessels are larger in luminal size, larger in diameter and have less well organised walls 
than arterial vessels.36 They also have lower flow velocities within them. These properties 
allow the venous system to have larger capacitance, constituting over two thirds of all 
systemic blood. Consequently they are not prone to the atherosclerotic diseases that occur in 
arterial channels. Conversely, these properties mean they are more prone to dilation, 
compression, and the effects of gravity in causing venous pooling.  
Venous disease includes all pathology which involves changes in venous vessel anatomy and 
function. Varicose veins and thrombophlebitis (usually of deep veins) account for 90% of total 
venous disease.32 Other venous diseases include venous thromboembolism, valvular 
incompetence, venous ulcers, deep venous thrombosis, pulmonary embolism, and post 
thrombotic syndrome.  
Venous incompetence and consequential venous ulceration are common lower limb vascular 
conditions with treatment costs accounting for 1% of the healthcare budget in Western 
cuntries.37, 38 Lifestyle modification and compression therapy are mainstays of treatment for 
venous pathologies to improve venous return, often implemented in general practice.38, 39  
While ABPIs are not used at all to detect venous pathologies, they are used to detect mixed 
vessel disease (arterial and venous disease together) when patients present with venous-
related symptoms (see Section 2.4.3.3 Determination of Ulcer Management). Verma et al 
emphasises the importance of determining the presence of mixed disease before embarking 
on venous intervention.40 ABPI use before compression is also recommended by the New 
Zealand Wound Care Society.39  
 
2.3.3.3 Lymphatic Vessel Anatomy and Pathophysiology 
For completeness, lymphatic anatomy and disease is mentioned, but there is little research 
regarding lymphatic PVD. Lymphatic vessels are thin-walled and their endothelium lining helps 
to drain excess interstitial fluid (lymph).41 Besides this, the vessels also carry mononucleocytes 
and proteins. This lymph mixture becomes filtered into lymph nodes promoting an 
inflammatory or infection fighting response.   
Lymphatic diseases are rare (least common PVD) and tend to be caused by secondary 
processes rather than primary ones.41 Lymphangitis is caused by a secondary process of 
inflammation arising when infectious agents spread through the channels. Primary familial 
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and secondary lymphoedema can cause ulcers and change the connective tissue structure 
around skin resulting in altered function and a brawny induration (peau d’orange) 
appearance.  
ABPIs have no role in detecting or managing lymphatic diseases so discussing lymphatic 
disease in any more depth is beyond the scope of this thesis. Lymphatic disease is excluded 
from this study as the focus is on the ABPI and PAD.   
 
2.3.4 Classification 
2.3.4.1 Classification by Clinical Categorisation Systems 
Clinically, PAD can broadly be split via symptomology into:23 
 Asymptomatic PAD- patients are diagnosed via ABPI but no symptoms are reported 
(patients may have atherosclerotic narrowing which does not greatly impede blood 
flow to the extremities).  
 PAD with intermittent claudication- patients have discomfort in the calf muscles with 
exertion that resolves with a few minutes of rest. This is due to failure of meeting 
oxygen demands on exertion.   
 Chronic limb ischaemia- patients have long-term ongoing pain at rest due to restricted 
blood flow causing damage to the tissues.  
 Acute limb ischaemia- a surgical emergency where patients have great pain in their 
limbs due to a significant restriction of blood flow which is causing damage to the 
tissues.  
Fontaine was the first to classify PAD into clinical stages, developing the Fontaine classification 
staging system in 1954.22 Stages range from I (asymptomatic) to IV (ulceration or gangrene). 
The Rutherford-Baker classification 1997 is a more recent and updated classification system 
which uses six categories as opposed to four.9, 42 Table 3 compares and contrasts both 
systems. Table 4 shows the Rutherford Classification system for acute limb ischemia.  
The ABPI can also be used clinically classify ABPI into mild, moderate and severe PAD.23, 43 The 




Table 3:  Comparison of Fontaine and Rutherford-Baker Classification Systems for Chronic 
Limb Ischaemia  
Fontaine Classification Rutherford-Baker Classification 
Grade Clinical description Grade Category Clinical Description Objective Criteria  
I Asymptomatic  0 0 Asymptomatic -Normal treadmill* or 
reactive hyperaemia test  
IIa Mild (intermittent) 
claudication 
I 1 Mild (intermittent) 
claudication 
-Completes treadmill exercise 
test  
-Ankle BP following test 
˃50mmHg but at least 
20mmHg lower than resting 
value  
IIb Moderate to Severe 
(intermittent) 
claudication 
I 2 Moderate (intermittent) 
claudication  
-Between categories 1 and 3 
II 3 Severe (intermittent) 
claudication 
-Cannot complete treadmill 
test and; 
-Ankle BP after exercise 
˂50mmHg 
III Ischemic rest pain II 4 Ischaemic rest pain -Resting Ankle BP <40mmHg 
-Ankle or metatarsal PVR is 
flat or barely pulsatile 
-Toe BP <30mmHg  
IV Ulceration or gangrene III 5 Minor tissue loss- non-
healing ulcer, focal 
gangrene with diffuse 
pedal ischaemia) 
-Resting Ankle BP ˂60mmHg 
-Ankle or metatarsal PVR is 
flat or barely pulsatile 
-Toe BP <40mmHg  
III 6 Major tissue loss- 
extending above 
transmetatarsal level, 
functional foot no longer 
salvageable 
(as above)  
BP= Blood Pressure  
PVR= Pulse Volume Recording  
*Treadmill test= 5 minutes at 2mph on a 12% incline 
NB: Under the Rutherford-Baker classification Grades II and III, and Categories 4, 5, 6 are all 




Table 4:  Rutherford Classification System for Acute Limb Ischaemia (Acute PAD) 
Category Description Findings 
I  Viable- not immediately threatened -Clinically: Nil sensory loss or muscle weakness 
-Doppler signals audible for arterial and venous 
vessels 
IIa Marginally threatened- salvageable with 
prompt treatment  
-Clinically: Minimal sensory loss at toes only 
-Doppler signal may be inaudible in arterial vessels 
IIb Immediately threatened- salvageable with 
immediate treatment 
-Clinically: Sensory loss detected, may have rest 
pain, and/or mild to moderate muscle weakness 
-Doppler signal may be inaudible in arterial vessels 
III Irreversible- major tissue or nerve damage -Clinically: Profound sensory and motor loss 
-Doppler signal inaudible in both arterial and 
venous vessels 
 
2.3.4.2 Classification by International Statistical Classification Codes  
The International Statistical Classification of Diseases and Related Health Problems 10th 
Revision (ICD-10) is a free medical reference coding system created by the WHO to 
systematically code all known health conditions, abnormal findings, complaints or 
circumstances.44 Having a standardised coding system aids in comparability during analysis of 
research data.  
ICD-10 codes have been applied to the New Zealand Health Tracker, a national health census 
which links data in the NHC and MoH collections. A recent NHC report on cardiovascular 
diseases published on December 2013 included the following ICD-10 codes under PAD: 11  
I70.2  Atherosclerosis of arteries of extremities  
I72.0  Other aneurysm and dissection [of arteries of the upper or lower extremities]  
I73.9  PVD, unspecified  
I74.0  Arterial embolism and thrombosis  
The above codes fall under category IX: “Diseases of the circulatory system”, and more 
specifically under the subcategory I70-I79: “Diseases of arteries, arterioles and capillaries”.  
These codes cover the most common forms of PAD, but are highly selected and fail to 
incorporate rarer related conditions sometimes considered PAD too.  
ICD-10 codes are also used in the New Zealand secondary care system. PAD and all other 




2.3.5 Clinical Aspects  
The aim of management for PAD is to reduce symptoms, improve functioning and where 
possible reverse or diminish progression. Preventive strategies are important for primary 
prevention (lowering blood pressure, the use of statins, smoking cessation) and secondary 
prevention of unwanted cardiovascular events and complications (through treatment 
intensification). As with every patient consultation, a thorough history and examination is 
pivotal in the analysis of patients’ problems to formulate appropriate treatment plans.  
 
2.3.5.1 Clinical History 
PAD has a broad spectrum of disease progression from asymptomatic through to painful limb-
threatening ischemia. A comprehensive and detailed history is required for clinicians to 
determine current PAD severity and impairment, along with patients’ overall longitudinal 
illness experience.   
The history should include a targeted vascular review of symptoms; assessing any 
claudication, walking or exertional impairment, ischemic rest pain, site of pain, description of 
pain and any non-healing wounds.16 A review of systems should include wider cardiovascular 
symptoms and risk factors such as smoking status.  If the presenting complaint was not of 
vascular origin, but such that other cardiovascular risk factors are identified, the 2005 
ACC/AHA guidelines strongly encourage a vascular history and assessment in these 
circumstances as well.16   
Patients with symptomatic PAD classically present with intermittent claudication. Intermittent 
claudication is defined as continuous exercise-induced discomfort and may be described by 
patients as pain when walking a certain distance, with a greater pace, or up a slope. It is 
generally relieved with rest as blood flow returns to match demand. Claudicating pain may 
lead to lifestyle limiting consequences resulting in a more sedentary lifestyle than preferred. 
The distance walked should be documented so that changes in severity can be tracked over 
time. Symptoms that come on with less effort and distance may mark advances in disease.  
However, classical intermittent claudication is described by only 10-35% of PAD patients.16 
Most patients who have claudicating or resting leg pain actually exhibit atypical symptoms.45 
This could in part be due to comorbidities, sedentary lifestyles, and alteration in pain 
pathways.46 Descriptions may include discomfort, tightness, a burning sensation or fatigue in 
the legs.  
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Pain at rest (or rest pain) is an indication of severe vessel narrowing, and commonly requires 
immediate specialist review and intervention to reperfuse the limb. If metabolic demands of 
the muscles of the lower extremity at rest are exceeding oxygen supply received, this results 
in anaerobic metabolism and ultimately tissue ischaemia causing pain. Patients experiencing 
rest pain often relieve symptoms by placing the legs in a dependent position such as over the 
bedside when occurring at night, or by standing to allow gravity to aid perfusion. 
Patients may also present with lower extremity ulcers, which may be arterial in origin. Arterial 
ulcers often seem to be ‘non-healing’ due to inherent poor circulation. Ischemic ulcers may 
start as minor (often traumatic) wounds, but that then fail to heal. Non-healing wounds may 
lead to pain on light pressure (such as with clothing) or infection if not kept adequately clean. 
Arterial ulcers are often punched out and deeper in size than more common venous ulcers 
which are superficial and large.47, 48 It is important to define the aetiology of the ulcer to 
inform management (see Section 2.3.8 Management). Distinguishing the aetiology may be 
elicited on history taking, but a thorough examination should always be used to document the 
ulcer further to track ulcer progression.39  
Nonetheless, up to half of all PAD patients are asymptomatic.45 These patients are identified 
only when a screening ABPI or other vascular investigations are performed to uncover a PAD 
diagnosis. Detection of PAD in asymptomatic individuals may be of value because PAD is a risk 
factor for atherosclerotic disease elsewhere in the body (see Section 2.3.9 Complications), and 
patients may benefit from early intervention.  In the PAD Awareness, Risk, and Treatment: 
New Resources for Survival (PARTNERS) programme, only 1865 (29%) of 6979 patients with 
risk factors for PAD had been diagnosed prior to study investigations. Based on this study, 
physician awareness of PAD in their patient populations is claimed to be very low.45    
The 2005 ACC/AHA guidelines suggest that the distribution of PAD presentations in patients 
over 50 years is as follows: 16, 21, 49 
 10-35% exhibit classic claudication symptoms  
 40-50% experience atypical leg pain 
 20-50% are asymptomatic 
 1-2% present with a threatened limb- such as with rest pain, gangrene (i.e. Rutherford 
categories IIa and IIb for acute PAD)  
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Based on the global estimate of 202 million people living with PAD by Fowkes et al, this would 
mean up to 100 million people have atypical leg symptoms.21  
Although a thorough history should document all of these important features, many guideline 
documents state that an ABPI assessment should be made to confirm or deny clinical 
suspicion of PAD elicited in the history.  
 
2.3.5.2 Clinical Examination  
The assessment of patients with vascular history should include a full vascular examination. A 
systematic approach should be used.  
The examination should include recording of resting brachial blood pressures and assessing all 
relevant pulses, including femoral, popliteal, dorsalis pedis and posterior tibial pulses. Any 
dampening, delay or diminishing of a pulse could be a sign of disease and should be 
documented. Similarly, inter-arm pressures or pulse asymmetry should also be documented.  
Palpation and auscultation of carotid and abdominal aortic pulsations may be included to 
investigate further vascular disease. Auscultation may reveal bruits indicating disease.  
Foot inspection for wounds, colour, temperature, distal hair loss and skin integrity should be 
assessed for perfusion status.16  
The Buerger’s test is a commonly used assessment of arterial insufficiency. With the patient 
supine, clinicians lift the examining leg straight into the air superiorly. The angle between the 
patient and the leg when it becomes pale due to poor circulation is called the Buerger’s angle 
(or vascular angle).  
Patients who show signs of abnormally cool peripheries, presence of bruits or pulse 
abnormalities have an increased risk of PAD. In asymptomatic patients, the presence of 
femoral bruit or any pulse abnormality are highly suggestive of PAD, with likelihood ratios 
being above three, described by Khan.50  
An evaluation of pain, pallor, pulselessness, paraesthesia and paralysis is often discussed in 
textbooks and is used to indicate PAD severity.36 It is possible to find pulses in some cases of 
peripheral limb ischaemia owing to a microvascular thrombosis as a cause of PVD, but this is 
rare.51  
Although clinical history and examination are necessary in every consultation with patients to 
give clinicians an impression of PAD, clinical examination findings alone are of only limited 
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value for diagnostic accuracy. Skin colour and temperature are influenced by individual 
characteristics (of both clinicians and patients) as well as the ambient environmental 
temperature. Pulse calculations may be incorrect due to inconsistency of technique and where 
clinicians feel a pulse from their own fingertips. Pulse examination alone misses up to half of 
all PAD cases.9 Therefore, there is a need for a more reliable assessment such as the ABPI 
investigation (see Section 2.4 Ankle Brachial Pressure Index (ABPI)). This can be used in 
conjunction with examination.    
The National Institute for Health and Care Excellence (NICE) has developed a succinct and 
practical resource for clinicians to follow in the assessment and diagnosis of lower limb PAD.17 
The pathway advises examination in individuals who have symptoms suggestive of PAD, who 
have diabetes, non-healing wounds, unexplained leg pain, or who are being considered for 
interventions to the leg or foot, including compression hosiery. Although a short guide, the 
pathway provides primary care clinicians with a brief explanation of the necessary aspects of 
vascular assessment. It also recommends use of the ABPI following examination.   
 
2.3.6 Risk Factors 
As PAD is generally attributed to atherosclerosis, risk factors for the condition are 
appropriately similar to that of other cardiovascular diseases. Internationally recognised risk 
factors for PAD include all of: 21, 52  
 Older age (>50 years) 
 Diabetes mellitus 
 Hyperlipidaemia  
 Hypertension 
 Cigarette smoking (previous and present) 
 Previous or co-existing atherosclerotic disease  
PAD patients have a high rate of co-existing atherothrombotic or cardiovascular disease. The 
getABI study showed an odds ratio of 1.8 for having any cerebrovascular event ever in PAD 
patients compared with non-PAD patients.53 Similarly the odds ratio for having any 
cardiovascular event ever in PAD patients was 1.5.53 
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The 2005 AHA/ACA guidelines state that individuals at risk of lower extremity PAD, and whom 
the ABPI is recommended for, are patients: 16  
 Aged 50 years or below with diabetes and one other atherosclerosis risk factor 
(smoking, dyslipidaemia, hypertension) 
 Aged 50-69 years and a history of smoking or diabetes 
 Aged 70 years or older 
 Having leg symptoms suggestive of claudication 
 Having an abnormal lower extremity pulse examination, or  
 Having known atherosclerotic coronary, carotid or renal artery disease 
The 2011 ACCF/ACHA Guidelines recommend modifying the age for ABPI consideration to ≥65 
years (rather than ≥70 years) in light of the getABI trial.49 This trial determined that 21% of the 
patients aged >65 years have diagnosed PAD (see Section 2.3.2 Epidemiology and Public 
Health Relevance).     
 
2.3.7 Differential Diagnoses  
When attempting to diagnose lower extremity pain, and in many cases of atypical 
claudication, clinicians must think widely about possible causes. Although common, 
atherosclerotic PAD may not be the correct diagnosis despite a perceived ‘clear’ history of 
claudicating limb pain.  
Pain caused by spinal stenosis, arthritis, fibromyalgia, neuropathy, statin-induced myalgia and 
non-specific muscular pain should all be considered.9  
Often clinical clues may lead into deciphering aetiology. Typical claudication often affects 
older individuals, is predictable, is unlikely to vary between days, and affects muscle groups 
rather than joints. In younger patients who present with claudication with associated sores 
and Raynaud’s phenomenon, a low ABPI value may suggest thromboangiitis obliterans 
(Buerger’s disease) rather than lower extremity atherosclerotic PAD.  
Difficulty may ensue when patients present with ‘pseudo-claudication’, that may be difficult to 
distinguish from true claudication. For example, pseudo-claudication is a cardinal feature of 
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pain in spinal stenosis. However subtle features, such as the discomfort relieved by sitting 
rather than by standing (as in PAD) may help to distinguish true claudication.54  
Furthermore, concurrent PAD with co-morbidity (such as diabetes or other chronic illnesses) 
could obscure a classic clinical picture. A full history and examination alongside a broad 
differential diagnosis are pivotal in determining whether features are most suspicious for PAD 
or for other conditions to determine best management.  ABPIs may also aid this process.  
 
2.3.8 Management  
Managing patients with PAD combines skills in using recommended diagnostic and therapeutic 
interventions based on evidence-based guidelines as well as reasoned clinical judgment. It 
often depends on when the PAD is detected (early versus late), on symptomology in respect to 
co-morbidity, and on patient preference. The ultimate goal in management of PAD is to 
improve both functionality and quality of living.16  
Several guideline standards have been published regarding management pathways. The most 
widely cited and used include: 
1. American College of Cardiology and American Heart Association (ACC/AHA) 2005 
Guidelines 16 with an ACC/AHA 2011 update 18  
2. Trans-Atlantic Inter-Society Consensus for the Management of PAD II (TASC II) 
Guidelines 2007 9  
Mohler compared the ACC/AHA and TASC II guidelines above and concluded that there was 
consensus in most areas, although there were differences regarding weighting of evidence to 
supplement recommendations.55 
In addition, several other guidelines have discussed management of PAD:  
3. The very recent 2015 (American) Society for Vascular Surgery practice guidelines for 
atherosclerotic occlusive disease of the lower extremities 56 
4. New Zealand Best Practice Advocacy Centre (BPAC) Guideline Article on ABPI use 52 




All the above recommend the use of the ABPI in assessment of PAD, and that the 
interpretation of the ABPI value can determine the next best step in management.  
Algorithms pertaining to ABPI values have been created to guide management. An ABPI value 
of <0.9 is considered diagnostic of PAD. Patients with severe PAD (<0.5) should generally be 
referred to secondary care where surgery may be considered to eliminate the blockage. An 
ABPI value of 0.9-1.2 is considered normal, and no further PAD management is deemed 
necessary. An ABPI of >1.2 may require further vascular tests such as Doppler waveforms or 
toe pressures to better evaluate these patients (see Section 2.4.5.4 Interpretation).  
Despite these algorithms, individual tailoring is advised by several guidelines. Individualised 
treatment should be guided by patient comorbidities, severity of disease, functional 
impairment, anatomic variances and predictions on the success of any chosen management. 
To be considered an effective treatment, “a minimum threshold of over 50% likelihood of 
sustained efficacy for at least 2 years” is one suggested benchmark.56 For instance, there 
should be at least a 50% chance that a surgery being considered will decrease symptoms or 
reverse disease progression for at least the following 2 years without major complications.  
The management of PAD should address the claudication symptoms and prevent disease 
progression. Medical interventions such as using the phosphodiesterase inhibitor cilostazol or 
xanthine derivative pentoxifylline have proven to be effective in improving ABPI.16, 57, 58 In 
other cases, surgical means such as angiographic techniques (with potential intervention such 
as angioplasty, atherectomy, stenting), other endovascular treatments or surgical 
revascularisation (such as bypass grafting) can effectively treat PAD.54  
All the guidelines emphasise the importance of cardiovascular risk factor modification and 
medical intervention to improve general cardiovascular outcome measures. ABPI values of 
<0.9 are associated with a three to six times increased risk of cardiovascular mortality.9 
Conservative measures to modify risk factors include appropriate exercise therapy 
prescription, diet and nutritional guidance, smoking cessation, motivational interviewing, 
improved glycaemic control and general health education. Medical intervention measures 
include antidiabetic, antiplatelet, and antihypertensive treatment, and statins where 
appropriate. Cardiovascular risk management therapies and regimes are well-established in 
the literature as effective in reducing the risk of ischaemic and thrombotic events occurring.16 
It is also important to note the management of ulcers and wounds.  
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It is recommended that patients with ulcers and wounds should have an ABPI assessment to 
distinguish between arterial and venous or mixed pathology (see Section 2.4.3.3 
Determination of Ulcer Management). Further, the ABPI value can indicate the best type of 
management for patients.  
The most recent Accident Compensation Corporation review document endorsed by the New 
Zealand Venous Leg Ulcer Advisory Panel stated that the recommended treatment for venous 
ulcers is high compression bandaging.59 High compression elastic or inelastic multi-layer 
systems are more effective than low compression or single layer compression bandaging.39 
Bandaging should be adequately graded, and should have protective padding at the tibial crest 
and malleoli. The document concludes that compression hastens the healing process for 
venous ulcers.  
For ulcers with arterial pathology (based on ABPI results), referral to a vascular specialist is 
advised. Compression therapy is contraindicated in mixed or arterial ulcers where ABPI 
<0.7/0.8 because compression could occlude and compromise blood flow to the muscles and 
capillary beds.52, 60 Therefore it has been argued that these patients (where ABPI values are 
<0.7/0.8) should be considered for percutaneous revascularisation for timelier wound 
closure.60  
Pain management may be required. Regular analgesia (such as paracetamol), management of 
oedema, elevation of wound, and using non-adherent wound dressings are advised.  
Education on the condition (venous or arterial) is pivotal in encouraging patient compliance. 
Further, conservative advice such as walking (activating calf pumps, and increasing venous 
return) can reduce symptoms and complications.  
Ideally, multidisciplinary teams involving primary care providers, medical and/or surgical 
specialists, podiatrists, diabetes specialists and other health care providers should be 
appointed in accordance with a patient-centred approach.  
 
2.3.9 Complications  
PAD can lead to loss of limb and loss of life, and progresses if not diagnosed and treated early. 
Complications include worsening claudication, functional impairment, critical limb ischaemia 
and non-fatal and fatal cardiovascular events. Figure 2 displays a schema for 5-year outcomes 




Figure 2:  Natural History of Atherosclerotic Lower Extremity PAD Syndromes. Source: Hirsch 
et al, 2005.16  
 
 
2.3.9.1 Critical Limb Ischaemia 
Around 1-2% of patients with PAD diagnoses may progress to develop critical limb 
ischaemia.16 This is characterised by severe resting ischaemic leg pain, non-healing wounds or 
gangrene which could necessitate limb amputation. It is predicted that 50% of patients with 
critical ischaemia will require revascularisation, 25% require aggressive medical intervention 
and 25% primary amputation.9 Further, patients with critical limb ischaemia have an annual 
mortality rate of 25%.9  
 
2.3.9.2 Cardiovascular Disease and Mortality  
Another key complication of PAD is the associated increased risk of ischaemic events. PAD 
patients are six times as likely to experience all-cause mortality within 10 years as non-PAD 
patients, whether symptomatic or not.54, 61 Specifically, the largest cause of mortality for PAD 
patients is coronary artery disease (40-60%) followed by cerebrovascular disease (10-20%).54 
This means that PAD confers equal risk for a major vascular event as a past myocardial 
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infarction.62 Equally importantly, the severity of the PAD is correlated with poorer survival 
rates.63  
A 5-year prospective cohort study of 6880 participants in primary care demonstrated that 
patients with PAD were 1.7 times more likely than others to experience ischemic stroke. 
Further, it showed that people with PAD were 1.4 times more likely to experience nonfatal 
stroke and 2.5 times more likely to experience fatal stroke.64 Lower ABPI values were 
associated with increased risk for stroke. Another recent study identified a 2.8 times greater 
risk of cardiovascular mortality with a decline in ABPI value of 0.15 within a 10 year period.65  
As a result, PAD should not be taken lightly, even if asymptomatic. 
 
2.3.9.3 PAD & Diabetes 
PAD and its complications can present additional challenges in patients with diabetes. PAD 
patients with concomitant diabetes: 66, 67  
 Have higher risk of cardiovascular mortality and morbidity    
 Tend to be younger 
 Tend to have PAD progress more rapidly 
 Tend to have poorer outcomes following surgery  
In addition, PAD patients with diabetes tend to be asymptomatic for a longer duration than 
PAD patients without diabetes.66, 67 This may mean that PAD is detected at a later or more 
advanced stage. Consequently these patients may also be subject to a larger number of and 
riskier procedures than otherwise they should have had.  
Early detection of PAD and risk factor management is pivotal to preventing complications for 
diabetic PAD patients.  
 
2.4 Ankle Brachial Pressure Index (ABPI)  
2.4.1 Introduction and Definition  
The Ankle Brachial Pressure Index (ABPI, or ABI) is an objective measure of arterial blood flow 
and pressures in the lower extremities.  It is considered the simplest, most effective tool to 
detect and diagnose PAD in a large population.45, 68 The ABPI is crudely the ratio of the systolic 
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blood pressure in the ankle versus the brachial (arm) arteries. Pressures are obtained using 
standard blood pressure cuffs, a handheld Doppler ultrasound and probe.  
In normal healthy patients, this ratio should usually be 1, meaning the blood pressure is equal 
in both the upper and lower extremities. If the ABPI is <1, there is suggestion of lower 
extremity PAD, caused most likely by atherosclerosis and a narrowing of arterial lumen. An 
ABPI value of <0.9 is diagnostic of PAD.17, 19 
 
2.4.2 History of the ABPI 
Doctors were investigating lower limb arterial pressures as early as 1930.69 However, theory 
behind the use of the ABPI was first documented by Californian doctor, Travis Winsor, in the 
1950s.12 He described difference in pressure gradients in the extremities between normal and 
diseased legs and found a gradient of as much as 50-60mmHg distal to the site of an 
obstructed artery. Since Winsor’s description, ABPIs can now also be measured using a 
Doppler ultrasound (gold standard) and peripheral angiography techniques.16  
The concept of the ABPI was popularized by Yao et al in 1969 who showed a marked 
difference in the pressure index between normal patients versus patients with proven 
occlusion, stenosis and atheroma (see Figure 3).70 The ABPI is now used internationally.5  
 
Figure 3:  The Ankle Systolic Pressure Index in Four Groups of Patients in 1969. Source: Yao et 





2.4.3 Uses and Indications 
The ABPI is a widely used assessment for several related but distinct purposes. The uses of the 
ABPI include aiding in diagnosis or exclusion of PAD, ongoing assessment in measuring PAD 
severity for management purposes, to guide management of ulcers to reduce the risks of 
compression in arterially compromised patients, informing cardiovascular risk status and also 
it can be used to screen for asymptomatic individuals.  
 
2.4.3.1 Diagnosis or Exclusion of PAD 
One of the primary uses of the ABPI is to diagnose or exclude PAD in patients who present 
with symptoms indicative of vascular pain (see Section 2.3.5 Clinical aspects). ABPI 
assessments follow standard vascular physical examinations in the evaluation of patients, and 
can confirm suspicions of PAD or atherosclerotic claudication found in the history.  
The ABPI can also quantify severity of PAD. Lower values or ratios correspond to more severe 
disease (see Section 2.4.5.4 Interpretation). Measure of severity can convey level of urgency 
for revascularisation in secondary care.  
The TASC II guidelines strongly recommend ABPIs are conducted in patients experiencing 
difficulty walking, patients aged 50-69 years (inclusive) with known cardiovascular disease risk 
factors, patients aged ˃70 years regardless of risk factors, and patients with an existing 
Framingham risk score of 10-20%.9  Similar recommendations were given by the updated 
ACC/AHA guidelines.18 Therefore the ABPI can be used to diagnose PAD in not only 
symptomatic patients, but should be used with a high index of suspicion where any risk factors 
are present.  
 
2.4.3.2 Ongoing Assessment of PAD  
The ABPI is a reliable tool for ongoing assessment of PAD severity or reoccurrence  
If used in the community, the ABPI can quantify changing disease severity in patients with 
established but not significantly impairing PAD. This could reinforce ongoing conservative 
management if ABPI values remain constant over time, or alert clinicians to changes and the 
need for further investigation or referral.45 For example, a patient who has an ABPI value of 
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0.85 (mild PAD) may only require GP follow-up in the community. Where GPs believe there is 
no current need for a referral to vascular surgeons, GP monitoring may be appropriate.  
In addition, the ABPI could monitor the short and long term efficacy of medical and surgical 
management in the in-patient or hospital setting.45 This would help secondary care clinicians 
to monitor the status and success of treatment, such as before and after revascularisation 
surgery, and inform whether and when discharge is possible.  
  
2.4.3.3 Determination of Ulcer Management  
Common vascular issues seen in both primary and secondary care settings are leg ulcers. The 
NZ Wound Care Society (NZWCS) recommends using the ABPI to evaluate whether an ulcer 
may be arterial or mixed in pathology (see Section 2.3.3.2 Venous Vessel Anatomy and 
Pathophysiology).39 Diagnoses of aetiology help to inform ulcer management.  
In addition, the ABPI can be used to determine appropriateness of compression therapy in 
treating venous ulcers and wounds, by excluding any arterial insufficiency.71 If compression is 
used in the presence of arterial disease inappropriately, this could result in worsening of 
ulceration, progression to gangrene and potentially limb amputation. 
The ABPI value can also indicate what type of compression hosiery is safe to use. BPAC 
guidelines state that in patients with an ABPI >0.8, compression therapy is safe, while in 
patients with ABPI <0.8, high compression hosiery is not recommended, and if ABPIs are <0.5, 
compression hosiery should not be used.52  
The ABPI is a practical assessment to help inform clinicians in general practice (such as GPs 
and nursing staff) on whether to implement compression therapy and types of compression to 
use.  
 
2.4.3.4 Determination of Cardiovascular Morbidity and Mortality risk 
A low ABPI value (<0.9) is an independent risk factor for cardiovascular morbidity and 
mortality.4 Patients with low ABPI values have a 5.5 times increased risk of mortality by any 
cardiovascular cause, and a 2.5 fold increased risk of any coronary artery disease or stroke 
(see Section 2.3.9 Complications).72  The ABPI can provide information on risk stratification, 
and prompt risk modification in at-risk patients.  
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One systematic review revealed the specificity of a low ABPI to detect future cardiovascular 
events as being high (88%), making it fairly accurate in predicting future morbidity.72  
A 2008 meta-analysis examining at the specific use of the ABPI in predicting cardiovascular 
mortality found a J-shaped relationship between ABPI value and cardiovascular risk. Risk 
increased greatly at every 0.1 ABPI increment below 0.9. Risk also increased above ABPI values 
of 1.4, creating the J-shape.73 The same study found that when compared to the well-known 
Framingham Risk Stratification tool, a low ABPI (<0.9) approximately doubled the risk of ten 
year total mortality, total cardiovascular mortality and of major coronary events for all 
Framingham risk categories. This would mean a significant reclassification of risk (with 
treatment implications) for 36% of females and 19% of males previously classified by the 
Framingham risk score.73  
The ABPI can be useful as another aid in detecting and communicating cardiovascular risk to 
patients, and initiating primary prevention measures to minimise the chance of future cardio-
ischaemic events. 
 
2.4.3.5 Screening for PAD in Asymptomatic Individuals 
Asymptomatic individuals with PAD have similar morbidity and mortality risk to patients who 
are symptomatic so it may be just as important to identify these individuals in order to 
prevent previously unforeseen consequences.8, 25, 74 Some studies suggest that ABPI screening 
in generally healthy individuals may confer advantage to lower overall prevalence rates via 
early intervention.75  
However, the literature has polarising views on whether screening for asymptomatic PAD is 
cost-effective and worthwhile at the population level.  
Marshall considered the ABPI against each of Wilson’s Criteria for Screening, criteria that 
should be met to consider a health screening campaign worthwhile. Marshall found that the 
ABPI tool only met six the ten criteria.66, 76 It was unclear or unknown if three of the remaining 
four criteria could be met. No evidence though could be identified demonstrating that the 
benefits outweigh the economic cost of screening.  
The USA Preventive Services Task Force agrees that the benefits do not outweigh economic 
cost of screening. The task force recommends against routine screening for PAD based on the 
rational that the ABPI would not provide additional practical information beyond the standard 
cardiovascular risk assessment.20  
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A recent Cochrane review found no randomised controlled trial evidence for PAD screening, 
and suggested that high quality research is required to inform whether this would be 
advantageous for populations.77  
Currently, screening is a theoretical use of the ABPI in the literature with much debate.  
 
2.4.3.6  Other Specialised Uses 
Additional research into the role of ABPIs has identified alternative and specialised situations 
where the ABPI could be helpful. Although many of these specialised uses are beyond the 
scope of this thesis, they show the wider usefulness and utility that the ABPI may have as a 
clinical tool.  
Recent studies have found that a low ABPI value (<0.9) is associated with worse cognitive 
performance in older patients.78, 79 Cognitive performance relates to a range of cognitive 
changes from mild cognitive impairment to dementia, and can be grouped collected together 
under the umbrella term ‘cognitive disorders’. A recent systematic review examined 12 
publications, of which all but one reported a significant association between low ABPI values 
and cognitive disturbances.79 Confounding variables including age, sex, childhood mental 
ability and history of cardiovascular or cerebrovascular disease were controlled for in this 
review. The significant association remained even when participants with a past history of 
stroke were excluded.80 Further, it was determined that patients with low ABPIs were also at 
increased risk for cognitive decline and Alzheimer’s dementias and not only poorer cognitive 
performance. Research suggests that the ABPI could have further relevance to neurological 
and geriatric fields.  
There is an association between a low ABPI and an increased risk of rapid decline in renal 
function, and accordingly an increased risk of renal failure.81 This association was present even 
when adjusted for age, sex, baseline estimated Glomerular Filtration Rate and standard risk 
factors for chronic kidney disease. This indicates that ABPI is a useful marker of generalised 
atherosclerotic processes that are commonly co-present in the kidney. PAD patients 
commonly have atherosclerotic changes in the renal vasculature.81  
 
2.4.4 Equipment  
ABPIs require relatively little equipment, making primary care adoption feasible. Some 




2.4.4.1 Standard Equipment 
A mercury sphygmomanometer attached to an appropriately sized blood pressure cuff is a 
standard piece of equipment in any practice, and is used to measure individual blood 
pressures of arteries in the limbs. An appropriately sized blood pressure cuff is one that has a 
bladder 20% larger than the diameter of the measured limb, or 40% of the limb 
circumference.68  
A Doppler ultrasound is required for easy auscultation of arterial flow, and for the calculation 
of the ABPI value. The Doppler ultrasound consists of a probe transducer, connected to a small 
ultrasound device which can be hand-held. There are many different varieties and brands, 
some having different capabilities, but all serving the same purpose of evaluating vascular 
flow. The machine operates by transmitting high-frequency sound waves that are reflected off 
of internal structures back to itself.82 It communicates information in the form of audible 
sound to the sonographer. When assessing arteries, it produces a ‘whooshing’ noise denoting 
blood flow at changing velocities. The movement of blood flow causes a change in reflected 
sound pitch; known as the Doppler Effect. Where there is no flow, the pitch will not change. 
Therefore, the Doppler ultrasound is essentially an electronic stethoscope, and listening to its 
messages helps users to easily determine patency of the vascular channels and possibility of 
disease.    
Doppler ultrasounds can be manipulated in several different ways to gain selected 
information. Some common types of Doppler ultrasound include:83  
 The continuous wave or bedside/pocket Doppler solely uses the sound function as 
explained above. It is an easy and relatively cheap tool with basic diagnostic abilities 
(see Section 2.4.4.2 Cost and Availability of the Doppler Device). This is usually the 
type required to calculate ABPIs discussed in guidelines and research.  
 The Duplex Doppler ultrasound uses computer methods to produce visual pictures of 
blood vessels and surrounding organs (much like the traditional obstetric ultrasound) 
for enhanced interpretation.  
 The Colour Doppler ultrasound is like a Duplex Doppler ultrasound, but has the added 
value of having overlaid colours on ultrasound images of vessels, representing 
different speeds and directions of flow.  
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Aside from manually operated (pocket) Doppler ultrasounds, automated devices are also 
available to calculate ABPIs, though are more commonly used in vascular laboratories (see 
Section 2.4.8 Alternative of Adjunctive Non-invasive Techniques to the ABPI). Pocket Dopplers 
may be more useful in primary care due to its lower capital cost and availability.84  
The correct probe transducer should also be used in relation to what information users want 
from their Doppler ultrasound. Probe transducers pick up different frequencies, and users 
should have an understanding of each probe’s capabilities. Common types include the 5MHz 
or 8MHz transducers. The 5MHz transducer is used for deep vascular studies or assessing 
larger oedematous limbs. This is due to having an optimum transduction range of 1-8cm. The 
8MHz probe is used for standard or ‘average sized’ limbs. This is because the 8MHz probe 
transducer has an optimum transduction range of 2mm-4cm. An 8MHz probe transducer is 
generally sufficient for ABPI assessment, except if patients have significant adiposity or 
oedema.  
Diagnostic ultrasound is a safe tool as it uses no ionising radiation and no adverse biological 
effects are reported with in the literature its use. The USA Food and Drug Administration 
(FDA) states that ultrasound imaging tools “have been used for over 20 years and have an 
excellent safety record”.82 However, ultrasound theoretically confers heat transfer which 
theoretically could confer damage to tissues if overused. The American Institute of Ultrasound 
Medicine recommends that a prudent amount of ultrasound use should be considered 
because of this.85 The risk of thermal effects is discussed more in depth in relation to its use in 
an obstetric setting with its potential impact on foetuses.86 However, there have been no 
thermal risks described regarding the ultrasound in any of the literature surrounding ABPIs.  
Ultrasound transmission gel or ultrasonic gel is required to promote the passage of sound 
waves from the ultrasound through to skin. The gel is typically viscous and water-soluble. It is 
applied to patients’ skin and sits between the area being assessed and the probe transducer 
as arterial pressures are being measured. It is safe to use.  
A standard sized examination table (“bed”) is used to lie patients supine.  This is part of a 
normal general practice so would not confer any added expenditure.  
No anaesthesia is required as the Doppler ultrasound is generally non-invasive and non-
painful. Despite this, pressure upon inflating the cuff has potential to cause mild discomfort 
which the patient should be warned about.  
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Cling film or light bandaging may be appropriate to cover any ulceration present, and to 
confer as much sterility as possible.  
 
2.4.4.2 Cost and Availability of the Doppler Device  
As the Doppler device is the only piece of equipment which is not part of standard general 
practices, an understanding of the cost and availability of these machines is needed if they are 
to be used in this setting. Haigh et al suggests that one of the reasons ABPIs are not 
performed more often in general practice is due to the reported lack of available equipment.87  
Hand-held portable Doppler devices (8-10MHz) can generally be purchased for under 
NZ$700.52  
There is a large range of Doppler types found easily among New Zealand medical supplier 
websites, with cheaper devices costing over $369 and more expensive devices costing up to 
$1,745.88-92 Differences in price owe to manufacturing location and how complicated each 
device is. More expensive types may come with printing options and liquid crystal display 
screens to show waveforms. This information is correct as of 30/01/2015 when the candidate 
made phone enquiries to NZ suppliers. 
Ultrasonic gel is relatively cheap, but will incur an ongoing cost to practices as it is used up. A 
250ml container costs around $10 from most NZ suppliers.88, 89, 91 However, this can be 
purchased in bulk (such as 5L containers) at cheaper rates.  
 
2.4.4.3 Calibration of Device 
Calibration is the act of adjusting the accuracy of the measurement device, often using 
another standardised piece of equipment to do so. It important to standardise diagnostic or 
therapeutic tools for accuracy, as well as for commercial quality assurance before devices are 
sold commercially.  
There are several older studies prior to 1991 which discuss possible Doppler ultrasound 
calibrating devices.93-95 One study of calibrated therapeutic ultrasound units showed that 
more than 33% of machines tested were outside the calibration standard for at least one 
variable setting.96 The study suggested that further improvements in calibration may be 
required in health workplaces. It would be inappropriate to extrapolate these data to 
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diagnostic ultrasound machines due to the differences in physical equipment and paucity of 
information.  
No literature could be identified regarding recommendations in or the need for calibrating the 
diagnostic Doppler ultrasound.  
Several NZ suppliers of Doppler ultrasound stated that calibration was not required for their 
machines when the candidate inquired by phone, including two companies Amtech and 
Hallmark Surgical. Again, this was correct as of 30/01/2015.  
 
2.4.5 Performing and Evaluating the ABPI  
2.4.5.1 Anatomy 
The ABPI tests three main arteries; the brachial artery in the arm, the Posterior Tibial (PT) 
artery and Dorsalis Pedis (DP) artery in the foot.  
In the upper limb, the brachial arteries arise from the axillary arteries around the lower 
margin of the teres major muscle.36, 83 The brachial artery continues in the upper arm down to 
the cubital fossa or elbow crease where it then divides into the radial and ulnar arteries of the 
forearm.  
In the lower limb, the popliteal artery behind the knee divides to become an anterior and 
posterior tibial artery in the lower leg (see Figure 4 Arteries of the Lower Limb). The PT artery 
runs down the posterolateral region, and around the medial malleolus to become the plantar 
arteries on the plantar aspect of the foot.36 The anterior tibial artery becomes the DP artery 
when it travels anterio-inferiorly and reaches the ankle.97 The DP then runs between the 
tendons of the extensor hallucis longus and the most medial tendon of the extensor digitorum 
longus (i.e. the tendons of the first and second toes). The DP and PT arteries branch into 
smaller arteries and join creating a collateral supply.  
Both PT and DP arteries are considered the most peripheral major arteries of the body. Where 
one artery develops significant atherosclerosis or becomes occluded, the collateral arteries 
from the other can help to supply the area that has occluded blood supply. It is pivotal to test 
both arteries when performing the ABPI because of the human body’s ability to produce 
collateral supply.  
Although these arteries are specifically targeted during ABPI assessment, the ABPI result may 
have wider implications on the rest of the cardiovascular system, and may indicate further 
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potential atheromatous pathology elsewhere (see Section 2.3.3.1 Arterial Vessel Anatomy and 
Pathophysiology). 
 
Figure 4:  Arteries of the Lower Limb. Source: Pozniak MA, Clinical Doppler Ultrasound Expert 
Consult: Online, 2013.83 
 
 
2.4.5.2 ABPI Measurement  
The standard method is described in Table 5 below:  
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1 Have all necessary equipment prepared in advance (see Section 
2.4.4 Equipment)  
Preparation to ensure a smooth procedure 
2 Explain the procedure to the patient 
Gain informed consent (considering language barriers and 
cognitive or learning difficulties)  
Information sharing  
Allows the patient to be confident and trust 
in the clinician  
3 Remove tight clothing form all limbs including stockings 
(considering cultural and sex differences)  
Allows for comfort and accuracy of the test 
4 Remove dressings and apply clear cling film over any ulceration 
(not of significant discomfort to the patient)  
Prevents trauma to the ulcer via pressure 
and contamination of the Doppler 
equipment 
5 Allow for a pre-test resting time of 10 minutes in a supine or 
seated position (see further in this Section below) 
Reduction in inaccuracies  
6 Wrap an appropriately-sized sphygmomanometer cuff around 
the limb of which the blood pressure is being measured (e.g. 
begin with the right arm/brachial artery) 
An inappropriately sized cuff will not be able 
to occlude the artery or will distort the 
pressure reading 
7 Locate the pulse by palpitation and apply a generous amount of 
ultrasound gel to the area located (enough to cover the entire 
skin surface the probe will be touching) (see further in this 
Section below)  
Finds the site at which the Doppler probe will 
be placed 
The ultrasound gel allows the Doppler to 
work effectively  
8 Place an appropriately sized Doppler probe angled at 45 degrees 
into the direction of the blood flow; the signal (sound of blood 
flow) should be heard  
Maintain and acquire the pulsation without 
occlusion 
9 Inflate the sphygmomanometer cuff until the signal disappears. 
Then deflate the sphygmomanometer cuff until the signal 
reappears- recording the value at this moment 
To obtain limb pressure 
10 Repeat the procedure with the other limbs (5 other arteries). 
There should be values or attempts at values for all of:  
-Right brachial artery 
-Right posterior tibial artery 
-Right dorsalis pedis artery 
-Left brachial artery 
-Left posterior tibial artery 
-Left dorsalis pedis artery  
To obtain all ABPI values required for 
calculation   
11 Calculate and Interpret the ABPI (see Section 2.4.5.3 Calculation 
and 2.4.5.4 Interpretation)  





Pre-test rest time 
Pre-test rest time involves resting the patient supine on the examination table (or 
alternatively, seated) in order to attain the patient’s physiologic or resting blood pressure as 
close to normal. This eliminates falsely elevated readings (such as in the case of stress or post-
exercise). The pre-test rest duration in the literature ranges from 5 to 30 minutes99 reflecting 
some inconsistency between guidelines. A systematic review of 1658 titles revealed that no 
study has directly evaluated the efficacy of differing pre-test rest durations on ABPI 
measurements.99 However, in studies examining the effect of pre-test rest time on ABPI, the 
hydrostatic effects of gravity on blood were reduced after approximately 10 minutes following 
supine or seated rest.99 No further reduction was gained following 10 minutes. Despite a lack 
of direct evidence, research suggests that 10 minutes is probably sufficient.  
Locating PT and DP Pressures  
To find the PT pressure, the area between the Achilles tendon and the medial malleolus is a 
reliable area for palpation.36  
To find the DP pressure, it is helpful to palpate within 1-1.5cm of the prominence of the 
navicular bone in the foot as a reliable bony landmark.97 The DP pulse is impalpable in 3.1-
13.8% of the healthy population but with Doppler ultrasound, only 1.9% if patients have an 
absent signal.97   
Pressures may be unobtainable or non-occludable in some instances. For example, anatomical 
variants such as an absent dorsalis pedis pulse would mean a DP pulse would be unobtainable. 
A calcified artery holding a vessel open despite external compression (as in diabetes mellitus) 
could mean that a DP pulse is non-occludable.  
Variation in measurement 
Klein & Hage reviewed 100 randomly selected publications commenting on technique and 
variations in ABPI method. The authors found that there were “no fewer than 39 different 
ways to calculate [ABPI]… reported in 77 of 100 studies” showing the diversity in using the 
ABPI.100 The other 23 of 100 studies did not report their technique and so findings are likely to 
be an underestimation of calculation variation. The method represented in Table 5 is the most 





To calculate the ABPI, the following formula is most commonly used, utilising appropriate 






ABPI (leg) = the Ankle Brachial Pressure Index for a specific right or left leg  
BP (leg) = the higher blood pressure obtained from the ankle vessels for that leg (either the DP 
or PT pressure)  
BP (arm) = the higher brachial blood pressure of the two arms (i.e. brachial artery pressure)  
 
2.4.5.4 Interpretation 
The 2005 and 2011 ACC/AHA Guidelines for ABPI Interpretation are summarised as follows: 
Table 6:  2005 and 2011 ACC/AHA guidelines for ABPI Interpretation 
 
 
The ABPI interpretation differed between 2005 and 2011 based on publication results by the 
Ankle Brachial Index Collaboration reviewed by the ACC/AHA Guideline Working Group.18, 73  
Using <0.5 as a marker of severe PAD 
Research has suggested that <0.5 is a sufficient marker of severe PAD from a clinical point of 
view.4 Patients who have ABPI values <0.5 are at higher risk of having lower extremity pain 
while resting.29, 54 Further, cardiovascular disease risk in ABPI values <0.5 is estimated to be 
ABI limits based on 
2005 ACC/AHA 
Guidelines 
Interpretation ABI limits based on 
2011 ACC/AHA 
Guideline update 
Greater than 1.30 Non-compressible  Greater than 1.40 
1.00-1.29 NORMAL 1.00-1.40  
0.91-0.99 Equivocal or 
borderline 
0.91-0.99 
0.41-0.9 Mild to moderate 
PAD 
0.41-0.9 
<0.4  Severe PAD <0.4  
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37%, compared to 27% in patients with ABPI 0.5-0.7.101 Therefore, previous research has 
commonly used 0.5 as a marker of severe disease as well as <0.4 which 2005 ACC/AHA 
guidelines have used.  
Normal Variance  
Similar to other biological measures (such as blood test results, tidal breathing volumes, 
height and weight), there is inter- and intra-variability in ABPI values in individuals. The ABPI 
may differ between days, as blood pressure does. Baker et al defines a significant change in 
ABPI value as being a difference of at least 0.15.102 This means that clinicians should be aware 
that changes of ≤0.15 may not be clinically significant in the absence of symptomatic change.  
Normal ABPI values are also subject to ethnic and sex variability. The Multi-Ethnic Study of 
Atherosclerosis found ABPI values were approximately 0.02 lower in blacks than in non-
Hispanic whites.103 Similarly, the study showed women having a lower ‘normal’ distributive 
curve than men (0.02 ABPI units lower). Although small, this study shows normal variation.  
 
2.4.6 Additional Merits of the ABPI   
Many of the merits of the ABPI have been highlighted in Section 2.4.3 Uses and Indications. 
However, there are other aspects of this assessment which make the ABPI highly useful in 
clinical practice, as discussed below:  
 
2.4.6.1 Well-Established and Used Globally  
There have been many internationally published research articles and evidence-based 
guidelines which have reinforced the benefits that the ABPI has to offer.7, 16, 17, 19, 29, 39, 77 The 
ABPI is widely used in many countries in secondary care and some primary care facilities and 
its use has been reviewed extensively by medical and research communities.29, 104-106 The tool 
objectively measures PAD severity and values correlate well to self-reported quality of life.107  
 
2.4.6.2 Relatively Low Financial Cost  
The ABPI is described repeatedly as a relatively inexpensive investigation in the literature, 
which can result in diagnosis and measurement of a modifiable disease.8, 16 Most of the 
required equipment is already available in a standard general practice office or hospital 
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setting. A Doppler ultrasound is the only incurred capital cost and inexpensive ultrasonic gel is 
the only continued expenditure (see Section 2.4.4 Equipment). 
 
2.4.6.3 Specificity and Sensitivity  
Overall the ABPI has high specificity and sensitivity.  
The specificity of a low ABPI to detect leg stenosis of ˃50% is 98% (Ranging from 83-99% in 
different studies).68, 70, 105 Higher specificity will result in a lower false-positive rate.  
ABPI sensitivity ranges broadly between 15-79% based on a meta-analysis completed by Xu et 
al.105 In contrast, many other papers have evaluated ABPIs and have stated higher sensitivities 
reaching 90-95%.15, 45, 63 A relatively lower sensitivity may be due to several things: (A) that 
mild PAD may not be detected as significant narrowing is required to reduce ankle blood 
pressure; (B) the ABPI does not pick up lesions along the internal iliac or profunda femoral 
arteries; and (C) if calcifications are present, an ABPI value may not be obtained. These 
inherent limitations are discussed in Section 2.4.7 Limitations of the ABPI.   
Despite varying sensitivities reported, it was concluded that pooled sensitivity, specificity and 
accuracy measures allowed the ABPI to fall within acceptable diagnostic ranges to detect PAD 
with significant stenosis.105 
 
2.4.6.4 Ease of Use  
Little training is involved with being able to perform the ABPI, and results are reliable when 
performed by different users. The ABPI has been shown to be reproducible between vascular 
surgeons, vascular physicians, general practitioners, and nurses with Doppler sonography 
training, with intra-observer variability differing only by 8% and inter-observer variability 
being 9% according to one study.108, 109 Therefore it could be said that the ABPI is as practical 
as the simple blood pressure measurement used universally in the medicine. Klein and Hage 
found that estimates of intraobserver variability ranged from 12% for less experienced 
assessors to 7.3% for experienced assessors.100 Undergraduate and postgraduate training in 




2.4.7 Limitations of the ABPI   
Despite being a valuable diagnostic investigation, the ABPI does have limitations, as do all 
investigations:  
 
2.4.7.1 Inherent limitations  
Although the ABPI is a simple, widely available and a relatively inexpensive assessment, it is 
unable to detail length, type, or extent of disease.  
Further, the ABPI is limited in sensitivity with regards to patients with certain pathologies such 
as diabetes mellitus and renal failure, as well as elderly patients.111 For instance, calcified 
arteries may result in non-occludable pressure. If pressures cannot be found or arteries are 
‘incompressible’ the ABPI cannot be accurately interpreted.16 Potier states that efficiency of 
the ABPI is limited in diabetics with “concomitant clinical peripheral neuropathy or high risk of 
arterial calcification”.112  
In contrast, a New Zealand study of podiatric ABPI assessments for Māori patients with 
diabetes had a mean ABPI value in the normal range despite claims that ABPIs are distorted 
(generally high) in diabetics.113 However, the sample may not be representative of all diabetic 
patients as many participants were reported to have good foot-care knowledge (over 95% 
knew about general diabetic foot care and when to contact a podiatrist).  
ABPIs can also miss arterial occlusions, depending on site affected. In patients with high grade 
aorto-iliac arterial occlusion, the Doppler ultrasound may not detect this due to the presence 
of a rich collateral arterial supply allowing for normal blood flows.63  
In cases where PAD is strongly suspected but not indicated by ABPI, referral for additional 
vascular review or further investigation is still warranted. Pulse volume recordings and toe 
brachial pressure indices are often used for patients with abnormally high or difficult to obtain 
ABPIs (see Section 2.4.7 Alternative or Adjunctive Non-invasive Techniques to the ABPI).  
 
2.4.7.2 Assessment Variation 
Finding patients’ true ABPI values can be difficult due to normal variation in patients as 
explained in Section 2.4.5.4 Interpretation. Just as expected for obtaining normal blood 
pressure, the patient-observer interaction, cuff sizing and placement, inflation and deflation 
rates and length of the pre-test rest period may all contribute to changing the clinically 
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measured ABPI value. Also, patients’ blood pressures vary physiologically, again complicating 
the measurement.108 Inflating the cuff continually or leaving the cuff inflated for a lengthier 
period of time can cause a hyperaemic response, and a reduction in distal blood pressure.98  
The variability of ABPI assessment attributable to the assessor and technique is considerably 
less than the variability attributable to biological factors.  
Standardisation is recommended to overcome avoidable variability, and awareness of normal 
biological variation will aid in interpreting values found.  
 
2.4.7.3 Contraindications  
There are several contraindications to performing the ABPI which inhibit its use. These include 
patients being unable to lie supine (e.g. heart failure), and the presence of cellulitis, Deep Vein 
Thrombosis (DVT) or painful ulcers. In these circumstances, performing the ABPI could 
exacerbate symptoms or cause unnecessary pain. Aside from the obvious discomfort and 
stress, symptom exacerbation could also disturb the blood pressure readings and the ability to 
interpret the test accurately. If contraindications are present, further investigation into 
managing the contraindication is first recommended, and an additional appointment for an 
ABPI should be scheduled when resolved (either at the practice or vascular laboratory).  
 
2.4.7.4 Lack of Knowledge  
Lack of knowledge of either the ABPI itself, or of how to perform it correctly are limitations of 
its use in settings outside of vascular surgery or clinics.114 Wyatt et al found that common 
errors internal medicine residents made when performing the ABPI in 2010 included: 115  
 Failure to use a Doppler to assess brachial pressures (residents used stethoscopes 
instead) 
 Failure to assess both pedal vessels (DP and PT)  
 Failure to assess both brachial systolic pressures 
 Failure to accurately record a Doppler signal from a brachial or pedal artery  
In the same study, only 35% of participants reported previous experience with using the ABPI. 
Once educational intervention and feedback were provided, post-intervention ABPI tests 
showed a significantly reduced number of errors compared with baseline results. Both paucity 
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in previous experience and the common errors identified at baseline display a gap in the 
knowledge of the ABPI. Post-educational interventional studies showed a reduction in 
common errors.115  
 
2.4.8 Alternative or Adjunctive Non-invasive Techniques to the ABPI 
The literature strongly supports the use of the resting ABPI as first line in assessing suspected 
PAD or arterial occlusion. However, there are numerous alternative or supporting techniques 
to using the standard ABPI, discussed below: 
Automated devices are often used by vascular technicians to obtain segmental pressures in 
the lower limb. They can provide more information in defining more precise anatomical data 
regarding arterial blockages or narrowing.116 Some studies state that ABPIs calculated via 
automated devices and the standard ABPI yield comparable results and can be interpreted 
similarly.84  
However, there has been suggestion of variability between standard ABPI and automated 
device readings in other studies. Jeelani et al found that the DINAMAP™ device produced 
significantly higher median ABPI values than the Doppler method, although this study had only 
14 patients.117  Aboyans also demonstrated that ABPIs by automatic devices did not compare 
reliably to Doppler ultrasound ABPIs.14 More research is needed to fully evaluate the precision 
of automated devices.  
The term ABPI has been used to denote single level or single limb ABPIs within this thesis so 
far. Multilevel or segmental ABPIs are used to describe the simultaneous ABPI measurement 
of all limbs at different sites (calf, above knees, thighs, arms), where multiple cuffs are used at 
the same time. This is done using an automated device. Segmental ABPIs may be able to 
determine the location of occlusion by comparing values with one another. This is often 
completed at a vascular laboratory where site determination is important for secondary care 
intervention.  
Stress ABPIs or post-exercise ABPIs are assessments carried out following a short period of 
exertion such as on treadmill. It is indicated when resting ABPI is found to be normal but a 
high degree of clinical suspicion exists.16 The stress test is thought to induce a reduced ABPI 
value (via reduced ankle pressure to stress demands) indicating PAD. Diehm et al found that 
post-exercise ABPI did not have any significant influence on ascertaining the prognosis of 
mortality or selected cardiovascular events beyond the resting ABPI.118  
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Migliacci et al compared the traditional ABPI via Doppler ultrasound with ABPI via palpation 
only.119 There was sufficient sensitivity of the palpation method (88%) to exclude PAD but it 
had a poor positive predictive value (18%).119  Similarly, Aboyans et al found that ABPI via the 
palpatory method underestimated the true ABPI when done by Doppler.14 Therefore, it would 
be possible to consider the palpatory method only as a method to exclude PAD but it is not 
specific or reliable enough to detect true positive results. Therefore it performs poorly as a 
conclusive diagnostic test.    
Carmo et al studied the accuracy of obtaining the ABPI via a stethoscope (Korotkoff method), 
compared to using the gold standard Doppler probe. Using a stethoscope yielded a sensitivity 
of only 71.4% and a specificity of 91%, showing that it may be a suitable screening tool to 
measure the ABPI in the absence of a Doppler ultrasound.120 However, this method is still 
suboptimal compared to the standard ABPI (see Section 2.4.6.3 Specificity and Sensitivity).  
Specific questionnaires have been developed to subjectively assess PAD and impairment.121, 122 
However, questionnaires may be inadequate to identify PAD in many patients, including 
patients with atypical features and asymptomatic patients.54 For instance, the Edinburgh 
Claudication Questionnaire has a sensitivity of 56.2% in finding PAD, which is low with a 
positive predictive value of 59.4%.122 In comparison, the ABPI has higher sensitivities (see 
Section 2.4.6 Additional Merits of the ABPI). Questionnaires may be useful as an aid to 
assessment, but should not replace the ABPI.  
Pulse Volume Recordings (PVR) can be used in conjunction with the ABPI to show waveforms, 
useful in identifying PAD where arteries are incompressible.123 PVRs visually display volume 
changes in an artery. Multiple pressure cuffs are applied to different parts of the leg, and 
inflated to a nominal pressure to obtain all PVRs at once. Volume changes will translate to 
changes in pressure in the cuff bladder, being detected and graphed via a transducer.123  
The Toe Brachial Pressure Index (TBPI) is the toe equivalent to the ABPI, and requires a smaller 
toe cuff replacing the ankle cuff. This assessment is performed when there are abnormally 
high amounts of plaque and calcification, resulting in a high or non-compressible ABPI value. It 
is recommended for assessment in patients with diabetes.112 The TBPI is generally more 
accurate than the ABPI in identifying perfusion in the feet and extremities in these patients as 
it finds end arterial pressures.124 This has been recommended for use by the 2005 ACC/AHA 
guidelines.49 The cut-off points for normal and abnormal TBPIs are different to the ABPI with 
>0.7 indicating no arterial disease and <0.64 indicating arterial disease.125  
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Measuring the difference between brachial blood pressures is another proposed way of 
assessing risk of cardiovascular disease in people without using the ABPI. A difference of less 
than 10mmHg is said to be normal, while a difference of over 20mmHg is said to be abnormal, 
indicative of underlying vascular pathology.126 NICE guidelines recommend this as an easy way 
for general practitioners to evaluate risk, and this measure could be used in conjunction with 
the ABPI.17 
The duplex ultrasound is another ultrasonic imaging tool commonly used in secondary care to 
identify the site of atherosclerotic lesions (see Section 2.4.4 Equipment). This device is costlier 
than the simple Doppler ultrasound, and requires more specialised training for use.  
Other, more invasive secondary care techniques are beyond the scope of this thesis.  
 
2.5 Primary Care & Use of ABPI 
There is limited previous research examining any use of ABPIs in NZ primary care. The 
literature surrounding potential or existing use of the ABPI in general practice or primary care 
internationally is presented in this section.  
 
2.5.1 Benefits of ABPI Use in Primary Care 
Several papers have concluded that the Doppler ultrasound ABPI method is a reliable tool in 
general practice and primary care.53, 63, 105 Aside from its inherent uses, ABPI is suitable for use 
in primary care as it allows confident appropriate referrals to secondary care services, 
provides a patient-centred service for people with vascular issues and is a relatively simple 
tool for use in the community.  
 
2.5.1.1 Aids with Appropriate Referrals to Secondary Care  
A 2014 study examining the impact that service provision has on referral rates showed a 
positive association between Doppler ultrasound use in general practice and referrals to 
specialist services.127 Approximately 22% of the patients evaluated by the Doppler were 
referred to hospital internal medicine, dermatology, neurology, surgery or orthopaedics 
services. Use of the Doppler may have revealed morbidity which was not treatable by GPs, 
allowing for necessary referral.  
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Further, there is evidence to suggest that ABPI use in general practices could reduce 
inappropriate referrals to secondary care settings.128 Poots et al states that in 41% of 
diagnosed intermittent claudication cases, diagnosis by history alone led to inappropriate 
referrals to vascular surgery departments. Poots’ study concluded that ABPI could result in a 
more efficient use of clinical resources. This would mean that waiting lists could be reduced, 
and secondary care clinicians’ time would be used to see ‘appropriate’ cases only (for patients 
with objectively measured PAD or questionable ABPI values).  
 
2.5.1.2 Patient-Centred Service  
ABPIs in primary care contribute to more patient-centred services. Discussion of ABPI results 
along with PAD between clinicians and patients increases awareness of the disease and its 
implications, which may encourage healthier behaviours.55 Adherence and cardiovascular risk 
factor management is pivotal in reversing, preventing and treating PAD (see Section 2.3.8 
Management).  
The Society of Vascular Surgery practice guidelines for PAD state that the “management of 
PAD is multidisciplinary, involving primary care physicians and vascular specialists with varying 
expertise in diagnostic and treatment modalities”.56 This conveys the importance of primary 
care physicians working in collaboration with secondary care physicians to manage this 
common chronic disease.  
 
2.5.1.3 Ease of Use in General Practice 
Much research has stated that the ABPI is a simple test which can be introduced to new users 
relatively easily. When discussed in the context of primary care, ease of use is contentious in 
the literature. Nexoe et al concluded that ABPIs are not simple procedures but are easily 
introduced into general practice.129 More education may help to reduce variability and 
increase precision of technique. Another study measured and found that there was great 
variability between individuals’ ABPI measurements carried out in primary care and the 
vascular laboratory. Despite this, the study concluded that there was overall comparability 
and relevance for the ABPI to be done at a population level.130 While there may be some 
question of accuracy when completed in a general practice setting, the ABPI is said to be very 
achievable in attaining its goal of diagnostics in the primary care setting (comparatively to 




2.5.2 Barriers and Limitations for ABPI Use in Primary Care  
Several barriers to the use of the ABPI in primary care were identified in the literature. These 
included the ABPI taking too much time in general practice, primary care practitioners being 
unaware of the value of the ABPI, potential inaccuracies in measurement, and lacking staff 
availability to be able to carry out the ABPI.  
 
2.5.2.1 Time as a Barrier 
Time is a recurring limitation of ABPI use in primary care in publications.131, 132 The average 
time to complete an ABPI is 5 minutes, ranging from 3-11 minutes.63, 133 This may be seen as a 
trivial amount of time in secondary care or to the patient, but can be viewed differently by 
primary care clinicians. When coupled with the time it takes to explain the test, set up the test 
equipment, and obtain and explain the test results, the full ABPI assessment could take up 
over 20 minutes.133 In general practice the time allocated to each patient is usually 10-20 
minutes (or 30 if a double booking is made) - meaning consultations of extended length are 
difficult to accommodate. The time an ABPI test takes is balanced against the need to see 
other patients, and if GPs do not think ABPI results will add anything to their management 
they may decide that it is of less value than seeing another patient. Further, if GPs are not 
compensated financially for that time, then conducting the test is not cost-effective for them.   
Chen et al found that time restrictions were an underlying reason for infrequent ABPI use in a 
cross sectional study of Western Australian Podiatrists.132 This supports the concept of time 
poverty being a barrier to ABPI use in a heterogeneous group of professionals, not only GPs.  
If clinicians were given clear and consistent guidelines on how to perform the entire vascular 
assessment and ABPI, this could reduce the total time it would take to perform the test. Bjork 
et al published guidance titled “Bedside ankle-brachial index testing: Time Saving Tips” in 
Wound Care Advisor, designed to help practitioners mitigate the barrier of time.134 Tips 
include using initial Doppler sounds to avoid unnecessary ABPIs and advice on how to 
integrate ABPIs into initial assessments to be more efficient in the clinic.  
2.5.2.2 Lack of Knowledge Regarding Benefits or Recommendations 
A French survey of 165 general practitioners showed that only 42% knew that the ABPI was 
recommended by health authorities.131 Further, 1 in 5 respondents considered ABPI to be 
irrelevant, possibly because they did not know of guidelines. The main barrier to ABPI use was 
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lack of knowledge of the benefits of the ABPI, and the recommendations of health authorities 
to use it. Wyatt et al found similarly that only 35% of a group of internal medicine residents 
reported previous practical experience with ABPIs (see Section 2.4.7.4 Lack of Knowledge).  
 
2.5.2.3 Inaccuracies in ABPI Measurement  
Nicolai et al found that ABPIs are often not correctly carried out in general practice due to 
inaccurate methods of measurement and calculation.130 Another study found that a high 
number of false-positive tests occurred when the ABPI was used by nurses and GPs following a 
course.129 Unlike in the community, tighter quality control can generally be applied in regional 
vascular laboratories allowing more consistency in technique and interpretation.129  Despite 
the inter-user variability, some studies conclude that there is overall comparability and 
relevance for the ABPI to be performed in primary care (see Section 2.5.1 Benefits of ABPI Use 
in Primary Care). 
 
2.5.2.4 Staff Availability and Reimbursement  
Having the personnel available to undertake the investigation is a concern for some general 
practices.  
Less than a third of health professional respondents to the large ultrasound PAD Awareness, 
Risk, and Treatment: New Resources for Survival (PARTNERS) ABPI utilisation study in the USA 
stated that a family physician was the sole staff member who performed the test. Around 38% 
of respondents indicated that a nurse or nurse practitioner was responsible for performing it 
in addition to the doctor.106 As the results of the ABPI are not usually indicative of imminent 
death, the test may be placed lower on priority lists. General practitioners commonly have 
access to a vascular laboratory in urban centres so referring to the laboratory could save the 
practice time, financial and staff resources needed in doing the ABPI themselves.    
 
2.6 Chapter 2 Summary 
The literature review indicates that the ABPI is generally described as a simple, relatively 
quick, inexpensive and non-invasive assessment useful in detecting PAD in patients presenting 
with varying symptomology. There is a well-established literature supporting its use and it has 
been the focus of many guidelines groups around the world. ABPIs are critical for initial and 
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ongoing assessment of patients with vascular disease, and determination of the best next step 
in management. ABPIs have a logical scientific base and have been shown to be reliable and 
effective as a diagnostic and measurement tool by many authorities and research agencies. 
Yet ABPIs are still underutilised in general practice.7  
PAD has also been described extensively in the literature, with focus on its clinical 
consequences such as critical limb ischaemia, cardiovascular events and increased risk of 
mortality and morbidity from these. Due to the global increase in ageing and chronic disease 
such as diabetes, PAD is predicted to increase in prevalence and will be a condition needing to 
be addressed in more and more people.54 Fortunately, PAD can be prevented or delayed by 
cardiovascular risk factor management and lifestyle modification. The ABPI can detect and 
quantify levels of atherosclerosis in patients easily in the community.   
There is some literature regarding use of the ABPI in general practice. Some studies have 
discussed its value, while others have identified practical barriers to use, and variability among 
results and methods. Completing the ABPI assessment in general practice helps to identify 
PAD as a definite diagnosis in patients, and allows for appropriate referrals to be made to 
secondary care where needed. It aids clinicians in guiding management of patients who 
present with ulcerations and prevents the compression of ulcers with mixed aetiology. 
Practical barriers such as time and staff availability tend to prevent its utility in general 
practice. With these barriers addressed, it would be useful to implement ABPI use in general 
practice.54 Nevertheless, no literature pertaining to ABPI use in New Zealand general practice 




Chapter 3: The Use of the ABPI in a General 
Practice Over Ten Years- The Quantitative Arm 
of the Study 
3.1 Introduction  
Dr Hywel Lloyd is a GP of 23 years’ experience, and has been performing ABPIs on patients for 
nearly 10 years (2006 – 2015) at the Mosgiel Health Centre (MHC).  
Dr Lloyd first became aware of ABPI tests when he was a GP in Wales, but became more 
interested when he came to New Zealand in 2003. This was because he noticed that there 
were very few ABPIs being done in primary care compared to Wales and the only alternative 
was referral to a secondary care vascular service.  
In 2006, Dr Lloyd began performing ABPIs so he could diagnose and manage patients with 
lower leg vascular disease. Subsequently, he began accepting referrals for ABPIs from other 
GPs at MHC and from GPs outside MHC. Dr Lloyd sees the ABPI as a valuable tool GPs can use 
to more effectively and efficiently manage patients in the community. Ultimately, he believes 
it improves healthcare for patients in the community.   
Chapter 3 describes the first of this study’s two arms. This arm is a quantitative analysis which 
examines descriptive data collected by MHC and Dr Lloyd to present demographic 
characteristics of patients for whom ABPIs are being conducted at the practice. The analysis 
also examines how and why it is being used, and whether ABPI measures are associated with 
changes in management subsequently. These findings will contribute to conclusions about the 
usefulness of the ABPI in this community setting.  
 
3.1.1 Aims 
 To describe MHC patients 2006 – 2015 when the ABPI data were collected. 
 To describe the sample of patients receiving ABPI investigations conducted at MHC 
between 2006 and 2015. 
 To describe why and how the ABPI is used in the MHC. 
 To analyse whether ABPI use is associated with a change in clinical management 
(compared to what would have been done without ABPI). 
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 To interpret the significance and effectiveness of conducting the ABPI.  
 
3.1.2 Hypothesis  
The study hypothesis of this quantitative arm is that the use of ABPIs in this general practice 
(MHC) is associated with changed clinical decisions regarding vascular management.  
 
3.2 Study Design  
The design of the entire study is split into a quantitative analysis arm (Chapter 3) and a 
qualitative analysis arm (Chapter 4).  
The study design involved in this arm is a quantitative analysis of ABPI data collected between 
2006 and 2015 by MHC and Dr Hywel Lloyd.  
 
3.2.1 Study Participants and Setting  
3.2.1.1 Participants 
Participants were patients seen at MHC 2006 – 2015 including both patients of Dr Lloyd’s, and 
patients referred to Dr Lloyd who have had an ABPI completed at MHC.  
 
3.2.1.2 Population Setting  
All participants were seen physically as patients at MHC, 21 Ingles St, Mosgiel (see Figures 5 
and 6).  
Mosgiel is part of Dunedin city. The area has a total population of 3,975 in Mosgiel East (3.3% 
of Dunedin City’s population) and 2,733 in Mosgiel South (2.3% of Dunedin City’s population) 
according to the New Zealand census 2013.135, 136 MHC also serves patients from nearby areas 
such as Bush Road (2,502 people) and East Taieri (1,527 people) 137, 138.  
MHC had 9,890 enrolled patients at 25/04/2015. The practice has 7 full-time GPs, 7 part-time 
GPs (totalling 2.5-3 full time equivalents), 7 nurses, 1 nurse manager, 1 clinical administrator, 




Figure 5:  Google Maps Image of the location of Mosgiel Health Centre (MHC) in relation to 
Mosgiel and Dunedin, New Zealand. Accessed 20/07/2015. Released to the public 
domain, reproduced with permission under fair use, Google Incorporated.   
 
 
Figure 6:  Sign outside Mosgiel Health Centre, 21 Ingles St, Mosgiel. Photo taken with 




Figure 7:  MHC Practice Boundary Map (Patients served in the region). Reproduced with 





3.3 Methods  
3.3.1 Quantitative Methods Used  
This quantitative arm of the study uses routine electronic practice data from MHC for analysis 
and evaluation. This was from the practice’s Patient Management System (PMS).  
 
3.3.2 Data Collection 
In this arm of the study, data were collected in a variety of ways. 
 
3.3.2.1 Collection of Demographic and Other Descriptive Data  
Demographic and other descriptive data for all MHC patients were collected between 2006 
and 2015. Data were stored on Medtech32 and extracted for analysis on 25/04/2015 (see 
Section 3.3.2.5 Data Extraction and Cleaning).   
Further chapters describe what is meant by demographic and other descriptive data (see 
Section 3.3.4.2 Demographic Definitions, and Section 3.3.4.4 Definitions of Medical Conditions 
and Risk Factors).  
Demographic and other descriptive data were originally recorded by administrative or health 
professional staff at MHC on the practice’s Medtech32 PMS throughout the 10 years. Data 
were gained either by speaking with patients (e.g. ethnicity, deprivation indexes from address 
information), or through clinical encounters (e.g. consecutive high systolic blood pressure 
measurements and a clinician coded diagnosis of hypertension). Further information could 
have come from previous medical records sent to MHC by former healthcare providers.   
To maintain accuracy of demographic data, administrative staff often checked information 
provided earlier with returning patients. Similarly, the nursing team do a standard check of 
demographic information and other descriptive data whenever a new patient arrives at the 
clinic. These procedures maintain quality and accuracy of information stored on the practice’s 
electronic records system, and therefore enhance the quality of the data used for this arm of 




3.3.2.2 Collection of ABPI Data  
ABPI data were collected between 2006 and 2015 using an electronic ‘ABPI Data Capture tool’’ 
on the Medtech32 database following ABPI measurements by clinical staff (see Section 3.3.2.3 
ABPI Data Collectors and Section 3.3.3 ABPI Test Method).  
ABPI data include the date of the ABPI procedure linked with the patient identification 
number, left and right brachial pressures, left and right PT and DP pressures, left and right 
ABPI values and whether any pressures were non-occludable or unobtainable.  
The clinician performing the ABPI simply recorded values for each of the arteries seen, and an 
automatic calculation by the form then produced the left and right ABPI values or ratios. 
Figure 8 shows the ‘ABPI Data Capture Tool’, built by Dr Lloyd using Advanced Form 
technology within the Medtech32 system. Visual basic scripting was used to ensure data 
quality for input and the correct calculation of the ABPI ratios. The data collected from the 
Advanced Form was written back to Medtech32 and stored in a ‘[MEASUREMENT]’ table 
visible to all clinicians under the ‘screening’ tab of the patient manager window. The data 
were then able to be extracted from the ‘[MEASUREMENT]’ table (see Section 3.3.2.5 Data 
Extraction and Cleaning).  
 
Figure 8:  Display of the ABPI Data Capture Tool based on an Advanced Form Built by Dr Lloyd 
for Input of ABPI Values on the MHC PMS. Reproduced with permission from MHC.  
 
 
3.3.2.3 ABPI Data Collectors  
ABPI data were collected and recorded primarily by Dr Lloyd.  
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A minority of ABPI investigations were conducted by nursing staff from MHC. Two registered 
nurses (under the pseudonyms “MH” and “NC” within the data) were trained by Dr Lloyd to 
conduct the ABPI.  Dr Lloyd often validated values obtained by the nurses by completing the 
ABPI again himself. In all instances where Dr Lloyd redid the ABPIs, values did not differ 
significantly. ABPI data was recorded only once in these cases to prevent duplication in 
reporting. 
Dr Lloyd graduated from the University of Liverpool medical school in 1989 and in 1992 
became a successful cndidate of the UK’s vocational training scheme for GPs (MRCGP 
programme). He worked as a GP in the UK for 9 years, between 1994 and 2003. In this setting, 
he conducted ABPIs. He moved to New Zealand in 2003 and has been working at MHC since, 
for a total of 12 years till 2015. Dr Lloyd currently works part time at the practice.  
Dr Lloyd based his ABPI method and clinical management on an older version of the Scottish 
Intercollegiate Guidelines Network (SIGN) PAD guidelines while in the UK, and on a former 
New Zealand Guidelines Group (NZGG) guideline document while in NZ.139 Full texts of both 
guidelines could not be found in the literature as they are outdated. A newer SIGN PAD 
guidelines document which has similar protocol guidelines to earlier versions was found.19 
NZGG was closed under voluntary liquidation in 2012, and previous web links to old guidelines 
had been removed. As a result, no current NZGG documents could be found.   
 
3.3.2.4 Collection of Indications and Outcomes Data  
Data regarding indications and outcomes for the ABPI were collected by the candidate. This 
was done by searching through relevant patient records, and inputting findings into an Excel 
spreadsheet. This was completed during July 2015.  
Permission for this study was granted by both the Human Ethics Committee and MHC (see 
Appendices A, D and F and Section 3.3.6 Ethical Considerations).  
Clinical record entries by staff and scanned referral letters were read and used to collect data.  
Binomial results “YES” and “NO” were used to identify presence or absence of indications and 
outcomes (see Table 7). Binomial results on an Excel spreadsheet were used as this is easily 
understood by statistical software packages, and allows for proportions and percentages to be 




Table 7:  Dummy Table showing how Indication and Outcome Data were collected 
ABPI Number Indication 1 Indication 2 Outcome 1 Outcome 2 
1 YES NO YES NO 
2 NO YES YES NO 
3 YES NO NO YES 
 
The following describes how indications and outcomes data were organised: 
Indications for having the ABPI 
There were three overarching ‘indication category groups’ for the use of ABPI: (1) To 
investigate suspected PAD, (2) To guide management of venous disease, and (3) other. There 
were nine indication categories in total under these three groups, some of which were split 
into further subcategories, seen in Figure 9.  
The candidate based the presence of indication categories on key words in the clinical notes 
or letters (e.g. where “intermittent leg pain” was stated, a “YES” was entered into under the 
category “intermittent leg pain”) or where descriptions clearly matched indication categories 
(e.g. “having pain in legs following walking 100m, of which he needs to stop, rest, and can 




Figure 9:  Indication Category Groups, Indication Categories, and Indication Subcategories  
 
Outcomes following the ABPI  
All outcomes were categorised into ‘outcome category groups’ via their ABPI outcome and 
clinical features (see Figure 10).  
Patients who had an ABPI value of under 0.9 and related clinical symptoms were managed as 
having PVD/arterial disease (a single outcome category group), whereas patients who had 






•Clear history of classic 















Foot or leg ulcer














•E.g. Tiredness in legs
•E.g Weakness or 
numbness in legs




category group) and data were entered into the outcome categories beneath these groups 
accordingly.  
For patients who had ABPI results >0.9, any management arranged was classified under ‘other 
management arranged’ as the management did not relate to the any of the other outcome 
category groups. Where nothing more was found to have been done or where no 
management changed following the ABPI, this was recorded under the ‘nil further peripheral 
vascular management’ outcome category group.  
‘Nil further management’ within each of the outcome category groups refers to no change to 
the normal management of the patient, however recognising the problem as PVD/arterial 
disease, venous disease with ulceration or venous disease without ulceration via the ABPI 
result or clinical findings.  
In the case of managing venous disease, mixed disease identified using the ABPI would usually 
be referred to the secondary care vascular service, and would be recorded under 




























































































Vascular Secondary Care Services Categories 
Where referrals were made to vascular secondary care services, any investigation or 
management implemented was also recorded in the data tally. These outcomes were 
recorded as it was seen as important to follow through patients requiring more invasive 
treatment, and to examine the appropriateness of referral (if added opinion or further 
intervention was necessary).  
Following referral to secondary care vascular services, information regarding certain data 
categories was collected, as shown in Table 8:  
 
Table 8:  Vascular Secondary Care Services Categories 
 
 Investigations 
o Formal vascular lab ABPI 
o PVR 
o Exercise ABPI 
o Arterial duplex scanning 
o Angiography 
o Venous duplex scanning 
 Compression stockings or bandaging 
 Referral to the wound care nurse specialist or ulcer care clinic 
 Angioplasty 
 Lower limb endarterectomy 
 Ulcer or wound debridement 
 (Arterial) bypass operation 
 Amputations 
o Toe amputation 
o Below-knee amputation  
o Above-knee amputation 
 Sclerotherapy  
 Other management 
 Nil- this includes referral back to the GP with no change in management, or recommending 
conservative “watch-and-wait” management 







3.3.2.5 Data Extraction and Cleaning  
At the end of the study period on the 25/04/2015, all descriptive and ABPI data were 
extracted from Medtech32 by the creation of an activity report of the ‘[MEASUREMENTS]’ 
table (see Section 3.3.2.1 Collection of Demographic and Other Descriptive Data and Section 
3.3.2.2 Collection of ABPI Data). This was exported into Comma Separated Values (CSV) file 
formats for analysis purposes; one CSV file for demographics of the patients at MHC between 
2006 and 2015 and another for ABPI data.   
These tabulated data were then cleaned manually by the candidate. A majority of the cleaning 
involved shifting misplaced information back into correct original columns. This was because 
data was divided inappropriately into separate rows during the extraction process (into CSV 
files). This affected data such as clinician coded diagnoses, as clinicians may have added 
commas to their written notes. The data were checked for any other errors upon cleaning. The 
information was not altered.  
Missing data was also recorded in the process of cleaning the data (see Section 3.3.5 Missing 
Data).   
Indications and Outcomes data were not extracted, as this was manually collected by the 
candidate (see Section 3.3.2.4 Collection of Indications and Outcomes Data).  
 
3.3.2.6 Time Period Chosen for Data Collection  
The time period captured for this data is between 01/01/2006 and 25/04/2015. This 
corresponded to the time ABPIs were conducted at MHC.  
 
3.3.3 ABPI Test Method  
The method of ABPI testing was discussed with Dr Lloyd, detailed below. This method is 
comparable to what is stated in published guidelines discussed Chapter 2 (see Section 2.4.5.2 
ABPI Measurement).  
 
3.3.3.1 Equipment and Apparatus  
The equipment used to complete ABPIs at MHC included:  
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 One Seward Vascutrack 120 Doppler ultrasound owned by the practice 
o Made by Seward Medical Systems Ltd, Newport, United Kingdom  
o It was unknown by staff at MHC when this was purchased and how old it was 
o Tested and calibrated by Dental and Medical Equipment Ltd yearly 
 A standard blood pressure sphygmomanometer and cuffs (varying sizes)  
 A standard examination table  
The ABPIs were all conducted in the treatment room at MHC, with the same equipment used 
for each patient (aside from different sized blood pressure cuffs based on individual patients).  
 
Figure 11:  Three Photographs of the Seward Vascutrack 120 Doppler Ultrasound Used by MHC 
in Completing ABPIs. Photos taken with permission from MHC.  
   
 
3.3.3.2 Protocol 
The protocol used for conducting the ABPI was as follows:  
 The patient was taken to the treatment room by a practice nurse and was asked to lie 
down supine for 15-20 minutes.   
 An explanation of what the investigation entailed was given to the patient by the 
clinician.  
 The ABPI was conducted as follows, using appropriate blood pressure cuff sizes to 
measure segmental pressures: 
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o The left arm (left brachial pressure) was measured first, followed by the right 
arm (right brachial pressure), followed by the left leg (PT then DP) and then 
the right leg (PT then DP). This order was followed for each patient. 
o In each case, the Doppler ultrasound probe was angled onto the patient’s skin 
over the relevant artery. The cuff was inflated until no sound was heard by the 
ultrasound, and the cuff was slowly deflated until a wave form or sound was 
heard by the clinician.  
 These values were recorded onto the Medtech32 system (see Section 
3.3.2.2 Collection of ABPI Data). 
 If the pulse was unobtainable, or not found, then it was recorded as 
‘unobtainable’. 
 If the pulse was non-occludable by the sphygmomanometer, then it 
was recorded as ‘non-occludable’. 
o The left and right ABPI values (or ratios) were then calculated automatically by 
Medtech32 using these segmental pressures.  
 
If referred by another clinician, the patient’s clinical records were read by Dr Lloyd only after 
the ABPI had been performed.  
 
3.3.3.3 Cost to the patient 
The ABPI investigation costs the patient the same amount as one 15 minute consultation at 
MHC. This amounted to NZ$36. This cost was independent of the amount of time spent doing 
the ABPI, and so would not cost the patient more than $36 in the unlikely event that the ABPI 
procedure took longer than 15 minutes. 
 
3.3.4 Definitions for Data Analysis  
Extracted or created tables of collected data in CSV format were imported into the open 
source R statistical software.140 This software package was used to calculate prevalence, 




3.3.4.1 Population Definitions  
Populations to be examined within the total sample were defined prior to analysis. These 
populations include (1) the total enrolled MHC population, (2) the patients who have had an 
ABPI (“ABPI group”) and (3) the MHC Population who have never had an ABPI before. These 
are discussed sequentially:  
(1) The total enrolled MHC population consists of all patients enrolled at MHC and alive at 
25/04/2015. Enrolled MHC patients were defined in the data as patients who had been 
associated with the funding code “F” (denoting enrolment).  
Any patient data where the patient status was recorded as being “dead” were excluded. Cases 
with neither a “live” nor “dead” status were assumed to be living, and were included.  
(2) Patients who have had an ABPI (the “ABPI group”) are defined as including any patient who 
has been classified with a designated Read code of “585a”, denoting ABPI. Read codes are 
widely-used health codes that statisticians and government agencies use to classify 
investigations and diagnoses.141, 142 MHC utilises these codes.  
The ABPI group includes all patients who have had ABPI assessments. These patients are 
described in two ways: 
1. Patients who have had ABPI assessments. As all patient information pertaining to all 
ABPI assessments is included, patient demographics may be doubled if patients have 
had more than one ABPI assessment. 
2. Individual patients who have had (one or more) ABPIs before- a separate analyses of 
individual patients to describe the unique population who have had ABPIs ever, 
without doubling up information.  
Unlike the total enrolled MHC population, ABPI group includes ‘ABPI patients’ who may have 
become deceased before 25/04/2015. This is so that all data from patients who have had 
ABPIs can be analysed. Therefore in order to compare the total enrolled MHC population alive 
at 25/04/2015, it is necessary to find the enrolled ABPI population who were also alive at 
25/04/2015 as a subset of the ABPI group.  
Patients who were referred to MHC for ABPI assessments were described as non-enrolled 
‘casual’ patients.  
 (3) The MHC population who have never had an ABPI before includes all patients who have 
never been classified with the designated Read code of “585a”.  
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This was taken as the difference between the total enrolled MHC population and the total 
enrolled ABPI population.   
 
3.3.4.2 Demographic Definitions 
Descriptive statistics were calculated for several demographic variables for the three 
populations mentioned in Section 3.3.4.1 Population Definitions. Measures of normal 
distribution such as means and standard deviation (s.d.) were calculated for variables of 
continuous data. Raw numbers and proportions were calculated for all non-parametric 
demographic data. Graphs and histograms were used as appropriate to explain the data. 
The demographics which were analysed for these population groups included:  
Sex  
Sex categories included male, female or unknown.  
Age Distribution  
The mean and range of all ages as of 25/04/2015 were determined for each population, 
except for ABPI groups; which took age at the time of ABPI.  The age at ABPI was determined 
by deducting the date at which the ABPI was performed from the date of birth.  
10-year Age Bands  
Patients’ 10-year age bands were recorded, e.g. 80-89 years, 90-99 years. The only exception 
were all patients over 100 who are grouped together as the “100+” age band due to presumed 
small number of patients over 100 years.  
Ethnicity  
Patient ethnicity was based on Level 2 ethnicity codes as defined by the MoH.143 This 
quantitative analysis further grouped ethnicity as follows: 
 NZ European/Pakeha- combined the categories “European Pakeha”, “European not 
defined”, “Other European” 
 NZ Māori –classified as “NZ Māori ”  
 Pacific- combined the categories “Cook Island Māori ”, “Tongan”, “Samoan”, “Fijian”, 
“Niuean”, “Tokelauan”, “Other Pacific”, “Pacific not defined”  
 Chinese- classified as “Chinese”  
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 Indian- classified as “Indian”  
 Other Asian- combined the categories “South Eastern Asian”, “Asian not defined”   
 Other Ethnicity- combined the categories “African”, “Latin American”, “Middle 
Eastern”, “Other” 
 Not specified/defined- if there was no recorded ethnicity  
Socio-Economic Status by Quintile  
The New Zealand Socio-Economic Index (NZSEI) was used to quantify patients’ socio-economic 
status and level deprivation based on home address.144-147 The NZSEI scale uses a reliable 1-5 
sorting system where a quintile of 1 denotes most affluent mesh blocks and quintile 5 denotes 
least affluent mesh blocks.  
High Needs category 
Patients were recorded as being in a High Needs category if they were living in an area of 
quintile 5 or were of Māori or Pacific ethnicity. This was based on having a higher-risk of 
developing common conditions and clinical consequences.144 Individuals who did not meet the 
definition above were not in the High Needs category.  
 
3.3.4.3 ABPI Group Definitions  
The ABPI group (or population) was further organised into a number of subgroups. The 
subgroups are defined below:  
Enrolled and non-enrolled ABPI subgroups 
As discussed in Section 3.3.4.1 Population Definitions, the “ABPI group” includes all patients 
who have had an ABPI in the past, and includes both enrolled and non-enrolled “casual” 
patients.  
There was no possible method of finding funding status or enrolment on any retrospective 
date before 25/04/2015. Patients who have had an ABPI and who were enrolled at MHC at 
25/04/2015 were assumed to have been enrolled at the time of the ABPI, making up a 
majority of the “enrolled ABPI group”.  
Non-enrolled or casual patients in the data were defined as not having an enrolment code of 
‘F’ (funded) at 25/04/2015, and did not have a registration code of ‘R’ under their registration 
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code on Medtech32 (and who were not reported as being dead). All other patients were 
assumed to have been funded at the time of their ABPI.   
ABPI Value Subgroups  
The ABPI group can be further subdivided into clinically-relevant subgroups based on ABPI 
values.  
These included: 
 Individuals who had an ABPI result of 0.9-1.2- corresponding to clinically ‘normal’ 
healthy patients  
 Individuals who had an ABPI result of <0.9- corresponding to patients who have PAD  
 Individuals who had an ABPI result of <0.5- corresponding to severe PVD  
 Individuals who had an ABPI results of >1.2- corresponding to potential abnormality in 
patients who have diabetes due to calcification of arteries, raising the ABPI  
Table 9:  ABPI Subgroups 
ABPI Value Description  
>1.2 Potential calcification of arteries 
0.9-1.2 Normal 
<0.9 PAD- based on clinical guidelines  
<0.5 Severe PAD 
 
These parameters have been determined by multiple vascular surgical and cardiovascular 
societies and previous research as determined in the literature review (see Section 2.4.5.4 
Interpretation).  
 
3.3.4.4 Definitions of Medical Conditions and Risk Factors 
Prevalence of different medical conditions and risk factors within populations was calculated 
using the extracted data and R statistical software (see Section 3.3.2.1 Collection of 
Demographic and Other Descriptive Data and Section 3.3.2.5 Data Extraction and Cleaning).  
Medical conditions were defined as grouped Read codes established by the Primary Health 
Organisation (PHO) Performance Programme.141 The PHO Performance Programme outlines 
and recommends standardised codes for different medical conditions and classifications to be 
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used in data across the health sector in New Zealand. MHC used these codes in Medtech32 
system, and so Read codes can be utilised appropriately in this quantitative analysis.  
The definitions of each medical condition and risk factor are outlined in Tables 10 and 11 
respectively: 
 
Table 10:  Read code Definitions for Medical Conditions  
Medical conditions and subtypes Definition based on Read code 141 
Arterial Disease Arteriosclerotic Disease G70-G73z 
    PAD subset  G73-G73z 
Ischaemic heart disease  G3-G3z 
Cerebrovascular disease G6-G6z 




Peripheral Oedema R023 
R0234 
Diabetes Mellitus C10-C10zz 
C11y0-C11y0z  
Chronic leg or skin ulcers  M27 
G830 






Table 11:  Definitions for Medical Risk Factors via Read codes  
Medical risk factors  Subtype  Definition based on Read Code 141  
Hyperlipidaemia  n/a  C320-C325z 
Hypertension n/a  G2-G2z 
Smoking status Heavy smoker (20-
39 cigs/day)  
1375 





3.3.5 Missing Data 
There was no missing data for demographics and characteristics of the total enrolled MHC 
population, and therefore the total enrolled MHC population who have never had an ABPI 
before. However, alive/dead status was missing for 58 (0.59%) of the total enrolled MHC 
population, 2 (0.48%) of whom were enrolled patients who have had an ABPI at MHC.  
In regards to ABPI data, there were missing data for both all ABPI assessments and individual 
ABPI patients. This was generally in very minute quantities for sex, age and ethnicity. There 
was more missing data on socio-economic quintile and High Needs categories for just under a 
quarter of all patients who had an ABPI (see Tables 12 and 13). Caution should be taken to 
interpret these results.  
 
Table 12:  Missing Data for Demographic Characteristics of Enrolled and Non-Enrolled 
Patients who have had ABPIs at MHC for Total ABPI Assessments 
Data reported as NA or 
missing  
ABPIs completed on  
enrolled patients 
ABPIs completed on  
non-enrolled “casual” 
patients 
Total number of ABPIs 
completed on patients  
n % of total n % of total n % of total 
Sex 0 0% 1 7.1% 1 0.3% 
Age Band 0 0% 1 7.1% 1 0.3% 
Ethnicity  0 0% 6 42.9% 6 1.6% 
Socio-Economic Quintile 87 23.8% 9 64.3% 96 25.3% 
High Needs 87 23.8% 4 28.6% 91 24.0% 
 
Table 13:  Missing Data for Demographic Characteristics of Enrolled and Non-Enrolled 
Individual Patients who have had (one or more) ABPIs at MHC  
Data reported as NA or 
missing  
Enrolled patients who 
have had an ABPI 
Non-enrolled “casual” 
patients who have had 
an ABPI 
Total patients who have 
had an ABPI 
n % of total n % of total n % of total 
Sex 0 0% 1 7.1% 1 0.3% 
Age Band 0 0% 1 7.1% 1 0.3% 
Ethnicity  0 0% 6 42.9% 6 1.8% 
Socio-Economic Quintile 76 23.5% 9 64.3% 85 25.1% 





Table 14:  Missing Data for ABPI results 0.9-1.2, <0.9, and <0.5 
Data reported as NA or 
missing 
ABPI results 0.9-1.2 
(Normal) 
ABPI results <0.9 
(Abnormal) 
ABPI results <0.5 
(Severely Abnormal) 
n % of total 
obtainable 
values for 
either L or R 
leg 
n % of total 
obtainable 
values for 
either L or R 
leg 
n % of total 
obtainable 
values for 
either L or R 
leg 
Sex 1 0.3% 0 0% 0 0% 
Age Band 1 0.3% 0 0% 0 0% 
Ethnicity 3 1.0% 2 1.7% 0 0% 
Socio-Economic Quintile 53 18.3% 42 36.2% 5 22.7% 
High Needs 58 20.0% 39 33.6% 5 22.7% 
Total* 290  116  22  




3.3.6 Ethical Considerations 
The study gained ethical approval by the University of Otago Human Ethics Committee (see 
Appendix A). 
This study has also been through the Department of General Practice and Rural Health 
scientific review process prior to commencement (see Appendix B). The reviewers 
commented that the research uses appropriate research methodology. They approved the 
research following minor revisions undertaken whereby methodology was described in more 
detail as it was described very broadly initially.  
The study protocol was also reviewed and responded to by the Ngāi Tahu Research 
Consultation Committee (Te Komiti Rakahau Ki Kāi Tahu) who considered the research to be of 
importance to Māori health, and have recommended that this research should be 
disseminated to Māori health organisations (see Appendix C). It was important for the 
researchers to have undergone this process to be aware of any cultural considerations 
present. There are a small number of Māori patients making up the sample examined by the 
quantitative arm, but all implications of the research are relevant to both Māori and non-
Māori.  
Within the amended New Zealand Health Information Privacy Code 1994, Rule 2: Sources of 
Health Information states that the health agency or researcher “must collect the information 
directly from the individual concerned” (rule 2.1).148 However, Rule 2.2 states that 2.1 is not 
necessary where the information used will be used for research purposes [that have gained 
ethics committee approval] and will not be published in a form that could reasonably be 
expected to identify the individual concerned.148 This clearly describes the legal ability of this 
health data to be used for this research, when used in a de-identified manner.  
Authorisation of data was granted by MHC (see Appendix D) and a confidentiality statement 
was signed by both the MHC and by the candidate (see Appendix E). Most data provided to 
the candidate had already been anonymised using a unique randomised patient code, 
meaning only quasi-identifiers (such as date of birth, clinic visit, ethnicity) were supplied.149 All 





3.4.1 Demographics and Characteristics  
The demographics of the ‘total enrolled MHC population alive at 25/04/2015’ and ‘enrolled 
patients who have had an ABPI at MHC’ (and who were alive at 25/04/2015) are compared on 
Table 15 below:   
 
Table 15:  Demographics and Characteristics of the Total Enrolled MHC Population, Enrolled 
Patients who have had an ABPI at MHC, and the Total Enrolled MHC Population 
who have Never had an ABPI before 




patients who have had 
an ABPI at MHC* 
Total enrolled MHC 
Population who have 
never had an ABPI before*  
n % (2dp) n % (2dp) n % (2dp) 
Sex       
F 5,139 51.96% 156 64.46% 4,983 51.65% 
M 4,751 48.04% 86 35.54% 4,665 48.35% 
Total known 9,890 100.00% 242 100.00% 9,648 100.00% 
Age Band       
0-9 909 9.19% 0 0% 909 9.42% 
10-19 1152 11.65% 0 0% 1152 11.94% 
20-29 922 9.32% 0 0% 922 9.56% 
30-39 848 8.57% 0 0% 848 8.79% 
40-49 1,214 12.28% 3 1.24% 1,211 12.55% 
50-59 1,315 13.30% 11 4.55% 1,304 13.52% 
60-69 1,297 13.11% 28 11.57% 1,269 13.15% 
70-79 1,134 11.47% 74 30.58% 1,060 10.99% 
80-89 880 8.90% 91 37.60% 789 8.18% 
90-99 216 2.19% 34 14.05% 182 1.89% 
100+ 3 0.03% 1 0.41% 2 0.02% 
Total known 9,890 100.00% 242 100.00% 9,648 100.00% 
Ethnicity        
NZ European/ Pakeha 9,128 92.30% 236 97.52% 8,892 92.16% 
NZ Māori  476 4.81% 4 1.65% 472 4.89% 
Pacific 95 0.96% 1 0.41% 94 0.97% 
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Chinese 52 0.53% 1 0.41% 51 0.53% 
Indian 31 0.31% 0 0% 31 0.32% 
Other Asian   49 050% 0 0% 49 0.51% 
Other Ethnicity 59 0.60% 0 0% 59 0.61% 
Total known 9,890 100.00% 242 100.00% 9,648 100.00% 
*alive as at 25/04/2015  
 




patients who have had 
an ABPI at MHC* 
Total enrolled MHC 
Population who have 
NEVER had an ABPI 
before*  
n % (2dp) n % (2dp) n % (2dp) 
Socio-economic Quintile       
1 (most affluent)  3,388 34.26% 47 19.42% 3,341 34.63% 
2 2,051 20.74% 60 24.79% 1,991 20.64% 
3 1,799 18.19% 42 17.36% 1,757 18.21% 
4 2,030 20.53% 74 30.58% 1,956 20.27% 
5 (least affluent)  583 5.89% 19 7.85% 564 5.85% 
Total known  9,890 100.00% 242 100.00% 9,648 100.00% 
High Needs       
High Needs 1,106 11.18% 23 9.50% 1,083 11.23% 
Not High Needs  8,784 88.82% 219 90.50% 8,565 88.77% 
Total known 9,890 100.00% 242 100.00% 9,648 100.00% 
*alive as at 25/04/2015  
 
3.4.1.1 Demographics of the Total Enrolled MHC Population  
It was found that 22,328 individual patients received a service from MHC between 2006 and 
25/04/2015. Of these, 9,895 were enrolled. All other patients were non-enrolled ‘casual’ 
patients or were in the process of being enrolled. Five of the 9,895 enrolled patients were 
recorded as being deceased as on the 25/04/2015, leaving 9,890 as the total enrolled MHC 
population alive at 24/04/2015 (see Section 3.3.4.1 Population Definitions). These 9,890 
patients are described in the first column of Table 15 (above).  
The MHC population at 25/04/2015 had a mean patient age of 46.7 years, with a first quartile 
of 24 years and 3rd quartile of 68 years. The range varied between 0 (new-borns) to a 
maximum of 102 years (oldest patient).  
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The ethnic make-up of this population was mainly NZ European/Pakeha (92.30%). 
As shown in Figure 12, 73.19% of the total enrolled MHC population lived in an area of socio-
economic quintile 1-3. Less than 6% of the same population lived in quintile 5.  
Figure 12:  Socio-Economic Distribution in the Total Enrolled MHC Population, by Quintile  
 
 
There were 1,106 (11.18%) High Needs patients.   
There was no missing demographic data (see Section 3.3.5 Missing Data).  
 
3.4.1.2 Demographics of the ABPI Group  
There were 379 recorded ABPI assessments completed at MHC during the time period. The 
379 recorded ABPI assessments were attributed to 338 individual patients (see Section 3.3.4.3 



















































































































































































































































































There were 268 ABPIs completed on patients who were alive at 25/04/2015 and 97 
assessments on patients who were recorded as being deceased at 25/04/2015 (see Section 
3.4.6 Deceased ABPI patients).  
For comparability, only the 242 enrolled MHC patients who were alive at 25/04/2015 and who 
had an ABPI before that date were included in the comparison in Table 15 above.  
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Demographics of patients who have had ABPI assessments 
Table 16 displays the demographics and characteristics of patients having the 379 ABPI 
assessments. It also distinguishes 365 ABPI assessments of enrolled patients from 14 ABPIs of 
patients not enrolled in MHC.   
Table 16:  Demographic Characteristics of Enrolled and Non-Enrolled patients who have had 
an ABPI at MHC for Total ABPI Assessments 
Demographic 
Characteristics (at time of 
ABPI)  
ABPI assessments 
completed on  enrolled 
patients 
ABPI assessments 
completed on  non-
enrolled “casual” 
patients 
Total number of ABPI 
assessments completed on 
patients  
n % (1dp) n % (1dp) n % (1dp) 
Sex 
F 235 64.4% 11 84.6% 246 65.1% 
M 130 35.6% 2 15.4% 132 34.8% 
Total known 365 100.00% 13 100.00% 378 100.00% 
Total 365 14 379 
Age Band 
40-49 3 0.8% 0 0% 3 0.8% 
50-59 11 3.0% 0 0% 11 2.9% 
60-69 32 8.8% 0 0% 32 8.5% 
70-79 84 23.0% 2 15.4% 86 22.8% 
80-89 144 39.5% 6 46.2% 150 39.7% 
90-99 85 23.3% 5 38.5% 90 23.8% 
100+ 6 1.6% 0 0% 6 1.6% 
Total known 365 100.00% 13 100.00% 378 100.00% 
Total 365 14 379 
Ethnicity 
NZ European/ Pakeha 358 98.1% 7 87.5% 365 97.9% 
NZ Māori  5 1.4% 0 0% 5 1.3% 
Pacific 1 0.3% 0 0% 1 0.3% 
Chinese 1 0.3% 1 12.5% 2 0.5% 
Total known 365 100.00% 8 100.00% 373 100.00% 




Characteristics (at time of 
ABPI)  
ABPI assessments 
completed on  enrolled 
patients 
ABPI assessments 
completed on  non-
enrolled “casual” 
patients 
Total number of ABPI 
assessments completed on 
patients  
n % (1dp) n % (1dp) n % (1dp) 
Socio-economic Quintile       
1 (most affluent) 59 21.2% 2 40.0% 61 21.6% 
2 71 25.5% 1 20.0% 72 25.4% 
3 45 16.2% 1 20.0% 46 16.3% 
4 84 30.2% 1 20.0% 85 30.0% 
5 (least affluent) 19 6.8%% 0 0% 19 6.7% 
Total known 278 100.00% 5 100.00% 283 100.00% 
Total 365  14  379  
High Needs       
High Needs 23 8.3% 0 0% 23 8.0% 
Not High Needs  255 91.7% 10 100.00% 265 92.0% 
Total known 278 100.00% 10 100.00% 288 100.00% 
Total 365  14  379  
 
Of all 379 ABPI assessments, 246 (64.9%) were completed on female patients and 132 (34.9%) 
performed on male patients.  
The mean age of patients at the time of ABPI completion was 77.6 years (range: 38.0-99.4 
years).  
The mean year of ABPI classification for patients was 2010. The earliest ABPI recorded was on 
03/05/2006 and most recent on 31/03/2015.  
Of the 379 ABPI tests, the majority (365, 97.9%) were performed on NZ European Pakeha, 5 
(1.3%) on NZ Māori, 2 (0.5%) on Chinese and 1 (0.3%) on Cook Island Māori. As shown in Table 
16, there is a smaller percentage of NZ Māori having an ABPI than in the total enrolled MHC 
population (4.81%).  
Most (63.3%) patients who had ABPI assessments live in the least socioeconomically deprived 
neighbourhoods (quintiles 1-3). Only 6.8% live in an area of most socio-economic deprivation. 
In comparison, 5.89% of the total MHC population live in the most deprived neighbourhoods 
and 73.19% live in lesser deprived areas (quintiles 1-3).  



















































Number of ABPIs that individual patients have had completed
Individual patients who have had a left ABPI completed Individual patients who have had a right ABPI completed
Figure 14:  Number of ABPIs that Individual Patients Have Had Completed 
In regards to healthcare providers; 28 (7.4%) ABPIs were completed by nurse “NC”, 2 (0.5%) 
were completed by nurse “MH”, while the rest of the ABPIs, 349 (92.1%) were completed by 
Dr Hywel Lloyd (see Section 3.3.2.3 ABPI Data Collectors).  
Demography of individual patients who have had (one or more) ABPIs   
There were 338 individual patients who have ever had an ABPI completed. Of the 338 
individual patients, 82 (24.3%) patients were recorded as being deceased at 25/04/2015.  
Figure 14 is a graph showing the 338 individuals, and the number of ABPIs they have had, by 
left-sided and right-sided ABPIs. The most ABPIs that any one patient had completed was four 
(on both left and right sides).  
 
There were no large differences in demographics of the 338 individual patients who have had 
one or more ABPIs and of the patients who had the 379 ABPI assessments. Table 17 shows 




Table 17:  Demographic Characteristics of Enrolled and Non-Enrolled Patients who have had 
an ABPI at MHC for Individual Patients 
Demographic 
Characteristics (at time of 
ABPI)  
Enrolled patients who 
have had an ABPI 
Non-enrolled “casual” 
patients who have had 
an ABPI 
Total patients who have 
had an ABPI 
n % (1dp) n % (1dp) n % (1dp) 
Sex       
F 203 62.7% 11 84.6% 214 63.5% 
M 121 37.3% 2 15.4% 123 36.4% 
Total known 324 100.00% 13 100.00% 337 100.00% 
Total 324  14  338  
Age Band       
40-49 3 0.9% 0 0% 3 0.9% 
50-59 11 3.4% 0 0% 11 3.3% 
60-69 32 9.9% 0 0% 32 9.5% 
70-79 78 24.1% 2 15.4% 80 23.7% 
80-89 124 38.3% 6 46.2% 130 38.6% 
90-99 71 21.9% 5 38.5% 76 22.6% 
100+ 5 1.5% 0 0% 5 1.5% 
Total known 324 100.00% 13 100.00% 337 100.00% 
Total 324  14  338  
Ethnicity        
NZ European/ Pakeha 317 97.8% 7 87.5% 324 97.6% 
NZ Māori  5 1.5% 0 0% 5 1.5% 
Pacific 1 0.3% 0 0% 1 0.3% 
Chinese 1 0.3% 1 12.5% 2 0.6% 
Indian 0 0% 0 0% 0 0% 
Other Asian   0 0% 0 0% 0 0% 
Other Ethnicity 0 0% 0 0% 0 0% 
Total known 324 100.00% 8 100.00% 332 100.00% 







Characteristics (at time of 
ABPI)  
Enrolled patients who 
have had an ABPI 
Non-enrolled “casual” 
patients who have had 
an ABPI 
Total patients who have 
had an ABPI 
n % (1dp) n % (1dp) n % (1dp) 
Socio-economic Quintile       
1 (most affluent) 49 19.8% 2 40.0% 51 20.2% 
2 61 24.6% 1 20.0% 62 24.6% 
3 42 16.9% 1 20.0% 43 17.0% 
4 77 31.0% 1 20.0% 78 30.8% 
5 (least affluent) 19 7.7% 0 0% 19 7.5% 
Total known 248 100.00% 5 100.00% 253 100.00% 
Total 324  14  338  
High Needs       
High Needs 23 9.3% 0 0% 23 8.9% 
Not High Needs  225 90.7% 10 100.00% 235 91.1% 
Total known 248 100.00% 10 100.00% 258 100.00% 
Total 324  14  338  
 
Patients not enrolled in MHC 
Of the 379 patients who had ABPI assessments, there were 14 ‘casual’ non-enrolled patients, 
all of whom only had 1 ABPI each. Therefore the second columns on Tables 16 and 17 are 
exactly the same.   
Of patients not enrolled in MHC, 84.6% were female (compared to 62.7% for enrolled ABPI 
patients).  
All 14 patients were 70-99 years of age, with 46.2% making up the ‘80-89’ year age band. 
Similarly, most enrolled ABPI patients were in the ‘80-89’ year age band. The mean age for 
casual patients was 85.5 years, compared to 79.0 years for enrolled ABPI patients.  
There were some missing data for ethnicity, socio-economic quintiles and High Needs 
categories for casual patients because this information was not collected by MHC (see Section 




3.4.1.3 Demographics of the Total Enrolled MHC Population who have never had an ABPI 
before 
There were 19,017 individual patients recorded as being seen at MHC who had never had 
ABPIs. Only 9,648 individuals of the 19,017 were enrolled, making up the total enrolled MHC 
population who have never had an ABPI before (see Table 15).   
 
3.4.2 Medical Conditions and Risk Factors 
Prevalence for PAD, other medical conditions and risk factors were found for the total ABPI 
group and total MHC population.  
 
3.4.2.1 PAD 
There were 131 (1.3%) patients with recorded PAD between 2006 and 25/04/2015 in the total 
enrolled MHC population.  
In the ABPI group, 43 of 338 (12.7%) individual patients had PAD between 2006 and 
25/04/2015. There were 52 recorded sets of ABPIs completed on these 43 individual patients. 
Of these 43 patients who have had both PAD and ABPIs, 9 (20.9%) patients had 2 ABPIs each 
while the rest had 1 ABPI each.  
There was a significantly larger proportion of patients with PAD in the ABPI population (12.7%) 
than in the total enrolled MHC population (1.3%).  
Demographics of patients who have had ABPIs with and without PAD 
The mean age of the 43 patients who have had ABPIs and have PAD was 81.8 years. This was 
made up of 16 patients (37.2%) aged 80-89 years, 11 (25.6%) aged 70-79 years and 9 (20.9%) 
aged 90-99 years at 25/04/2015. The mean age at the time of the ABPI for this group was 77.9 
years. Age distribution was fairly similar in patients who have had ABPIs but without PAD.  
A slightly larger proportion of patients who had ABPIs with PAD lived in quintiles 1-3 than 
patients who have had ABPIs without PAD living in quintiles 1-3 (65.1% vs 61.0%)  
Similarly, of patients who have had ABPI, those with PAD were more likely to be in a High 
Needs category than those without PAD (11.6% vs 8.4%).  
There was no large difference between any characteristics of patients who have had ABPIs 




Table 18:  Characteristics of Patients who have had an ABPI with PAD versus without PAD 
Characteristics of PVD 
patients 
ABPI patients with 
PAD 
ABPI patients without 
PAD 
Totals 
n % n % n 
Sex      
F 27 62.8% 187 63.4% 214 
M 16 37.2% 107 36.3% 123 
Total 43 100% 295 100% 338 
Age Band      
0-49 0 0% 3 1.0% 3 
50-79 17 39.5% 106 36.1% 123 
80+ 26 60.5% 185 62.9% 211 
Total 43 100% 294 100% 337 
Ethnicity       
NZ European/ 
Pakeha 
42 97.7% 282 97.6% 324 
Other Ethnicity 1 2.3% 7 2.4% 8 
Total 43 100% 289 100% 332 
Quintile      
1-3 28 65.1% 128 61.0% 51 
4-5 15 34.9% 82 39.0% 62 
Total 43 100% 210 100% 253 
High Needs      
High Needs 5 11.6% 18 8.4% 23 
Not High Needs  38 88.4% 197 91.6% 235 
Total 43 100% 215 100% 258 
  
Mean ABPI Results in patients who have had ABPIs and have PAD 
The mean ABPI results for patients who have had a PAD classification in MHC between 2003 
and 25/04/2015 were 0.73 (s.d. 0.26) and 0.81 (s.d. 0.24) for right and left legs respectively. 




3.4.2.2 Other Medical Conditions and Risk factors 
Prevalence of other medical conditions and risk factors was calculated for the total enrolled 
MHC population and the total ABPI population. This is summarised on Tables 19 and 20 below: 
 
Table 19:  Medical Conditions among the Total Enrolled MHC population and ABPI Group 
Medical Conditions Total Enrolled MHC Population (9,890) ABPI Group (338) 
n % n % 
Arteriosclerotic disease  225 2.3% 53 15.7% 
    PAD  131 1.3% 43 12.7% 
    Ischaemic heart disease 819 8.3% 88 26.0% 
    Cerebrovascular disease  423 4.3% 42 12.4% 
Venous disease 233 2.4% 43 12.7% 
Peripheral oedema 64 0.6% 7 2.1% 
Diabetes mellitus 635 6.4% 43 12.7% 
Chronic leg or skin ulcers 50 0.5% 20 5.9% 
Congestive heart failure  162 1.6% 41 12.1% 
Gout  396 4.0% 39 11.5% 
 
Most medical conditions were over-represented in the ABPI group.  
There were 53 individual patients who had ABPIs (15.7%) who also had arteriosclerotic 
disease. In comparison, only 2.3% of the total enrolled MHC population were recorded as 
having the same condition.  
Of patients who had both a history of having ABPIs and a classification of arteriosclerotic 
disease, PAD was the commonest form of arteriosclerotic disease (43 of 53), eight patients 
had a non-ruptured abdominal aortic aneurysm, two had a ruptured abdominal aortic 
aneurysm, two had generalised atherosclerosis, two had claudication, and two had Raynaud’s 
syndrome recorded.  
Over a quarter of the ABPI population had ischaemic heart disease, compared with 8.3% in the 
total enrolled MHC population.  
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Of the 88 individual patients who had ABPIs and a recorded classification of IHD; 77 had 
‘ischaemic heart disease not specified’, eight had a record of acute myocardial infarction, two 
had a record of angina pectoris, and one had a record of unstable angina.  
Following a similar trend, cerebrovascular disease was more prevalent in the ABPI population 
(12.4%) than the total enrolled MHC population (4.3%) between 2006 and 25/04/2015.  
Venous disease was also over-represented in the ABPI group (12.7% vs 2.4%). Of the 20 
patients who had an ABPI and have had a ‘chronic leg or skin ulcer’; nine had chronic skin 
ulcers, five had venous ulcers of the leg, three had varicose veins with associated ulceration, 
two had leg ulcers (not specified), and one had a mixed venous and arterial leg ulcer recorded.  
 
Table 20:  Medical Risk Factors among the Total Enrolled MHC Population and the ABPI Group 
Medical risk factors Total Enrolled MHC Population (9,890) ABPI Group (338)  
n % n % 
Hyperlipidaemia  110 1.1% 8 2.4% 
Hypertension 2,044 20.7% 151 44.7% 
Smoking status- 
heavy or very heavy 
143 1.4% 3 0.9% 
 
Hyperlipidaemia was not very prevalent in both total enrolled MHC and ABPI samples (1.1% vs 
2.4%) but was greater for the ABPI group. The prevalence of hypertension in the ABPI group 
was over twice that the total enrolled MHC population.  
Heavy or very heavy smoking status was not very prevalent in either group, with less than 1% 
of the ABPI population attributed this risk factor.  
 
3.4.3 ABPI Values and Subgroups  
There were 379 individual sets of ABPI data recorded as being completed at MHC between 
2006 and 25/04/2015. One ‘set’ of ABPI data (from a single assessment) comprises 6 possible 
values including the right and left brachial pressures, the right and left PT pressures and the 




3.4.3.1 Segmental Arterial Pressures  
The mean segmental systolic arterial pressures as shown in Table 21 below: 
 
Table 21:  Mean Segmental Arterial Pressures among the ABPI Group 
Segmental arterial pressure Mean systolic 
pressure 
s.d.* (2dp)  
Right Brachial Artery Pressures 146.6 22.24 
Left Brachial Artery Pressures 146.4 22.76 
Right Posterior Tibial (PT) Artery Pressures 136.9 33.12 
Left Posterior Tibial (PT) Artery Pressures 140.8 33.66 
Right Dorsalis Pedis (DP) Artery Pressures 133.5 38.06 
Left Dorsalis Pedis (DP) Artery Pressures 133.7  36.14 
*Standard deviation (s.d.) is calculated only for known values; unobtainable/non-occludable pressures were 
excluded in calculation of s.d. 
 
The brachial blood pressures were normally distributed as shown in Figure 15:  
 
Figure 15:  Right and Left Brachial Systolic Pressures 
  
 
The PT and DP pressures are normally distributed as well (see Figures 16 and 17). However in 
the ABPI population, a larger proportion of patients had low DP and PT pressures (under 
100mmHg) than that of brachial pressures.  
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Figure 16:  Right and Left PT Systolic Pressures  
  
 




3.4.3.2 Calculated ABPI Values 
The mean ABPI values were 0.96 (s.d. 0.23) for right-sided ABPI values and 0.97 (s.d. 0.20) for 
left-sided ABPI values. Over 65% of right and left-sided ABPIs fell in the 0.9-1.2 range.  
In regards to the 379 right-sided ABPI values, 24.5% had a value of <0.9, diagnostic of PAD. 
This was made up of 7.4% of values 0.8-0.89, 12.1% of values 0.5-0.79 and 5.0% of values <0.5.  
In comparison, of the 379 left-sided ABPIs, 21.6% had a value of <0.9, made up of 4.7% of 
values 0.8-0.89, 15% of values 0.5-0.79 and only 1.8% of values <0.5.  
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ABPI values >1.2 made up 6.3% and 6.6% of right and left-sided ABPIs respectively.  
Right and left-sided ABPI values were calculated using sets of segmental pressures and are 
summarised in Table 22: 
 
Table 22:  ABPI values  
 No. right-sided ABPI values 
(%*, %**) 
No. left-sided ABPI values 
(%*, %**) 
Total no. ABPI 
values 
ABPI Value Ranges 
     ≥0.9 
     <0.9  
     <0.5 
 
271 (74.5%, 71.5%) 
93 (25.5%, 24.5%) 
19 (5.2%, 5.0%) 
 
283 (77.5%, 74.7%) 
82 (22.5%, 21.6%)  






     >1.2 





24 (6.6%, 6.3%)  
247 (67.9%, 65.2%)  
28 (7.7%, 7.4%)  
46 (12.6%, 12.1%)  
19 (5.2%, 5.0%)  
 
25 (6.8%, 6.6%) 
258 (70.7%, 68.1%) 
18 (4.9%, 4.7%) 
57 (15.6%, 15.0%) 








    Obtainable ABPI values 
    Unobtainable ABPI values† 
    Total ABPI sets 
 
364  










*% of obtainable ABPI values (1dp)  
**% of total ABPI tests (1dp)  
‡Implications of different values include:  
     >1.2 Normal or potential abnormality due to calcified vessels 
     0.9-1.2 Normal ABPI value 
     <0.9 PAD 
     0.8-0.89 Mild abnormality 
     <0.5 Severe abnormality  





The following graphs in Figure 18 show the distribution of ABPI values for right and left sides 
respectively. Most ABPI results fell in the 0.9-1.2 subgroup for both sides.  
Figure 18:  Right ABPI Value Distribution 
  
 
Unobtainable and non-occludable values 
There were 15 right-sided and 14 left-sided ABPIs in which a value could not be found. Of the 
15 right-sided ABPIs, 9 were non-occludable, 2 were unobtainable, 4 did not state whether 
unobtainable nor non-occludable. Of the 14 left-sided ABPIs, 11 were non-occludable, 2 were 
unobtainable and 2 did not state why a value was not recorded.  
 
3.4.3.3 Demographics of ABPI Subgroups  
The sex distribution of patients who had an ABPI value of 0.9-1.2 was similar to that of the 
total ABPI group. However, there were more males in the group of patients with ABPIs <0.9 
than in the group with ABPIs 0.9-1.2.  
In the subgroup 0.9-1.2, males made up 32.76%, however, made up 45.46% of the <0.5 
subgroup. This was not statistically significant (p-value=0.591).   
The mean age for right and left ABPIs 0.9-1.2 were 76.2 and 76.3 years (s.d. 10.4). This was 
slightly younger than the mean age for the ABPIs with values <0.9- with mean ages for right 
and left ABPIs being 79.9 and 80.2 years respectively. Therefore, patients with ABPIs 0.9-1.2 
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were on average younger than those with ABPIs <0.9. All subgroups except for ABPI values 
<0.5 display normal distribution for age. The median age for left and right ABPIs <0.5 were 
81.4 and 83.3 years.  
The ethnic distribution among ABPI subgroups was found to be fairly similar, as shown in 
Table 23. Each group is made up nearly entirely of NZ European patients. All patients with 
ABPI results <0.5 were NZ European.  
Table 23:  Ethnic distribution in ABPI Subgroups 
Ethnicity ABPI results 0.9-1.2 
(Normal) 
ABPI results <0.9 
(Abnormal) 
ABPI results <0.5 
(Severely Abnormal) 












Total no. patients with an 
ABPI of that value*  
287 114 22 
*with data on ethnicity 
 
Patients from all subgroups covered all socio-economic quintiles (see Table 24). There did not 
seem to be skewing of ABPI results to any specific quintile.  
The second and fourth quartiles tend to have larger proportions in each of the subgroups. 
Almost a third of patients with an ABPI result of 0.9-1.2 lived in quintile 4, and over 40% lived 
in quintile 1 or 2. Nearly 30% of patients who had an ABPI result of <0.9 lived in quintile 2 and 
30% lived in quintile 4.  
In contrast, nearly 35% of the total MHC population were living in an area of quintile 1, so 
there is more even spread of patients who have had ABPIs among different socio-economic 
quintiles, than in the total MHC population.  
The proportions of High Needs to Non-High Needs patients were similar among patients with 
ABPI results 0.9-1.2 and those with ABPI results <0.9 (see Table 25).  
Only 5.9% of patients with ABPI results <0.5 were of High Needs category. There were missing 




Table 24:  Socio-economic Distribution in ABPI subgroups by Socio-economic Quintile 
Socio-economic Quintile ABPI results 0.9-1.2 
(Normal) 
ABPI results <0.9 
(Abnormal) 
































Total no. patients with an 
ABPI of that value* 
237 74 17 
*with data on socio-economic quintiles 
 
 
Table 25:  High Needs patients in ABPI subgroups 
High Needs Categories ABPI results 0.9-1.2 
(Normal) 
ABPI results <0.9 
(Abnormal) 
ABPI results <0.5 
(Severely Abnormal) 












Total no. patients with an 
ABPI of that value* 
232 77 17 
*with data on High Needs categories 
 
 
3.4.4 Indications for Having the ABPI 
Of the 379 ABPI assessments completed, most (213, 56.2%) were used to guide management 
of a venous-related issue, 45.6% (173) were completed to investigate suspected PAD, and a 
minority (10.6%, 40) completed for an ‘other’ reason. These groups are not mutually exclusive 
and therefore percentages did not exactly add up to 100%.  




Table 26:  Indication Categories for completed ABPIs 
Indication Category 
Group* 












Foot or leg ulcer 118 55.4% 31.1% 
Traumatic foot or leg ulcer      41 23.9% 10.8% 




Leg pain (intermittent or resting)  105 60.7% 27.7% 
Intermittent 81 46.8% 21.4% 
Resting 37 21.4% 9.8% 
Clear history of classic vascular 
claudication or rest pain 
51 29.5% 13.5% 
Toe/foot pain 54 31.2% 14.2% 
Sensation of unusually cold feet 7 4.0% 1.8% 
Absence of pulse or very cold 
peripheries noted on examination 
50 28.9% 13.2% 
 
Discolouration to any of the lower 
extremities  
8 4.6% 2.1% 
Other  
 
To evaluate appropriate elective 
use of compression stockings for 
travel 
7 17.5% 1.8% 
Other** 34 85% 9.0% 
* *In order of most to least prevalent Indication Category Group  
**The “other” indication category included numbness in legs, numbness of feet, groin pain radiating into the legs, 
sensation of restless legs, strange lesions on the legs, tiredness in the legs, tingling in toes, and unspecified foot/leg 
problems.  
 
To guide management of venous disease 
Among ABPIs completed to guide management of venous disease, 55.4% had indications 
related to a foot or leg ulcer, and 54.8% had indications related to venous insufficiency. 
Venous insufficiency included peripheral oedema, varicose veins and varicose eczema. 
Under half of all foot or leg ulcers (41 of 118) were traumatic in aetiology. Ulcers that were 
not of traumatic cause may have been of venous insufficiency alone or diabetic neuropathy.  
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To investigate suspected PAD 
Of patients who had an indication for an ABPI relating to investigating suspected arterial 
disease as shown on Table 26, the majority (60.7%) had either intermittent or resting leg pain.  
With intermittent and resting leg pain considered separately, intermittent leg pain made up 
46.8% of reasons for patients investigated for suspected PAD. Resting leg pain made up 21.4% 
of indications for patients who were investigated for suspected PAD.   
Around 52% of patients who had an ABPI due to leg pain (intermittent or resting) had a clear 
history of classic vascular claudication or rest pain. Classic vascular claudication and rest pain 
made up 29.5% of all those who were suspected for PAD.  
There was a large proportion of patients who had ‘toe/foot pain’ (31.2%), or ‘absence of pulse 
or cold peripheries on examination’ (28.9%) contributing to reasons why patients required an 
ABPI.   
A minority (4.0%) of patients who were investigated for suspected PAD had sensation of 
unusually cold feet prompting ABPI investigation. Discolouration to the lower limbs was also a 
contributing reason for 4.6% of the ABPIs in this group.   
There were 33 (8.7%) ABPIs that had both indications to investigate suspected PAD, and to 
guide management of venous disease. For instance, a patient who had a leg ulcer and 
discolouration of the lower extremities, requiring ABPIs.   
‘Other’ indication category 
Among ABPIs completed for other reasons, a significant subset (17.5%) were used to evaluate 
the appropriate use of compression stockings for travel as prophylaxis for DVT. This accounted 
for 1.8% of the total population.  
Non-specific individual reasons were documented for 85% of patients who had ABPIs 
completed for ‘other reasons’. These included; numbness in the legs, numbness in the feet, 
groin pain radiating into the legs, and strange lesions on the legs.  
 
3.4.5 Outcomes Following the ABPI 
3.4.5.1 Outcome Category Groups and Categories  
Of the 379 completed ABPI assessments, 30.9% (117) were managed as having venous disease 
without ulceration, 29.3% (111) were managed as having venous disease with ulceration. 
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Further, 23.2% (88) had nil further peripheral vascular management, which meant they were 
not treated for either venous or arterial disease, and were reassured that their ABPI result was 
normal. Out of all ABPIs, 17.7% (67) had ‘other management arranged’ and 16.9% (64) had 
been managed as having PAD alone (not mixed disease). Outcome category groups were not 
mutually exclusive and so percentages did not add to 100%. 
Table 27 below outlines the outcomes of all ABPIs, grouped by the overarching methods of 
management (outcome category groups):  
Management of venous disease without ulceration 
Management of venous disease without ulceration was the most prevalent outcome category 
group among the ABPI group (117, 30.9%). Just under 70% of patients managed for venous 
disease without ulceration were managed via compression treatment (hosiery, layer 
bandaging) (80, 68.4%).  
In contrast, 11.1% (13) were managed conservatively (such as pain management, antibiotics 
for cellulitic-looking legs, education regarding oedema and foot care etc.), 8.5% (10) required 
district nursing services for care of legs (e.g. peripheral oedema), and 8.5% (10) involved a 
referral to a secondary care vascular department. Only 5.1% (6) had nil further management 
(see later on in this Section).  
Management of venous disease with any lower limb ulceration  
Of all patients who had management of venous disease with any lower limb ulceration, more 
than half of all patients who had ABPI assessments were managed with compression (hosiery, 
layer bandaging) (66, 59.5%) or other conservative treatment (58.6%). Conservative treatment 
included redressing of the ulcer, antibiotics for wound infection etc.  
Around half of all ABPI assessments managed for venous disease with ulceration were 
followed with patient referral to district nursing services (57, 51.4%) for wound care purposes. 
In respect to referrals, 47 (42.3%) ABPI assessments involved a referral to a secondary care 
vascular department, and a few (3, 2.7%) involved a referral to another secondary care 
department. This included two referrals to dermatology for squamous cell carcinoma review 
or excision, and one rheumatology review for co-morbidities contributing to neuropathic 
pressure ulceration.  
Only one (0.9%) had no further management (see later in this Section).  
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Table 27:  Outcome Category Groups and Outcome Category Results 
*In order of most to least prevalent Outcome Category Group  












all 379 ABPIs  
Management of 
venous disease 
without ulcer  
Nil further management 6 5.1% 1.6% 
Compression treatment 80 68.4% 21.1% 
Other conservative management 13 11.1% 3.4% 
District nursing Services 10 8.5% 2.6% 
Referral to secondary care Vascular 
Department 
10 8.5% 2.6% 
Management of 
venous disease 
with ulcer  
Nil further management 1 0.9% 0.3% 
Compression treatment 66 59.5% 17.4% 
Other conservative management 65 58.6% 17.2% 
District nursing Services 57 51.4% 15.0% 
Referral to secondary care Vascular 
Department 
47 42.3% 12.4% 
Referral to  secondary care other 
department 
3 2.7% 0.8v 
Nil further 
management  
Nil further peripheral vascular 
management 




Conservative management  26 38.8% 6.9% 
Investigations for other diagnoses 14 20.9% 3.7% 
Dermatological investigation 5 7.5% 1.3% 
Referral to secondary care vascular  
department 
5 7.5% 1.3% 
Referral to  secondary care other 
department 
22 32.8% 5.8% 
District nursing services 1 1.5% 0.3% 
Podiatry services 9 13.4% 2.4% 




Nil further management 14 21.9% 3.7% 
Other conservative management 15 23.4% 4.0% 
Referral to secondary care vascular 
department  
47 73.4% 12.4% 
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As stated in Section 3.4.4 Indications for Having the ABPI, there were 41 traumatic leg ulcers 
reported as indicating factors for having an ABPI in the sample of 379 (10.8%). Of the 41, 26 
(63.4%) had compression treatment following ABPI, 25 (61.0%) had other conservative 
management, 23 (56.1%) were referred to the district nursing service, and 16 (39.0%) were 
referred to a secondary care vascular department.  
Management of PAD 
Of patients who were managed as PAD based on the ABPI and clinical features (see Section 
3.3.2 Data Collection), nearly three-quarters of cases were referred to a secondary care 
vascular department (47, 73.4%).  
Approximately one quarter (15, 23.4%) of patients had other conservative management, such 
as prescription of pain medication, cardiovascular risk factor management, education about 
foot care etc. About 15.6% (10) of patients managed for PVD/arterial disease had both 
conservative management measures (such as pain medication) and were also referred to a 
secondary care vascular department.   
Nil further management followed 14 (21.9%) ABPI assessments managed for PAD. Patients 
who had nil further management were individually managed taking into account age, co-
morbidities, terminal illness, mobility and quality of life. For instance, some elderly patients 
(over 80 years) who had PAD based on ABPI results and mild symptoms did not receive any 
conservative treatment (e.g. to avoid discomfort of stockings) and no referral (e.g. as there 
was little point in seeing a vascular team due to significant comorbidities precluding them 
from interventions such as surgery).  
In terms of patients who had a clear history of classic vascular claudication or rest pain, 35 of 
51 (68.6%) were referred to a secondary care vascular department. Nine of the 51 patients 
(17.6%) had conservative management, while three (5.9%) had nil further vascular 
management.   
Of the 54 who did not have a clear history of classic vascular claudication (either intermittent 
or rest pain), 13 (24.1%) were identified as having PAD following the ABPI and were managed 
accordingly. Eight of those 13 patients were referred to the secondary care vascular services. 
Five of the 13 had conservative management and one required nil further management 
following the ABPI. The remaining 41 of 54 were managed differently- under ‘other 
management arranged’ as they had ABPI results >0.9, excluding PAD.  
97 
 
Nil further management  
Of all 379 ABPI consultations, 23.2% were not managed any further in regards to vascular 
treatment due to having a normal ABPI not suggestive of PAD, and having no restrictive 
vascular symptoms.  
Other management arranged 
Among patients who were managed under the outcome category group ‘other management 
arranged’, 32.8% (22) were referred to another secondary care department.   
Patients in this category often had conservative management (26, 38.8%) involving pain 
medications, pharmacotherapy or education for cardiovascular risk factors, and foot care 
education as examples.  
One in every five patients who were managed in ‘another way’ had investigations arranged for 
other possible diagnoses (14, 20.9%). Five of the 14 patients were referred for a 
dermatological investigation (i.e. punch biopsy) following ABPI assessment.  
Of all patients who had ‘other management arranged’, eight (11.9%) had compression 
treatment for DVT prophylaxis for travel purposes (in patients with risk factors).  
Five patients (7.5%) who had ‘other management arranged’ were referred to a secondary care 
vascular department (but not for PAD or venous disease). Reasons included referrals for 
symptomatic patients with normal ABPIs, or queries to the vascular lab for potential DVT.   
 
3.4.5.2 Secondary Care Vascular Department Outcome Categories  
There were 100 referrals made to the secondary care vascular department in total, equating 
to 26.39% of all ABPI assessments. Investigations and management categories were described 
for these referrals, as shown in Table 28:  
Investigations  
About a third (32%) of all referrals resulted in an arterial duplex scan for patients.  
There were 27 (27%) patients who were referred to a secondary care vascular department and 
had formal vascular laboratory ABPIs completed, and 20 (20%) patients who had PVRs 
completed. Exercise ABPIs followed 6% (6) of referrals. The purpose of the vascular 
department’s requests for formal vascular lab ABPIs was generally to re-check all ABPIs, or to 
have up-to-date resting ABPIs to be compared with PVRs or exercise ABPIs. Most patients 
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were seen three to five months following referral, sometimes meaning that there were 
changes in clinical history reported and at times the requirement of a more current ABPI 
result, and had to be repeated.  
Angiography was needed for 7% (7) of patients referred. Venous duplex scanning followed 5% 
of total referrals to the secondary care vascular department.   
 
Table 28:  Secondary Care Vascular Department Outcome Categories- Results 
Secondary Care Vascular 






referrals (100)  
Percentage of 
all 379 ABPIs  
Investigations:  
Arterial duplex scanning 32 32.0% 8.4% 
Formal vascular lab ABPIs 27 27.0% 7.1% 
PVR 20 20.0% 5.3% 
Angiography 7 7.0% 1.8% 
Exercise ABPIs 6 6.0% 1.6% 
Venous duplex scanning 5 5.0% 1.3% 
Other Management: 
Compression stockings or bandaging 35 35.0% 9.2% 
Referral to the wound care nurse 
specialist or ulcer care clinic 
9 9.0% 2.4% 
Bypass operation 9 9.0% 2.4% 
Nil 7 7.0% 1.8% 
Waiting to be seen 7 7.0% 1.8% 
Lower limb endarterectomy 5 5.0% 1.3% 
Ulcer or wound debridement 5 5.0% 1.3% 
Toe amputation 5 5.0% 1.3% 
Above-knee amputation 5 5.0% 1.3% 
Sclerotherapy  2 2.0% 0.5% 
Other management 2 2.0% 0.5% 





After patients had been seen by the vascular service at the hospital, 35 (35%) were given 
compression treatment (hosiery or bandaging), and 9 (9%) were referred to the wound care 
clinic (with specialist input from a wound care nurse). 
In regards to more invasive treatments, nine (9%) patients went on to have a bypass 
operation, five (5%) required debridement of a wound or ulcer and five (5%) patients had a 
lower limb endarterectomy. 
There were five (5%) patients who had toe amputations, none who had below-knee 
amputations but five (5%) had above-knee amputations which all followed referral. Above-
knee amputations were required in patients who were unresponsive to other treatments, or 
who had necrotic tissue where there was no other option available.  
Only two (2%) patients required sclerotherapy for venous disease.  
There were two patient referrals which resulted in “other management”. One of these 
patients had ulcer excision and skin grafting, and the other had thrombolysis. These were 
outlier cases which do not represent the majority of the management for secondary care.  
Seven (7%) patients referred had nil further management and were re-referred back to the 
GP. The reasons for this are highlighted on Table 29 below.  
Seven (7%) patients who had been referred were still waiting to be assessed by the vascular 





Table 29:  Cases Referred to a Secondary Care Vascular Department which did not result in 
Further Management 
Case  Reason for referral 
(Outcome Category)  
Reason for nil further management 
A Other- Low left dorsalis 
pedis pressure, needed 
compressive therapy for 
travel 
Patient was found to have normal ABPIs in clinic 
(no formal ABPIs) and was reassured that no 
further management was required.  
B Management of venous 
disease with ulceration 
Patient declined any further intervention following 
discussion with the vascular team.  
C Management as PAD Secondary care assessment found that the patient 
was asymptomatic and had atypical calf pain not 
typical of vascular pain. No further management 
necessary.   
D Management as PAD The impression by the vascular team was that of 
spinal stenosis and a re-referral to neurology was 
made.   
E Management of venous 
disease with ulceration 
The patient was referred with a non-healing ulcer 
and a reduced ABPI, but the ulcer had healed 
completely upon seeing the vascular team. Wait 
time was 2 months between referral and being 
seen.  
F Management as PAD The impression by the vascular team was that of 
spinal stenosis and a re-referral to neurology was 
made 
G Management of venous 
disease with ulceration 
Patient declined any further intervention following 





3.4.6 Deceased Patients 
Total MHC population 
There were relatively few deaths (‘dead’ statuses) recorded in the data (only five found upon 
data cleaning). Governmental funding is allocated in three month blocks only, and if patients 
die in that three month block, records are still recorded in the enrolled population. When a 
new three month block begins, because no dead patients are eligible for funding, patients’ 
records would be removed from the PMS. Therefore during the last three month block period, 
five patients died. This explains the scarce number of enrolled patients being classified as 
‘dead’. 
Upon cleaning the data, 58 of the total enrolled MHC patients had no “dead/alive” status, and 
their data has been included as they are assumed to be living. 
ABPI Group 
There were 82 individual patients who had been recorded as deceased as at the 25/04/2015, 
and who had been recorded as having at least one ABPI in the past. The mean age of these 82 
patients at the time of their ABPI was 88.7 years (compared with 77.6 years for the entire ABPI 
group). There were 97 ABPI assessments recorded for these 82 individual patients.  
Table 30:  ABPI Values and Co-Morbidities among Deceased and Non-Deceased ABPI Patients 
ABPI Values and co-morbidities  Deceased ABPI patients (enrolled)  Non-deceased ABPI patients 
(enrolled) 
Right Left Right Left 
ABPIs (ABPI result)     
Mean  0.91 0.94 0.98 1.00 
Range (Min-Max)  0.10-1.39 0.30-1.71 0.27-1.55 0.32-1.64 
ABPI Results (n)     
>1.2 4  5  15  14  
0.9-1.2 48  47  167  178  
<0.9 27  26  48  41  
<0.5 5  1  10  5  
Unobtainable or non-occludable  3  2  12  9  




Of the deceased ABPI patients, 57% were female, and all but one patient was of NZ 
European/Pakeha ethnicity. There was substantial missing data on socio-economic quintile 
and High Needs for this population (see Section 3.3.5 Missing Data).  
The mean ABPI results for right and left legs for deceased patients were 0.91 and 0.94 
respectively (at the time of their ABPI). These mean results were lower than the mean results 
for non-deceased patients (0.98 and 1.00).  
 
Figure 19:  Percentage of ABPI Values for Deceased and Non-Deceased Groups 
 
Of all enrolled ABPI patients, a larger percentage of non-deceased patients had ABPI values 
0.9-1.2 than patients who had died before 25/04/2015. Conversely, a larger percentage of 
patients who had died before 25/04/2015 had ABPI values <0.9 than those still alive. The 





3.5 Chapter 3 Summary 
This quantitative study describes the use of the ABPI in MHC over 2006-2015.  
ABPIs were conducted by Dr Hywel Lloyd at MHC between 2006 and 2015. ABPI data collected 
showed that 379 individual assessments were completed on 338 patients during that time. 
The main reasons that ABPIs were completed were to aid in guiding management of venous 
disease and to investigate suspected PAD. Patients who had ABPI assessments had similar 
demographic characteristics to that of the total enrolled MHC population. However, patients 
who had ABPI assessments had higher prevalence of other non-communicable medical 
conditions than the total enrolled MHC population.   
Nearly a third of patients having undergone ABPI assessments were managed as having 
venous disease without ulceration, a third were managed as having venous disease with 
ulceration, and about a quarter had no further peripheral vascular management. These 
categories were not mutually exclusive. Just over 16% of patients were managed as having 
PAD (without mixed disease). Of patients referred to a secondary care vascular service, 93% 




Chapter 4: Interviewing Local Health 
Professionals Regarding the ABPI in Primary 
Care- The Qualitative Arm of the Study 
4.1 Introduction  
The benefits of conducting ABPIs in both primary and secondary care are well documented in 
the literature, yet the actual use of the ABPI in primary care is still limited.4, 29, 68, 104 
Internationally, quantitative and qualitative studies conducted among patients and health 
professionals in general practices acknowledge usefulness in using the tool but concerns have 
been raised regarding practical barriers such as taking too much time and being costly.106 To 
date, no research has examined the usefulness of the ABPI in New Zealand general practice.  
To understand the possible practical barriers for undertaking ABPI assessment in primary care, 
a qualitative study involving interviews with health professionals in both primary and 
secondary care settings was conducted. This qualitative study gives insight into how and why 
the ABPI is or is not used currently by practicing clinicians, in order to identify the advantages 
and disadvantages of this assessment tool. This study examines the views of health 
professionals regarding the role of the ABPI in primary care, highlighting potential challenges 
to be addressed. If the ABPI is seen to be beneficial, then addressing and attempting to 
eliminate the barriers identified could help to enable future facilitation of this assessment in 
general practice.   
 
4.1.1 Aims 
 To explore perspectives of health professionals on the ABPI in general, and in terms of 
its role in primary care specifically.  
 To understand the prior knowledge and experience that health professionals have had 
regarding the ABPI. 
 To understand the perceived advantages of using the ABPI in general practice. 




4.2 Study Design  
The entire study is split into a quantitative analysis arm (Chapter 3) and a qualitative analysis 
arm (Chapter 4).  
The study design of this arm is a qualitative analysis of a series of in depth face-to-face semi-
structured interviews.  
 
4.2.1 Study Participants and Setting 
4.2.1.1 Participants, Inclusion Criteria 
Participants were recruited using a snowball sampling technique.150  
Snowball sampling is a non-random sampling method in which members of the study 
population are engaged by recommendation from other members. This allows for acquisition 
of participants who may have been difficult to contact otherwise. Snowball sampling allows 
stakeholders and professionals in the field to determine suitable candidates, such as 
colleagues with a special interest or expertise in the topic. In practice, this meant asking 
participants about recommending colleagues (e.g. GPs, nurses) for invitation to the study, 
following their interview. Contact details were collected, and invitation emails sent.  
Perspectives were also drawn from secondary care health professionals working in the 
vascular surgery department at Dunedin Public Hospital. Vascular referrals in the Otago 
Southland region are made to this service, and so it is prudent to appreciate opinions from 
this end of the referral pathway. Interviews with secondary health professionals also allowed 
a more holistic view to the subject, and to gain information from another viewpoint to 
supplement analysis of the other primary care health professionals’ interviews.  
Each participant read and signed an information sheet and consent form prior to recruitment.  
Inclusion Criteria  
Inclusion criteria for participants included:  
 Being situated in the wider Dunedin area 
 Being available to be interviewed in person for roughly fifteen minutes to half an hour 




4.2.1.2 Sample Size 
Sample size was determined based on the theoretical saturation point (when information 
redundancy was achieved).151, 152 This was estimated to be at around 8-10 primary care 
participants initially.  
Similarly, there was room to expand the number of participants interviewed should the 
researcher discover new themes or differences in data in order for information redundancy to 
be achieved (and more data on viewpoints to be shared).  
 
4.2.1.3 Population Setting 
The sample is confined to practitioners in the Otago/Southland region, in Dunedin. This is 
based on practical capabilities of the candidate being able to physically interview health 
professionals face-to-face.  
 
4.3 Methods   
4.3.1 Qualitative Methods Used  
This qualitative arm of the study involved conducting face-to-face interviews with health 
professionals for evaluation of the ABPI in general practice.  
 
4.3.2 Interview and Interview Design  
Participants were interviewed using a semi-structured format. Open questions were chosen as 
a method of engaging a fuller response, and allowing flexibility for the interviewer (candidate) 
to probe for further clarification or information.151  An interview schedule was written as a 
guide for each interview (see Appendixes I and J) with pre-determined categories (topics) and 
questions to be explored.  
Categories included prior experience of health professionals with the ABPI, views on 
advantages of the ABPI, views on barriers or challenges to using the ABPI, and views on the 
use of ABPI in the primary care sector.   
Traditional interview techniques were incorporated into interviews to stimulate conversation 
and reasoning. Techniques used by the interviewer to establish rapport included reflective 
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listening, being unassuming, and using encouragers (such as nodding of the head).153 This 
helped to maximise the amount of information interviewees were willing to share.  
Interviews were audio recorded using an Olympus digital voice recorder (model DS-2300), and 
audio files of all interviews were saved onto a secure computer. These audio files were used 
for manual transcription by the candidate into textual format, allowing for analysis and coding 
(see Section 4.3.3 Data Analysis).  
Anonymised field notes were also written during the interview to note any thoughts, 
emotions, perceptions or pertinent ideas that the interviewer may have faced during the 
interview.  
 
4.3.3 Data Analysis 
A systematic Framework Method approach of qualitative data analysis was completed to 
reflect a true representation and interpretation of the data gathered.154  
Recorded interviews in audio file format were transcribed verbatim by the candidate manually 
onto a word document text format. Once interviews were transcribed, different opinions and 
subjects which arose in the transcribed interviews were coded in the text margins.  Similar 
opinions and subjects are described as codes or ‘themes’. Data were read multiple times in 
order to add, collapse, expand, and revise codes.155 In addition, field notes were collated and 
analysed (coded) alongside transcribed interviews.  
A process of triangulation was used whereby coded data was re-read by and discussed with an 
external analyst (in this case, a fellow research student) to validate and highlight the coding 
used by the candidate. This approach was used to improve reliability, and decrease 
subjectivity (researcher bias). Discussion with the secondary analyst also provoked further 
thought, scrutiny or justification for coding (see Section 5.3.1 Strengths).  
The data analysis was carried out using a constant comparative method in which coded items 
were checked with the rest of the data already collected in order to match or distinguish 
codes.152 The constant comparative method allows categories to reflect as many nuances in 
the data as possible, to provide specificity in results. A split screen computerised approach 
facilitated comparative techniques.  
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A grounded theory approach was used to identify analytical categories as they emerged from 
the data.156 This means that hypotheses were developed as the analysis process continued, 
rather than defined a priori.  
Once a number of interviews had been analysed, charting was used to rearrange the data 
according to the thematic framework.154, 156 Charting involved generating a spreadsheet where 
themes were entered as headers. In order to illustrate and provide evidence of themes and to 
distil summaries of specific views and experiences, meaningful quotes were collected and 
grouped into the chart. Charting funnels evidence into a sorting system which can help check 
whether there is sufficient evidence for the proposed theme.  
The charts were then used in a process of mapping and interpretation. This meant deriving 
similar and dissimilar features among categories and themes, mapping the range and nature 
of results, as well as defining any relationships between the data.  
 
4.3.4 Sequential Analysis 
The process of data collection and data analysis occurred simultaneously, also known as 
interim or sequential analysis.156 This process allowed for the interviewer to begin assessing 
data as soon as it was collected, aiding familiarity and for the possibility of any interview 
questions to be refined, removed, or added.  
 
4.3.5 Ethical Considerations 
The literature review highlighted the need for qualitative analysis in order to understand 
health care professionals’ reasoning for using or not using ABPIs as part of their service. This 
important aspect of the study was realised only after ethics approval had been gained solely 
for the quantitative arm. An amendment was made in writing to the ethics committee and 
ethical approval was obtained on the 28th January 2015 for the interviews (see Appendix F).   
Clinicians recommended for interview were given a Participation Information Sheet (see 
Appendix G) to inform them of the intentions of the study and purpose of the interview. A 
Participation Consent Form was subsequently signed if participants were happy to proceed 
(see Appendix H).  
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In order to protect the confidentiality of participants, all transcribed and analysed data were 
anonymous. Pseudonyms were used in place of real names. Following analysis, all digital 
recordings were deleted.  
There were no anticipated harms of the study.  
 
4.4 Results 
The results are grouped into sections correlating to different aspects and views on the use of 
the ABPI.  
 
4.4.1 Demography of Participants  
In depth interviews with 13 health professionals (participants) were completed (see Table 31).  
Table 31:  Participants and Demographics 
Participant  Sex  Primary Occupation  Other current roles  
1  M GP  Senior lecturer, Research, Guidelines group, 
Others 
2 M GP  Guidelines group 
3 F GP  
4 F GP Management, GPSI  
5 F GP Teaching, Others  
6 M GP Management 
7 M Vascular surgeon Research, Teaching, Others 
8 M GP  
9 F Vascular surgeon Teaching 
10 F Clinical manager of vascular 
diagnostic laboratory 
(secondary care clinician) 
Research 
11 F GP Research 
12 M Wound care nurse specialist 
(secondary care clinician) 
 
13 F GP Hospice medical officer 
 
Of these 13, sex was divided fairly equally with six males and seven females interviewed.   
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Nine (69%) of the participants were health professionals in the primary care sector. All were 
general practitioners who had a Bachelor of Medicine and Bachelor of Surgery qualification.  
No registered nurses, nurse practitioners or other allied health professionals in the primary 
care sector were interviewed.  
Four (31%) of the participants were health professionals in the secondary care sector. Of 
these, two were vascular surgeons, one was a clinical manager of Otago Vascular Diagnostics 
and one was a wound care nurse specialist.  
Many of the health professionals interviewed had many other roles. Some had unique clinical, 
medical or academic roles which were personally identifiable. Where this was the case, roles 
have been listed as ‘other’ in Table 31.  
All of the health professionals interviewed practiced in Dunedin, New Zealand. None worked 
elsewhere except for one vascular surgeon and the wound care nurse specialist who 
completed clinical work in the wider Otago Southland region monthly.   
 
4.4.2 Primary Care Health Professionals’ Use of ABPIs 
Participants in primary care were asked whether they had access to a Doppler ultrasound at 
their practice, and whether they performed ABPIs themselves.  
Six of the nine participants in primary care had access to a Doppler ultrasound. However, 
there were only two GPs identified who performed ABPIs regularly.  
There were no health care professionals who stated that they had done them regularly in the 
past as a GP.  
 
4.4.3 Previous Experiences with the ABPI  
Participants were asked what their previous experience, if any, has been with using or 
observing the ABPI. There were varying levels of experience. Seven of the participants in 
primary care had some experience with ABPIs in the past. None said they had ever had any 
formal training on ABPIs. Of the seven who had some experience, four (31%) had heard of or 
seen it being done vaguely during their time at medical school: 
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“I’m sure I saw them at med school but not as house surgeon. I never worked for the 
vascular team, my surgical teams ended up being urology and yeah I never worked 
with the vascular team so I never saw them in action that way.” –GP  
“I remember a little bit of the clinic stuff with venous ulcers and arterial ulcers and 
stuff like that, but not a big part of a my surgical training as a med student” –GP  
“No, I don’t think I actually ever did them. I just observed [at medical school].” –GP  
Three (50%) had exposure when they were a house officer:   
“I just used the vascular Doppler on the ward in the hospital as a house surgeon and 
[had] been shown how to do it when I got the machine. I think I rang the vascular 
technicians and just double checked what sort of thing you could do and I only think 
they just gave me a verbal description of what they did, and I didn’t’ think it was too 
hard so I just did it.” –GP  
 “I did a [house surgeon] vascular run, so yeah, we would be using equipment then, but 
that was a while ago… that’s a good many years ago now.” –GP  
Two of nine professionals in primary care had no previous exposure to ABPIs. 
“Well I’ve never even seen one done.” –GP  
“No, I haven’t, no [In response to asking about previous exposure].” –GP  
The two GPs who regularly do ABPIs both had minimal previous experience. One had 
experience with ABPIs as a general practice trainee and one had exposure while doing some 
emergency department work. Neither had any formal training. They began doing them for the 
reasons of venous ulcer disease treatment, and cardiovascular risk factor, in addition to their 
ability to diagnose peripheral vascular disease.  
“I have been through GP training and did a number of attachments in geriatric 
medicine, or care of the elderly medicine as it is called here, and general medicine 
attachments, and wasn’t really familiar with it until I went into general practice and it 
was probably the mid-90s that I started doing them again for the same reasons, 
mainly around four-layer bandaging treatment of venous ulcer disease” –GP 
“I would have used it for part time work in the emergency department but… I don’t 
know, I definitely never had any special training on it as such…Yeah, so there’s a 
couple of ways that I use it and the first thing that made me get a vascular Doppler 
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was, was some research around using ABPIs as an extra cardiovascular risk marker so 
if you could detect a, a low ABI it suggests that people have got vascular disease, so 
that’s one use. Another use is if we want to look at compression therapy for venous 
stasis, so we would have to make sure there is adequate arterial supply to the legs to 
make sure that they’re not contraindicated. And then you can use them as diagnostic 
for diagnosing peripheral vascular disease.” –GP   
 
4.4.4 Beneficial Role of Using the ABPI 
The potential or perceived benefits and advantages of using the ABPI in general practice were 
discussed with all participants. Themes included being able to diagnose peripheral vascular 
disease, to be able to check for mixed vascular disease in patients with venous disease 
presentations, ability to aid referral, decreasing the burden on secondary care, ability to 
manage patients in primary care, ease of use, and aiding cardiovascular risk factor education 
for patients.  
 
4.4.4.1 Diagnose PAD 
Many of the participants recognised firstly that the ABPI is able to evaluate and diagnose 
peripheral vascular disease in patients in conjunction with clinical symptoms. Professionals 
stated that it is a diagnostic tool helpful in defining disease as well as ruling out PVD in 
considering differential diagnoses.  
“So probably the main critical clinical intervention area is when, is when a GP suspects 
that someone has got peripheral vascular disease, but they’re kind of not sure. The 
patient’s come in with vague symptoms of leg or foot pain that may not be classical 
claudicating pain, or even night pain and restless legs type syndrome.” –GP  
“Low [blood] pressure, absent pulses you know you’d look for, patient presenting with 
intermittent claudication; clearly you’d think of that they’d need vascular studies to 
quantify [PVD]” -GP  
“There’s a lot of overlap between lower leg cramps, pain, restless legs even peripheral 
neuropathy can be misinterpreted as vascular disease. The ABPI gives you pretty good 
reassurance that if the ratios are higher than 0.9, you can be pretty comfortable that 
there are no major blockage of any of the major arteries going down the leg” –GP 
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“I suppose in terms of clinical diagnostic purposes if I had somebody that was 
presenting with symptoms if I wasn’t sure if it was spinal or vascular claudication, then 
doing an ABI would help to differentiate that possibility.” –GP  
“I think sometimes it’s handy to be able to say that there isn’t any obvious peripheral 
vascular disease to kind of clinically satisfy.” –GP  
“Ensuring that somebody presenting with say leg pain and no clear no definite history 
of arterial problems just as part of the examination just to give confidence that the 
diagnosis is other than arterial disease.” –Vascular surgeon  
Some professionals stated that using defined ABPI results to diagnose or rule out PVD can help 
to define the next step in management for patients in primary care.  
“I think it makes a big difference in some patients, so say if you get a patient with leg 
pain and the history is not very clear whether it represents rest pain or leg pain or foot 
pain from another cause, if we have an ABI associated with it you can make a 
judgement call whether that patient needs to be seen as soon as possible in [a hospital 
outpatients] clinic if we think they’re having rest pain, or whether it’s more likely to be 
limb pain for another cause where we could have another appointment booked for an 
assessment. So from that point of view it’s very helpful.” –Vascular surgeon   
“One [patient]… he must just be 65 now, would have been a few years ago when he 
presented with intermittent claudication, quite classical you know pain with walking, 
and resolving with rest, and he ended up, you know I referred him down there, and he 
ended up having ABIs and they ended up saying it wasn’t peripheral vascular disease. 
Whereas if we had availability of doing that, we could have screened him in the clinic 
and not wasted the resource of sending him down there.” –GP  
One GP who does ABPIs stated that diagnosing peripheral vascular disease has been one of 
the most significant advantages for doctors in primary care.  
“That’s the… most impact that can be generated by that, and doing it over the years, 
that’s probably where the most benefit has been gleaned from acute intervention and 




4.4.4.2 Check for Mixed Vascular Disease 
The ABPI was also seen as useful for many primary care professions in being able to evaluate 
whether there is arterial disease in patients with a venous disease presentation such as in 
patients with varicose veins, venous ulcers or dependent oedema. This was because it meant 
GPs were able to recommend compression treatments and immediately manage patients if no 
arterial disease was present, or conversely, to refer to secondary care services where there 
was arterial disease.  
“That would be a great advantage to be able to check their flow and see whether 
[patients] were suitable for compression bandaging or not and it would have sped up 
the treatment process sometimes.” –GP  
 “If you have patients with venous changes or varicose veins and you’re thinking about, 
compressing them then again you could be reassured without necessarily having to 
refer for a specialist opinion.” –Vascular surgeon  
Identifying whether patients are able to have compression earlier rather than later was seen 
to be beneficial for allowing faster healing times, reducing risk of complications and wasted 
health professional and patient time.  
“You know, and if I [ruled out] arterial problems early, it would help [patients]  in 
assisting definitely with compression bandaging, and compression support stockings 
and really, that’s most important for lower leg wounds that people go very quickly to 
support stockings or compression bandaging...” –Wound care nurse specialist 
“Clearly treating venous disease is important. We see an awful lot of minor lower leg 
lacerations that get that don’t receive compression early enough that go on to form 
ulcerations or slowly heal, and that creates associated morbidity for patients, health, 
inappropriate use of health resources, doctor time, nursing time, patient time, using 
dressing without using compression” –GP  
GPs commented that there was a substantial need for compression treatment in patients in 
primary care.  
“Mostly, before we look at putting compression stockings on [which] would be the 
main way that I use it” –GP  
“In my last practice, where I was full time, we had a lot of oldies with a lot of ulcers, 
non-healing ulcers, who we wanted to do compression bandaging on.” –GP  
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ABPIs were seen as helpful in aiding choice of compression stocking type (higher or lower 
levels of compression).  
“It’s a really good assessment too for seeing the blood flow into the lower leg and give 
us an understanding of what type of compression we can use if any… we follow 
Australasian guidelines, so there’s a range between 0.8 and 1.2 where we say it’s a 
normal ABPI and we use full compression, where the compression is 40mmHg at the 
ankle…0.6-0.8, we would put some light compression on… between 0.6-0.8, you use 
light compression 20-30mmHg at the ankle site.” –Secondary care clinician  
 
4.4.4.3 Aid Referrals Being Accepted 
ABPI results included in patient referrals to secondary care professionals were seen as a 
significant advantage as it added more information to support the referral.  
“I think it might strengthen your referral letter, you know, if you show the surgeon, 
you’ve taken their problem seriously and particularly if you are referring to someone 
who always likes that measure that would be a good reason to do it.” –GP  
 “If you can, in a referral letter, say, well if this is what I already know about this 
person, you know, they are at high risk or you know, it would perhaps help with 
triaging to get appointments and stuff cause everybody is under pressure and 
secondary care is under pressure so anything that tries to help that would be good.” –
GP 
“Certainly, it’s some sort of scientific rigour to the referral rather than, often they’re 
quite vague” –Secondary care clinician  
A secondary care clinician agreed that more information led to a better referral (where 
information was relevant) and that this improved the quality and overall standard of referrals:  
“We reject those [poor] referrals because we want to change the culture. We want to 
change and get better referrals, so when I say, the Southern District Health Board, 
there’s a vascular consultant who grades that, they want to know more. So that is 




4.4.4.4 Decrease Burden on Secondary Care  
ABPIs in primary care were believed to help reduce unnecessary referrals to the hospital. 
Participants believed that ABPIs allowed identification of patients with less severe or no 
disease to be managed in the community, and so aided in decreasing the number of patients 
seen in outpatient units or vascular laboratories in the secondary care setting:  
“If we are doing them out here [referring to general practice], it saves another job in 
there for them that if they actually test out to be OK here, we don’t need to refer them 
further. So it leaves a system in the hospital if we are doing them in general practice.” 
–GP  
“Anything, things that can improve outcomes and speed up referrals, or make more 
appropriate use of referrals then, yeah, that’s got to be good for both primary and 
secondary care” –GP  
Some participants believed that ABPIs would allow more appropriate use of different types of 
referral, such as using an ‘advice only’ referral, rather than referral for full assessment: 
“I suspect there would be more of a role for using the advice only part of our referrals 
that we can do… so you can say yes you want a clinic assessment or you can refer into 
a consultant saying ‘I just want some advice about this person and if you’d had this 
person saying ABPI’s 0.7 or whatever, what would you advise management given 
other comorbidities’ and [vascular surgeons] could have potentially spent 5 minutes 
reading that and saying that we wouldn’t do anything, it’s probably not severe blah, 
blah, blah, and sending that back” –GP  
Correspondingly, secondary care professionals agreed with GPs. They discussed that having 
ABPI values in referrals would mean they would not have to evaluate patients who did not 
need to be seen (inappropriate referrals) and that it would improve waiting times for patients 
who did need to be seen.  
“The biggest advantage I would see is that those who do not need to come through to 
the vascular lab would not attempt it.” – Secondary care clinician  
“There is an issue with waiting times and trying to reduce number of people who don’t 
necessarily need a specialist assessment having come through… There is no doubt that 
reducing the waiting list for vascular lab assessment as well as clinical assessment, it 
would improve things.” –Vascular surgeon  
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“It saves your referrals, and in one setting, because we get a lot of referrals, just to do 
ABPIs.” –Vascular surgeon  
This would mean that more appropriate spending would occur in secondary care services.  
“It’s not good economics for us to being using top end to do stuff [secondary care 
services] for can you wear stockings or not, and there’s where I believe your practice 
nurse and in particular GP should have great confidence in doing.” – Secondary care 
clinician 
 
4.4.4.5 Triaging in Secondary Care 
Further to decreasing the burden of unnecessary referrals in secondary care, the ABPI result 
itself was seen to have an impact on triaging patients so that those with lower ABPI results 
would be seen more rapidly, and be treated quicker than those with less severe disease.  
“I suppose the advantage is that you’d have an answer much quicker and refer to the 
vascular surgeons, yeah, so if someone needs bypass surgery, they’d get it done more 
quickly.” –GP  
“It seems reasonable that if GPs had the resources then they would be able to do [the 
ABPI], the ABPIs would at least be a start and would enable the vascular department 
to triage a little better in terms of their appointments.” –GP   
“Well clearly having a result and seeing if they are really compromised, clearly you’re 
going to refer them quicker but that would, [and] if they meet the criteria… they’re 
gonna be seen more quickly” –GP  
Professionals thought that using ABPIs in general practice would help to qualify the neediest 
patients, and minimise waiting times to be seen and treated:  
 “It also speeds up referral so you can get much better access into secondary care if 
you’ve got ABPIs, ABPI results to prove the level of obstruction” –GP  
“If we get a referral with an ABI because it helps us because the ABI is low. It means 
that the surgeon will immediately organise vascular studies, so that would speed it up” 
–Secondary care clinician  
“I don’t think we’ve disadvantaged patients. I think we have aided patients so less 




4.4.4.6 Ability to Manage Patients to a Greater Extent in Primary Care 
There were views that general practice ABPIs could allow more patients to be managed in 
primary care, which was seen as beneficial to patients because of ease in seeing their 
established family doctor, reducing unnecessary travel to the hospital. Both primary and 
secondary care professionals thought this.  
“Clearly being able to do things in your own practice with your own patients, they like 
that so they don’t have to go to the hospital, get their parking, and seeing someone 
else they don’t know, I think that’s a good thing.” –GP  
 “I think it’d be good to try and do as much as possible in the community” –GP 
“That’s been the view by some for a long time - leave it to the experts. But at the other 
end of the equation, some of your patients may be hospital based, or rest care based 
or whatever it might be, or circumstances might be that that’s not feasible to 
commute into these secondary, tertiary, institutes because they’ve got limiting factors, 
be it whatever social circumstance.” –GP  
“I don’t think patients would have any problem with having it done, you know, it’s non-
invasive from their point of view and apart from having them to wear something, it 
means you can get to the leg, they’re used to having their blood pressure done, it’s not 
really different in that sense.” –GP  
A GP summarises how being able to do ABPIs in general practice maintains patient-centred 
continuity of care without needing to rely on test results being sent back from the vascular 
laboratory: 
“The gentleman I mentioned before who I did refer down, he ended up seeing [the] 
vascular lab well ahead of any other appointment, but we never got the information so 
when he came back saying what did that show, you couldn’t discuss it, whereas being 
in control of that information, you can, you’ve got that there to discuss what it means 
and what the impact’s gonna be, so that’s definitely better to keep things centred here 
for them if you can.” –GP  
There was a perception that ABPIs completed in more rurally or distantly placed locations 
would aid in allowing patients to be managed in primary care, meaning patients would not 
necessarily need to go to distant hospitals to get assessed.  
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“So we’ve got quite a number of people trained already who do the ABIs. There are 
about four nurses in the community who do ABIs and they can do them at home. It’s 
not a problem because people train in Dunedin, Balclutha and in Oamaru. They do ABIs 
when there’s a need.” –Secondary care clinician  
“It would make life a lot easier for patients, especially if they have to come a long way 
for appointments.” –Vascular surgeon   
 
4.4.4.7 Ease of Use 
Many professionals believed that the ABPI was generally easy to perform and was not a 
difficult skill to learn: 
“From my understanding, it’s reasonably straight forward.” –GP  
“I think it’s a very simple test” –GP  
“Oh, it’s pretty straight forward, you know as long as you’ve got the cuffs that are the 
right size and things like that, it is fine.” –GP  
In response to what amount of training and expertise was needed to be able to do the ABPI 
from secondary care professionals’ views, there were mixed responses. Some thought it was 
very simple:  
“Very little. It’s easy-peasy… It’s easier than the stethoscope if you think about it. 
Because it doesn’t rely on your ears, how you put the thing in your ears, or whether 
you can hear you know. It is there in front of you” –Vascular surgeon  
“It only takes 10 minutes to learn how to use it. With a little bit of practice, and an 
understanding of principles, but you can read about that in most books. Fourth year 
medical students can do it.” –Vascular surgeon 
Others believed it required more experience to become proficient at performing the ABPI: 
“Is it an easy test? I think when it’s a normal ABI I don’t think technically it’s a difficult 
test. I think what can happen depending on experience, you might, the less experience 
you have the longer it might take to do it, the harder it may be to… in patients with 
low ABI. But I guess on the positive side, a lot of patients who may not require referral 
for specialist opinion, that group will be the one with normal ABIs, so you can be 
reassured that if it was a normal ABI, even though you may not necessarily get the 
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very low ones which you can then refer on and have them rechecked, I think it would 
still be useful.” –Vascular surgeon 
 
4.4.4.8 An Aid in Conveying Cardiovascular Risk  
Some GPs believed that the ABPI result would allow them to communicate to patients 
whether they had any signs of PAD, or any physical manifestations of cardiovascular disease. 
This is in contrast to just using markers such as lipids which may be more difficult for patients 
to understand or relate to.  
“It would probably be something more concrete for the patient, that they’re seeing a 
measure of end-organ damage as such. Like we are not just talking about their risk 
factors any more. It actually moves on to showing some disease.” –GP  
“Some talk about how useful it is just to calculate cardiovascular risk all over, you 
know, overall risk...I think, it can be a good tool probably to educate those people and 
also for the GP to know this is what it is now and maybe, can do it again later and see 
what a difference there was, or you know, if things are deteriorated...and perhaps if 
you’re struggling to make them aware that they need to change some things, so do 
they need to stop smoking? Do they need to lose weight? Do they need to walk more?” 
–GP  
“I think it would be a really useful thing to do, you know you could also capture them, 
you know, if you get numbers telling them somethings starting to happen and you can 
kind of tell them what might evolve over the coming years, it might be motivation as 
well to get lifestyle change.” –GP  
One GP who does ABPIs believed that screening patients with previous cardiovascular events 
for PAD using the ABPI could have a benefit:  
“Should you be doing ABPIs on … anyone who’s had a previous [cardiovascular] event, 
whether that be a TIA or stroke or a, or a cardiac event, you know, should you be 
assessing people for peripheral vascular disease using ABPIs, and there’s just a 




4.4.5 Challenges or Barriers to Using the ABPI 
Participants were asked to identify challenges or barriers to using the ABPI in general practice 
in their view. The main themes were of the ABPI taking up too much time, being too costly, 
interviewees being unaware of its value, having a low patient need for ABPIs, and other 
practical issues.  
 
4.4.5.1 Taking Too Much Time 
Primary care participants often commented on how the ABPI would take too much time, and 
would impinge on the time needed to see other patients or on other work related activities. It 
wasn’t necessarily the time itself which was the barrier, but the view that time was better 
spent elsewhere such as with seeing the next patient.  
“You don’t have much time [in general practice]. You have people coming through, and 
you don’t want something that’s gonna slow you down” -GP 
 “But yet you’ve got to balance that with doing the right thing in your consult, as well 
as not holding up the next person” –GP 
“You know, if you do an ABI, it takes about 25 minutes, half an hour to do it proper. 
Which GP has that time? I dunno, not many.” –Secondary care clinician  
“If someone comes in saying, yep I’m just here for this one thing, then you’d potentially 
have time within that consultation but actually if they come with their list, then they 
won’t be able to fit that in as well as everything else” –GP  
GPs stated that other aspects of ABPI use would take up significant amounts of time too. This 
included time taken for patients to remove clothing, and for doctors to find the necessary 
equipment if not situated in the room.   
“It’s time consuming, it’s really awkward for patients to strip them off, to get them up 
on the bed, and find a cuff that’s big enough to go around their legs, bits and pieces 
like that. So practically it’s not that easy.” –GP  
“So, unless you’ve got the Doppler machine sitting in your room right there… if it’s 
somewhere else in the practice, you’ve physically got to spend a couple of minutes 
going and getting it… every little bit that delays your 15 minutes makes you run later, 
a morning, or whatever, your whole session” -GP 
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Further, performing the ABPI would take up the time of extra staff, or other resources such as 
room availability. 
“Have you got enough time? [As in] staff time, room availability to actually do the 
measurement?” –GP  
 
4.4.5.2 Being Too Costly 
Another barrier to ABPI use mentioned by participants was the cost involved with doing the 
ABPI. This includes the capital cost of purchasing the Doppler ultrasound equipment itself, as 
well as the extra cost of a longer appointment (and so the opportunity cost of not having 
another paying patient instead). As general practices are businesses themselves, GPs tended 
to do a cost-benefit analysis regarding the test.  
In response to what barriers or challenges were seen for primary care professionals in doing 
the ABPI, some said:  
“The cost of the Doppler” –GP  
“You [have] got to line up all your hats, your sort of evidence hat, your business hat, 
you know, can you make a business case to recover that initial cost and all the rest of 
it?” –GP 
“Mainly money.” –Vascular surgeon 
“You’d think of the cost in both dollar terms and in time, and if it’s gonna be expensive 
and it takes a long time, then you’re not generally going to be very interested, 
especially if it’s a condition you don’t really see much of.” –GP  
The cost was not seen as being confined to just the Doppler ultrasound necessarily, but also 
the cost of the consequential treatment such as compression stockings:  
“[There is] a cost factor, because compression bandaging itself is not cheap. So who 
would pay for this, you know the government at the moment, picks up the cost for 
dressings and compression bandaging in the community funding model at the moment 
where in the primary model, when you go to the GP you have to pay yourself, or you 




One GP mentioned that the choice of using a test was also influenced by whether there is 
funding by the PHO.  
“We’re clearly running a business here and the funding issue, if we’d paid to do them 
by the, you know, PHO.” –GP 
Another GP did a brief online search for new Doppler ultrasound machines upon finding that 
their practice’s Doppler did not work. They commented that buying a new one was too costly.   
“I went to see how much a new one was and they were more expensive then I had 
expected so let’s put that by the way side.” –GP  
Conversely, one GP who does ABPIs regularly believed that the Doppler ultrasound was not 
that expensive: 
“They’re not cheap but they’re not that expensive and the clinical value you get from 
doing them is quite [good]” –GP  
Another believed that things would become more affordable over time: 
“Obviously the [machine] is obviously going to become cheaper as you know, as time 
goes [on].” –GP    
  
4.4.5.3 Lack of Awareness of the ABPI’s Value 
Some primary care professionals were unsure or unaware of the value that the ABPI brought 
to their practice. Some of these practitioners were unsure of the benefits of knowing the ABPI 
result, while others were unsure of how these results would change their management of 
their patients.  
“Well [it’s] always useful having a test that is telling you what you don’t know already. 
I don’t specifically know the value of the ABI though.” –GP   
“I don’t really see what specific advantages to find [ABPI results] out ourselves, rather 
than to refer them to the hospital.” –GP  
“As to whether they have a good intrinsic value, you know I’m not really that sure to 
be honest. I never found them very useful clinically [regarding management].” –GP  
One GP who performs ABPIs acknowledged that he was unsure of how useful the ABPI results 
he had put in his referrals were for the secondary care team receiving them.  
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“I sometimes do it and put it in my referral to the vascular clinic, I don’t know how 
much they use that information.” –GP  
 A GP who had minimal previous experience with ABPIs (only doing them in medical school) 
had a lack of knowledge regarding the value of the ABPI:  
“To be honest, I’ve never ever, ever, ever done it since then [laughs] so that’s kind of it, 
the limit of my knowledge.” –GP  
 
4.4.5.4 Having a Low Patient Need for ABPIs  
Many primary care professionals stated that they did not do ABPIs because there was little 
need to do them. Practitioners did not have enough patients presenting with reasons to do 
the ABPI. GPs reported a low number of patients who they believed warranted having ABPIs, 
so there has not been a great demand or need to consider the ABPI in their practice.  
“My volume of patients isn’t that large I just probably don’t have the need to do 
them.” –GP  
“I haven’t seen a patient with a good history of claudication for ages” –GP   
“I don’t see all that many people with vascular disease, all my patients are younger 
and yeah it’s not, well peripheral vascular disease I should say.” –GP    
“I don’t have many patients with severe peripheral vascular disease. I suppose if my 
demographic group was a bit different, I may use it a bit more, but so far I haven’t had 
that.” –GP   
“There’s not enough, if it was Sydney or Auckland maybe, but Dunedin is just a very 
small quota of, not sure if that would [work for compression bandaging clinics in the 
community].” –Secondary care clinician  
One GP suggested that the need is reducing due to better current care of vascular patients, 
and believed they were seeing less chronic leg ulcers as time went on:  
“I think one, we are better at dealing with them, better at getting them healed than 
perhaps what they used to be, you know, even over the last 10-15 years things have 
improved. I think we’re better at chronic medicine control, you know, better at 
controlling peoples’ diabetes and whatever else is going on, so it’s in my view less 
common than it was.” –GP  
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Professionals in secondary care had mixed views regarding need. Two acknowledged that the 
ABPI would be used much less frequently than in secondary care, which poses a dilemma in 
whether it should be used in primary care:  
“For someone like me, it’s my daily work, but for general practitioners, it’s an 
infrequent event. I have a brother who’s a GP who bought one… And now he’s telling 
me that he hardly uses it. So why should he have spent all that money on it, which is a 
fair question really. So it’s a bit of a catch twenty-two.  –Vascular surgeon  
“I’m not sure if we’ve got the, the critical mass for [ABPIs being done community 
wound clinics] to be honest.” –Secondary care clinician  
Meanwhile, a secondary care health professional challenged the notion that there was a lack 
of patients presenting with vascular problems in primary care based on their experience:  
“I find it hard it to believe that this population Dunedin not having much exposure to 
vascular patients when I know how many come through our laboratory” – Secondary 
care clinician 
 
4.4.5.5 Confidence in Ability  
Confidence in knowing how to perform the ABPI to proficiently was discussed as a challenge 
involved with doing the ABPI. Health professionals in primary and secondary care believed 
that a major barrier was lacking the confidence or ability to perform the ABPI:  
“I couldn’t give you the technique. You know, if you asked me to do it tomorrow or 
today, I couldn’t actually do it myself, yeah.” –GP  
“[The] training aspect of it [is a barrier] and having access to have somebody, to, to go 
through it with them and do a few cases with supervision so that you’re happy that 
your results are accurate, and there’s an awareness of what results mean” –Vascular 
surgeon  
“I think it is confidence and reliability of being, you know, having the confidence in, 
reassurance of what you are doing is right and accurate” –GP  
The technique of using an ABPI was seen to be a little difficult for some clinicians:  
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“Again there’s a degree of technique that’s used. It’s a bit like sort of patting your head 
and rubbing your belly… trying to maintain that co-ordination can be tricky sometimes.” 
–GP  
“You don’t [want to] look too silly, and as though you don’t know what you’re doing” –
GP  
Accuracy of ABPIs was a concern for one GP who does ABPIs regularly:  
“Do my readings compare with [the] vascular lab’s well, I don’t know, I have no idea!” 
–GP  
Despite many current GPs expressing concern with their ability, a secondary care health 
professional believed that this is changing with new cohorts of medical graduates. 
“I suppose part of that is becoming confident in examining, so I believe as part of the 
training for young med students nowadays is improving, and that young students are 
probably going out with a better knowledge base, I would hope, that allows them to 
have greater confidence as young practitioners, and thinking further in relation to this 
disease” – Secondary care clinician 
 
4.4.5.6 Test Results Not Changing Management 
Some participants mentioned that the ABPI test would not change their management of 
patients if completed in addition to taking a history and undertaking a thorough examination. 
Some practitioners felt that if they were worried about patients based on history and 
examination, they would refer them to secondary care anyway, despite a normal reading:  
“I guess by the time you’re referring someone to the vascular clinic, you want a little 
more than an ABI, you want a specialist opinion or nurse or wound care’s opinion or 
input or follow-up and opinion on whether they need to be offered any other 
investigations or treatments so it’s kind of similar to that.” –GP  
“If we think someone really needs it, we tend to refer them to the vascular clinic just 
because they have the expertise to go the next step...if you’re that worried about them 
you tend to send them in.” –GP  
“I’d probably still do the ABPIs even if they had a good history of rest pain, knowing I’d 
probably be referring them in anyway.” –GP  
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One GP mentioned that ABPI use could influence management but due to the fact that some 
practices do not offer particular lines of management themselves, would have to refer 
patients to another service anyway. Below, the GP discusses how the ABPI could be used in 
identifying suitable candidates for compression therapy, however compression therapy is not 
offered by their practice, so referral to a district nurse or wound care clinic would be required:  
“The problem is the next step, which is what compression therapy do you use, and for 
us to either stock or get experience with measuring up people’s legs and 
recommending different types of compression therapy or implementing it, and it’s a 
real big hassle, and it’s a cost risk. Whilst medicines are funded through Pharmac and 
that, the stockings of various strengths and that aren’t and so the other thing is that 
my practice is fairly small, a few doctors full time equivalent practice. To get enough 
doctor and nursing experience applying compression therapy just hasn’t been 
practical.” –GP  
 
4.4.5.7 Not a Priority for Primary Care 
Another barrier or challenge to using the ABPI in a primary care setting is that there are many 
other clinical or administrative tasks which are prioritised above its use. Practitioners stated 
that there were other tests or jobs which would be important to do first, and would demand 
the time of the professional above using ABPIs:  
“I’m not sure that it is high on my list of priorities of things that could be done in 
general practice to reduce the burden on secondary care, so there’s lots of other 
things, like colposcopy, ultrasound, lots of things that with the right training and 
equipment would provide a, from my perspective anyway, would seem to provide a 
greater release of the burden on secondary care than ABPIs” –GP  
“There would probably be other things that would be further up the priority list.” –GP  
A GP states that in conjunction with their busy role as a senior manager of the practice, they 
have limited time and would have to prioritise use of their time with patients and other tasks:  
“Because I’m sort of the senior person here, there’s a lot more of sort of management 
type things that you know, running the practice. From a practical point of view, you 
know, it’s not that I’m not interested in it.” –GP   
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The ABPI was compared to an ECG machine in one interview to illustrate the decision making 
process in choosing how to spend practice budget. There were pros and cons of using each, 
but the GP felt as if the ECG had more influence in changing clinical management:  
“I mean compared to say ECG which I find incredibly useful as a tool for picking up 
rhythm disturbance which could change your management on the spot, or for people 
with chest pain and a few other things, I wouldn’t use [ABPIs] as much as our ECG 
machine. But on the other hand, it doesn’t cost as much as an ECG, it’s probably about 
as easy to do, if not easier to do an ABI than an ECG in some ways…” –GP  
 
4.4.5.8 Inherent Limitations of the ABPI in Some Patients 
Some primary and secondary care professionals have emphasised inherent limitations of the 
ABPIs themselves and how this may affect its use in a general practice setting. They 
acknowledge that the ABPI may not accurately reflect the true vascular status of some 
patients, including patients with diabetes mellitus or end-stage renal failure as examples. They 
suggest that ABPI results for these patients should be interpreted with caution.  
A secondary care clinician notes the inherent limitations in simply doing a basic ABPI in 
general practice:    
“Ankle pressure can be exaggerated in patients who have other issues for example end 
stage renal failure and that of the diabetic patient where the artery can be calcified as 
a consequence of those disease types … So the ABPI has certain limitations therefore. 
And those limitations are reflected particularly in those two groups.” – Secondary care 
clinician 
 “The management advice that I [give]… usually has a guarded interpretation if the 
person has diabetes of a long duration, with the usual complications, microvascular 
complications of diabetes” –GP  
“It also may have limitation where the patient has a very oedematous leg, be it for 
whatever reason and as a result of that making it clinically difficult to palpate a pulse, 
so the request is again try and identify the presence or absence of the index in a more 




4.4.5.9 Having Enough Physical Space 
One GP indicated that having limited physical space in practices was a barrier to doing the 
ABPI: 
“The other thing for some practices is the space. We have the space now but actually 
having a room for privacy and stuff like that would be a consideration in general 
practice.” –GP   
One GP who does ABPIs regularly also stated that space was a consideration, as well as 
needing to use another staff member:  
“I just tend to like having one of my nurses rooms where I can get round both sides of 
the couch and just maybe have someone else to give me a hand to write down the 
numbers as I scoot around from, arm to leg to leg, or foot to foot, and so on so 
practically it’s not that big a deal to do it, but it is just nice to set aside a nurses room if 
you are planning it in advance and do it” –GP  
 
4.4.5.10 A Lack of Barriers and Challenges 
Conversely to the list of barriers and challenges described above, a few practitioners 
mentioned that there were not many barriers or challenges associated with using the ABPI in 
primary care. When asked, some stated:  
“Not really” –GP 
“I wouldn’t have thought so. No, it’s just a matter of doing it, and learning how to do 
it. Personally I mean.” –GP  
“Nope, not that I can think of. I’ll probably brush up on how to do it, and what the 
results meant [laughs], just so I knew what I was doing.” –GP  
 
4.4.6 Views of Primary Care Professionals who do Not Regularly do ABPIs 
Of the nine GPs interviewed, seven did not regularly do ABPIs.  
Of these, four had access to a Doppler ultrasound. The reasons for not doing them include 
many of the barriers mentioned in Section 4.4.5 Challenges or Barriers to Using the ABPI such 
as not having the knowledge to be able to do them, time, not having the current need for 
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them as they don’t see many patients presenting with vascular symptoms, and being able to 
refer to a colleague who does do them in a similar practice.  
“I don’t do them myself, and that’s kind of on my target thing’s to do is actually to 
learn to do them properly.” –GP  
“In a general busy practice setting, I don’t really see it as being that appealing, mainly 
because it’s time consuming.” –GP   
“[I must] say I don’t have very many vascular patients at all. So I haven’t necessarily, 
just trying to remember if I’ve referred anyone down through the vascular service. But 
apart from like DVTs and things which I think still get covered by them don’t think I’ve 
made very many referrals at all.” –GP  
 
Three GPs who did not regularly do ABPIs did not have access to a Doppler ultrasound. One 
stated they would do ABPIs if they had a Doppler ultrasound, while two would not. This was 
due to low patient need, and having extra commitments which would take up time.   
“I suppose I would if I thought there was going to be enough need for it, I have to say I 
don’t” –GP  
“I probably wouldn’t do it because I, I’m already far too busy, like I am, because I am 
doing this surgical [skin excision] thing… I’m focusing on that rather than developing 
another new skill. But I wouldn’t be opposed to if someone else wanted to them in the 
practice or if the nurses had the opportunity to have education to do it, then I think 
that would be fine. But I think for me personally, I’ve already got enough already on. 
Yeah.” –GP  
 
4.4.7 Views on the Role of ABPI in Primary Care  
Participants commented on their overall views on the role of the ABPI in primary care. 
Questions asked included:  
 What is the role of ABPIs in general practice overall and why? 




Some practitioners believed the ABPI is a more specialised tool, and that a GP with a special 
interest should be doing the test. This way it would mean that some professionals could 
become very efficient with using this tool, and would be able to see a larger portion of 
patients with vascular patients than a ‘regular’ primary care professional or GP would.  
 “So we could refer them to someone you know like… or someone who, that would 
make more sense than really qualify everyone to do the job, because it’s quite 
specialised really isn’t it?” –GP  
“It could be like a special interest that someone could, you know you could have a [GP 
with special interest] person to do that, you know, I could refer to a general 
practitioner who had a special interest that would be a good way to do that. You know 
we have … here who does the musculoskeletal medicine and so if you had someone 
clearly who was qualified and interested in you know… that would be good.” –GP   
“I wouldn’t probably be that inclined to do it myself in clinic because appointments are 
short but we could train nurses to do it, so I wouldn’t see it as a major issue to do it in 
the practice.” –GP  
“If I was confused I’d grab… my colleague and we’d do it together, you know, if there 
was something that we were concerned about” –GP  
One GP described how ABPIs may be better treated as GP special interest skill, so that 
referrals could be made within the community from GP to GP.  
“I think that maybe if you had someone with a special interest in it, so that would be as 
general practitioners in the community there may be four five GPs who did it in 
Dunedin just like the sports medicine and the skin [excisions] -GP 
Others felt that there is no reason why GPs couldn’t do the ABPIs themselves: 
“I don’t think it needs to be a specialist general practitioner, particularly if you are 
thinking about screening the asymptomatic population, I think it should be part of 
adding value to our cardiovascular risk assessments and you know from that point of 
view, in theory all practices should be able to do it, it’s not that difficult, but it’s a 
resource issue and funding for equipment I guess across the board.” -GP 
“It’s really if you have confidence, if you’re performing these tests, and you understand 
why you are doing them, then I believe you can teach people to do them it 
confidently.” – Secondary care clinician 
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Many practitioners believed that there was a role for nursing colleagues to be doing ABPIs: 
“Because we have great practice nurses, I think they’d easily be able to do it, and that 
would resolve some of the time issues” –GP  
“Probably makes it a bit cheaper for the patients too if we’re charging nurses fees for 
it rather than doctors’ fees for it.” –GP  
“If I was needing to use it regularly, it would be something I’d teach nurses how to do 
and get them to do it because it is cheaper to get them to do time-consuming tasks 
like that.” –GP  
“I’m a GP and I do them, but there’s no reason why you can’t train up a good 
competent nursing colleague to do them in the community I understand that some 
district nurses can do them. That was certainly the case before I came out to New 
Zealand.” –GP  
Some believed that there was no one professional who was responsible for doing the ABPI, 
but perhaps just a dedicated clinician who is able to do them effectively to meet the demand 
of the population served, and on a regular basis:  
“I think if you ask everybody to do it, it would be more of an issue with training and 
quality and standardising outcomes, but if you choose one or two individuals in each 
practice to, to train to do it, and do them, I think that’s probably the way forward. 
Who does it? I think it is whatever works in the circumstances.” –Vascular surgeon  
“It’s how you utilise your staff” – Secondary care clinician 
“Ideally in a [place] like a [large group practice]…, there should be one person to do the 
ABI to keep op top of it and to organise the compression bandaging and do the whole 
sort of thing… they probably should be done by one person.., somebody needs to do it 
on a regular basis.” –Secondary care clinician  
Although no participants stated that it shouldn’t be done in primary care, there were some 
views that it wasn’t necessarily the responsibility of primary care to be doing all ABPIs:   
“I think we’re quite fortunate here with the clinic at the hospital, the wound clinic, and 
if I had someone here with a chronic wound, and I would sort of liaise with them and 
they might organise the vascular studies. And with district nursing as well they would 
liaise with me” –GP  
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“It would be a huge shift within New Zealand to shift it back to primary care. It is 
purely a fact of education for primary care nurses, and then also for practicing it, 
because compression bandaging, [you] can teach it but you need to do it, and if you 
don’t do it often enough, you will forget, the same as the ABPI.” –Secondary care 
clinician  
One GP discusses how they are satisfied with the secondary care vascular services they use in 
Dunedin, and believes they are handling ABPIs referrals well:  
“I mean we’ve been pretty lucky in having reasonable access to the service in Dunedin, 
and I don’t have any big issues with them” –GP  
 
4.5 Chapter 4 Summary 
This interview study helped to reflect a large a number of views regarding the role of the ABPI 
in general practice.  
Nine GPs and four secondary care providers from Dunedin were interviewed face-to-face 
about their experience and perspective on the use of the ABPI in general practice. Only two 
GPs of the nine identified with performing ABPIs regularly. Less than half of the nine GPs 
stated that they had experience with the ABPI during medical school, three said they had 
exposure as a house officer, with two having no previous exposure ever.  
The main benefits that health professionals said the ABPI in general practice has includes the 
ability to diagnose PAD, being able to check for mixed vascular disease, and aids GP referrals 
to secondary care. ABPIs were perceived to help guide whether patients are appropriate for 
referral or not, and aid secondary care in triaging the most urgent patients.  Other advantages 
such as being easy to use, and a supplement to conveying cardiovascular risk to patients were 
noted.  
The main challenges to ABPI use in general practice were perceived as taking too much time, 
and being too costly in relation to the lack of patient need. Some GPs were unaware of the 
value of the ABPI and stated that confidence in their ability to perform or interpret the ABPI 
was a challenge.  Further, challenges such as the test results not changing GP management of 
the patient and not being a priority for primary care were themes discussed. However, some 
GPs believed that there were not many barriers associated with ABPI use in general practice.  
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Overall, interviewees had mixed views regarding the role of the ABPI in general practice. 
While no health professional said there was absolutely no role for its use, there were many 
perspectives on whose role it would be to do them. Some believed that GPs themselves could 
do them, or perhaps a GP with special interest in vascular disease. Others believed that nurses 
were well equipped to perform ABPIs, and if nurses performed them, would allow the barriers 
of lacking GP time to be mitigated. Some stated that it didn’t matter who, as long as a 




Chapter 5: Discussion 
5.1 Discussion of Methodology  
5.1.1 Electronic Health Records 
The quantitative arm of the study used electronic health record data from MHC’s PMS. There 
were many reasons why electronic health record data was appropriately chosen for use.  
Firstly, electronic health records are widely used in New Zealand general practice.157 Existing 
data allows the ability to harness ‘real-time’ clinical data without having to go through 
complex and often time-consuming processes of recruiting participants or undergoing tests in 
an artificial setting.158 Previous research has shown the value of data extraction for assessing 
efficacy of tests such as the ABPI within the health services research community.159-161   
Further, electronic health records enable extraction of a large amount of data in a small 
amount of time.158 Relatively few people in a single general practice need to undergo vascular 
and ABPI assessments in a ‘normal week’ relative to other investigations. By accessing the 
database of ABPI measures, more ABPI assessments than could be collected within one year 
were accessible (the time available for this work) (see Section 5.3.1 Strengths).  
Routine practice data provide convenient, timely and easy access to demographic details and 
medical history notes that may impact on the interpretation of the results. The breadth of 
data supplements the ABPI database. Longitudinal data included follow up details, clinical 
letters and test results, which may not have not been gained otherwise from the doctor or 
patient in a one-off isolated intervention study.162  
Using routine practice data is also practical and does not require time, effort, or money from 
patients. No physical harms or added involvement are associated with this method. Using 
existing records did not require separate efforts by doctors, patients or researchers as the 
ABPI has already been completed, making the process more patient-centred.160 As the 
investigation has arisen from usual care, and the data are anonymous, using them for research 
avoids many ethical issues.   
There ongoing benefits of harnessing electronic medical records for practices or GPs such as 
MHC. By collecting ongoing data that doctors and others know will be analysed, clinicians will 
be more motivated to record information accurately and comprehensively. There is a sense of 
“ownership of the data for success”.162 Quality note taking techniques are used not only for 
good GP practice, but can be used as quality data for future primary care research.161, 163  
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A major challenge of using routine practice data is in how to achieve appropriate levels of 
information security and privacy.158, 160 In the quantitative analysis, data provided to the 
candidate was anonymised prior to being analysed before leaving the practice, or was secured 
on a digitally locked private database (see Section 3.3.6 Ethical Considerations). The candidate 
signed a confidentiality agreement with the practice where records were identifiable. An 
ethics committee had also evaluated the project.  
Another challenge is data quality. All general practice staff need to be able to use the 
electronic health record competently so that the recording of information is complete and so 
there is reliability and consistency in the data. Further, practices require their medical staff to 
be able to correctly classify medical classifications based on accepted codes and coding 
systems. All staff at MHC had been trained and are competent at using the practice software, 
Medtech32 and Read codes (see Section 3.3.2 Data Collection).  
 
5.1.2 Semi-Structured Interviews 
The qualitative arm used semi-structured interviews. This allowed a naturalistic enquiry into 
understanding what using the ABPI would mean for primary health care professionals who 
work in general practice. Interviews allow for comprehensive and reasoned data to be 
collected, as well as a host of views, opinions and experiences.164 In this study, a qualitative 
enquiry gives insight into why general practitioners already do or do not conduct ABPIs, and 
their views on the use of the ABPI in general practice.  
The semi-structured interviewing technique allowed for a flexible yet focused approach to be 
balanced, and a greater amount of exploration to be gained than via a more structured and 
narrow method.153  
A number of interviewing techniques were employed to encourage the collection of data. 
These included using anonymised field notes (rough notes written by the candidate during 
interviews), using encouragers and reflective listening to maximise data gained from 
interviewees (see Section 4.3.2 Interview and Interview Design).  
 
5.2 Key Findings  
Both arms of the study provided insights into the usefulness of the ABPI in a primary care 
setting. In both analysing real world data on ABPIs done in primary care, and engaging the 
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perspectives of health professionals, a number of key findings, benefits and challenges are 
discussed, as well as the role of the ABPI in general practice.  
5.2.1 Characteristics of the ABPI group 
It was found that 338 individual patients had a total of 379 ABPIs completed between 2006 
and 25/04/2015. Most of these patients were enrolled MHC patients except for 14 who were 
patients referred to Dr Lloyd by GPs from other practices. Due to having a small number of 
non-enrolled patients, this study is limited to analysing the enrolled ABPI group.  
When the ABPI group was compared with the total enrolled MHC population (alive at 
25/04/2015), female patients made up 64% of the group (48% in the total enrolled MHC 
population). Despite this difference, no literature was identified regarding which sex ABPIs are 
done more commonly in, but global studies have found no significant sex variation in PAD 
prevalences.27, 28  Age distribution of the ABPI group was skewed towards older ages, with 
those in the ’70-79’ and ’80-89’ year age bands making up the largest proportion of the ABPI 
group. This skewing is expected as age is a risk factor for PVD (PAD and mixed disease), 
especially those over 70 years.21 Socio-economic quintile distributions were different for both 
the total enrolled MHC population and enrolled ABPI group, with larger proportions of 
patients living in more deprived areas in the ABPI group. This may reflect socioeconomic 
inequality in disease prevalence, as indicated in the literature.21  
Ethnicity distribution was similar among both the total enrolled MHC population and enrolled 
ABPI group, with over 90% of both groups being NZ European/Pakeha. NZ Māori made up 
4.81% of the total enrolled MHC population, but only 1.65% of the ABPI group. Similarly, NHC 
data shows a lower prevalence of PVD in NZ Māori.11 This could have been due to chance. 
However, it is documented in the literature NZ Māori have a higher prevalence of diabetes.113 
Patients with diabetes and PAD generally have a longer asymptomatic phase than those 
without diabetes, meaning less Māori are presenting with PAD symptoms.67 Further, the NZ 
Māori population is younger than other populations.165 Deaths due to cardiovascular disease 
may have occurred before PAD was detected or had time to develop. As PAD generally affects 
those older, it could be suggested that there are less absolute numbers of older NZ Māori, and 
consequently less PAD being developed, or detected. All other ethnicities made up <1% of 
each group.  
The mean age (at the time of ABPI) was lower for patients who were still alive at the end of 
the study period than those who had died before 25/04/2015. Conversely, those who had 
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died before 25/04/2105 were on average older when they had their ABPI. Being older 
increases the risk of PAD and PAD-associated morbidity and mortality.16 
As expected due to selection bias, arteriosclerotic disease (including PAD), venous disease, 
peripheral oedema, diabetes mellitus, chronic leg or skin ulcers, congestive heart failure and 
gout were over-represented in the ABPI group with compared with the total enrolled MHC 
population. ABPI patients had double the proportion of hyperlipidaemia and hypertension 
than the total enrolled MHC population, although other characteristics were not controlled 
for. Having indications for ABPI increase the chances of having risk factors such as 
hyperlipidaemia and hypertension as predicted. However, ABPI patients had lower 
proportions of heavy smoking status reported. This may have been under-reported in general, 
as prevalence of heavy smoking was less than 1.5% for both groups. This percentage is lower 
than the national prevalence of heavy smokers being 3% in 2006.166 These results suggest that 
ABPIs are being completed on the correct population at-risk for PAD, who may have relating 
risk factors and diseases, such as venous disease, other cardiovascular diseases and diabetes.  
 
5.2.2 ABPI Values and Subgroups  
The mean segmental arterial pressures for the 379 ABPI assessments completed showed that 
mean DP and PT pressures were lower than mean brachial pressures. The brachial pressures 
were in the normal range for an average general practice.167 Lower DP and PT values were 
expected as patients who have ABPIs are inherently at higher risk of having PAD (the reason 
for having the test), and the distribution of the lower limb segmental pressures would be 
skewed to the left (lower pressures), compared with the total MHC population who had not 
had ABPIs.  
Mean ABPI values, for both left and right-sided ABPI values were above 0.9, indicating that a 
majority of patients who had ABPIs did not have PAD. This correlated with 24.5% of right-
sided and 21.6% of left-sided ABPIs <0.9. These findings indicated that of patients who have 
ABPIs, one in four to five will have PAD. Of the 379 patients who had an ABPI test, this would 
mean that 82-93 had PAD.  
ABPI values <0.5 were more prevalent in right-sided ABPIs than left (5.0% vs 1.8%). There 
were a larger proportion of left-sided ABPI values 0.5-0.79 than right (15.0% vs 12.1%). The 
literature does not document whether one leg is more prone to severe PAD than the other, 
and so this could be explained by chance, but is currently unknown.  
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There were 15 right-sided and 14 left-sided ABPIs for which a value could not be found. A 
majority of these were non-occludable, most likely due to diabetic calcification (although not 
specifically stated in the data).112 A minority were unobtainable, and this is probably accurate 
as there are more patients with diabetes than with anatomical anomalies.  
In regards to demographics of ABPI subgroups, mean ages of patients with ABPIs <0.9 were 
greater than for those with values 0.9-1.2. This was expected due to the increasing prevalence 
of PAD with age.30 Age in patients with ABPIs <0.5 were not normally distributed as there were 
not many ABPIs<0.5, and perhaps these patients had varying risk factors at different age 
groups.  
In regards to deceased patients, mean ABPI results were lower for patients in the ABPI group 
who were dead at 25/04/2015 than patients not dead, suggesting that patients with lower 
ABPI results have a higher risk of mortality. These results correlate well with previous 
literature on risk factors, where indicates that lower ABPI results are correlated with higher 
risk of mortality in those with PAD.29, 118  
 
5.2.3 Indications and Outcomes of ABPIs 
Results about indications of the 379 ABPI patients showed that most (56.2%) were used to 
guide management of a venous-related issue, suggesting that this is a very common long-term 
condition seen at MHC. Investigation of suspected PAD due to PAD-related symptoms was the 
reason for 45.6% of the ABPIs. This left 10.6% of ABPIs completed for other reasons, with 1.8% 
of all ABPIs being done to evaluate the possible use of compression stockings for travel.  
Knowing the distribution of indications is important to enable MHC and other similar practices 
to organise their resources better if offering an ABPI service. Having a relatively large 
proportion of venous disease requiring ABPI means that more compression bandaging of 
different grades may be required than expected. Further, this may have implication on costing 
for the practice, and management will need to decide whether (and how much) patients pay 
for the compression therapy measurement and service.  
There were just as many patients who had the ABPI for venous disease with ulcers as without. 
Of the ulcers, just under half were reported as traumatic in aetiology. This is probably an 
underestimation as trauma may have happened without being reported by patients or 
recorded by clinicians.  
140 
 
Of patients who were investigated for suspected PAD and had leg pain, around 52% had 
classic vascular claudication or rest pain, leading to ABPI investigation. Without the ABPI, this 
group may have all been referred to the vascular laboratory or secondary care to have ABPIs, 
as would those with classic symptoms.  
It was found that 8.7% of patients who had ABPIs had both an indication to investigate 
suspected PAD and to guide management of venous disease. Multiple vascular symptoms and 
signs may or may not be present in patients, so arterial and venous presentations should not 
be considered in isolation, as evidenced by the 8.7%.  
In terms of outcomes for the 379 patients who had ABPIs completed, 100 (26.39%) patients 
were referred to the secondary care vascular department. This means that 73.61% of patients 
having ABPIs were not referred to the vascular department. If ABPIs were not available in 
general practice, secondary care could be overwhelmed by too many referrals- these findings 
suggest that if ABPIs were consistently provided in the community, then 73.61% of cases 
would remain in primary care.   
Of all outcome categories, 23.2% patients required no further peripheral vascular 
management. These patients were investigated for suspected PAD but were found not to have 
evidence of PAD on ABPI testing. In addition, of patients who were identified with PAD, 21.9% 
had no further management, due to age and co-morbidities or patient preference, and 23.4% 
had other conservative management. Assuming all guidelines were followed, this means a 
subset of those who had ABPI-identified PAD did not require vascular referral. Again, these 
patients may have been inappropriately referred if ABPIs had not been done in general 
practice, increasing the burden on secondary care. Approximately one quarter of patients who 
had ABPI-identified PAD were not referred to the secondary care hospital vascular 
department.  
Most patients who had ABPIs to guide management of venous disease were treated with 
compression treatment (59.5% of venous disease patients with ulcers, 68.4% without ulcers). 
Patients with venous disease who had co-existing arterial disease were appropriately not 
treated with compression, and may have been referred to other services such as secondary 
care. 
Patients with traumatic leg ulcers were managed in similar proportions to non-traumatic leg 
ulcers, with 63.4% having compression treatment and 61% receiving conservative 
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management following ABPI. This suggests patients with traumatic ulcers have similar 
outcomes to all leg ulcers.  
Among patients who had ‘other management arranged’, 32.8% (22) were referred to another 
hospital department, where another diagnoses may have been more likely than vascular 
disease. Many patients (38.8%) who had other management arranged were conservatively 
treated.  
The results for hospital vascular department outcome categories showed that 93 of 100 
patients referred had further investigation or treatment, leaving only 7% with no further 
treatment (see Section 3.4.5.2 Secondary Care Vascular Department Outcome Categories). Of 
those 7% (seven patients) who did not have any further treatment, two patients declined 
treatment offered by the vascular department. Of the other five patients, secondary care 
professionals believed two patients had spinal stenosis and re-referred them to neurology, 
one had informal ABPIs of normal value, one patient’s leg ulcer had healed completely when 
seen and one had atypical pain not recognised as vascular pain by the vascular department. It 
is difficult to say whether these patients’ referrals were inappropriate as PAD is able to 
progress and regress, and patients’ histories can change over time too.  
About a third of all referrals to the vascular department resulted in an arterial duplex scan. 
This could have meant that surgical intervention was a possibility in some of these patients as 
the duplex scan investigates sites of arterial blockage.  
Of all referrals, 27% had formal ABPIs tested at the vascular laboratory. However, this number 
was probably under-reported as ABPIs completed in outpatient clinics may not have been 
recorded, or letters regarding formal ABPI testing may not have been returned to the GP. 
Further, there were many reasons for re-checking ABPIs, including if time between being seen 
and their last ABPI was extended, or whether symptoms reported did not match ABPIs 
completed in general practice. So it is difficult to assess what the meaning of re-testing ABPIs 
were for a population without discussing cases with the clinicians involved.  
Compression bandaging was implemented in 35% of referred patients to the vascular 
department. Despite compression bandaging often being done in the community, referrals 
were applied consistently with guidelines. As the referrals were not inappropriate, this implies 
that specialist expertise considered benefits and risks of compression and concluded that it 
was worthwhile for use in those patients referred.  
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Only a minority of patients referred by GP to the vascular department received amputation 
(5% of referrals received above-knee amputation, none received below-knee amputation and 
5% received toe amputation). It would be prudent to compare vascular department referrals 
from practices not doing ABPIs with those who do to see if ABPIs completed on at-risk patients 
in the community leads to relatively less invasive surgery.  
 
5.2.4 Benefits Derived from Using the ABPI in General Practice  
The ABPI is well established in the literature as being a simple, non-invasive and reliable test, 
which even medical students are able to do.29, 109, 110 The findings of this study reinforces the 
literature that there are benefits of performing the ABPI in general practice at both individual 
and population levels.108, 109 Benefits are displayed from both quantitative and qualitative 
standpoints.  
Most notably is the advantage of being able to begin compression bandaging immediately 
once mixed arterial and venous disease is ruled out in patients presenting with venous 
symptoms or ulcers. Over half of all ABPIs done at MHC between 2006 and 2015 were done to 
guide management of a venous symptom or complaint. Just under 70% and 60% of patients 
who were managed as having venous disease without or with ulcers respectively were treated 
with compression therapy. Many primary care professionals believed that this was the main 
advantage of using ABPIs in general practice.  
Also, diagnosing and quantifying PAD was perceived by health professionals as an important 
advantage in being able to understand aetiology of symptoms, aid referrals in being accepted, 
allow for triaging of patients in secondary care, and identifying urgent cases to be immediately 
manged. The research shows that 73.4% of patients with PAD (diagnosed by ABPI) were 
referred to hospital. Conversely, just over 25% of patients with PAD were not referred, and 
were managed in primary care conservatively. Both are benefits as patients who required 
referrals had a numerical justification reinforcing clinical judgement to be referred. Patients 
who were not referred were managed conservatively based on objective measures, 
decreasing the need for unnecessary referrals.  
Further, the ruling out of PAD was appreciated as a huge advantage by interviewed health 
professionals, conferring the benefits of preventing unnecessary referrals, allowing full 
management of patients in general practice and decreasing the (patient and financial) burden 
on the secondary care vascular service. Close to 40% of cases in the quantitative arm had 
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either ‘no further management arranged’, or ‘other management arranged’ when the ABPI 
values ruled out PAD. This correlates well with the literature stating that referrals based on a 
clinical history of intermittent claudication alone may be inappropriate.128 Performing ABPIs in 
general practice benefits patients by providing patients with immediate results, and 
eliminates the need for long waiting times where referrals could have resulted 
inappropriately.  
There was a perception by GPs that ABPI results were highly valued by secondary care 
vascular departments, and having the ability to refer patients with values would aid referrals 
in being accepted. Those in the secondary care agreed by stating that the department 
encourages a high standard of referrals, which includes thinking about the problem at a 
deeper level, by using ABPIs and interpreting them.  
Further, GPs believed that ABPI use may be of more benefit for rural practices located further 
away from hospital. This was because ABPI testing allowed for more patient-centred 
healthcare in their own communities, and may prevent long and perhaps unnecessary trips to 
a city to get a relatively simple test done. GPs believed it was easy to use. A vascular surgeon 
described the test as being easier to use than a stethoscope, used daily by GPs.  
 
5.2.5 Challenges and Barriers to Using the ABPI in General Practice 
The largest barriers to ABPI use in this setting included issues of taking too much time, being 
too costly and having a lack of patient need for the test, as defined in the research.168   
Consistently, GPs reiterated that they were part of a larger business entity and that all 
examinations, tests and new procedures and their clinical benefits are considered in relation 
to the opportunity cost of other patients and tests. Compared to the relatively low number of 
patients presenting with vascular symptoms in many Dunedin practices, GPs said that it would 
take at least another consultation-long appointment to be able to complete the ABPI, which 
would mean forgoing the opportunity to see another patient, as well as having another paying 
patient at the practice.  
There are many other tasks which compete for the attention of primary care providers, and 
some GPs prioritised ABPIs lower on the list, under cervical screening, ECGs and other skills.  
Further, some GPs discussed in interviews their lack of access to a Doppler, and how it would 
be too costly to buy one in relation to its estimated use. Doppler ultrasounds range between 
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$367 to over $1000 by New Zealand suppliers.52, 88, 89 MHC charged patients an additional 
consultation fee for the ABPI which could have deterred some patients from consenting to the 
procedure. There were no records of any patient declining the ABPI in the data extracted.  
MHC had an average rate of 38 ABPIs completed per year, or around 3-4 per month which 
could be an overestimation of what an individual GP may encounter. Whether this is frequent 
enough to justify ABPI use would depend on the size of the practice, its financial situation and 
decisions of the owners (compared to the clinicians). Due to the variability of practice 
characteristics, it is unreasonable for this research to comment on whether this frequency is 
considered ‘enough for use’ for a single general practice. However, the result suggests that it 
could be more cost-efficient if one clinician completed the ABPI for an entire suburb or 
community, such as in Mosgiel (see Section 5.2.6 The Role of the ABPI in General Practice).   
A few GPs lacked awareness of the ABPI and its theoretical and practical value. This was 
strongly related to minimal previous experience with observing or using the ABPI in the past. 
This was a large barrier in that GPs who had a less comprehensive understanding of the ABPI 
did not feel that it was a necessary part of vascular assessment. Those who had more past 
experience with ABPIs discussed the benefits of the ABPI in more detail. So, education 
sessions held for GPs or nurses to assist their understanding of vascular assessment tools is 
recommended to increase awareness of the ABPI.  
Some GPs interviewed stated that they believed the ABPI results did not change their 
management of their patients. This was related to a lack of confidence or awareness of the 
ABPI’s value in some participants. A heavy reliance on patients’ clinical history and 
examination was stated by some GPs, and more weight was placed on these aspects than on 
the ABPI result. Further, some practices did not offer treatments such as compression 
bandaging which would mean that management itself was not possible despite an indication 
to do so via ABPI result. This was the case for one GP who did ABPIs regularly. Individual 
practices’ capabilities often determined the practical benefit of completing the ABPI.   
Understanding the barriers and challenges to ABPI use were a major goal of the study. General 
practices need to consider their own priorities and financial situations before attempting to 




5.2.6 The Role of the ABPI in General Practice  
There were polarising thoughts among primary and secondary care professionals regarding 
the role of the ABPI is in general practice. Although most professionals acknowledged the 
theoretical benefit, the challenges were significant enough to prevent its use to many cases. 
Many professionals discussed not if there was a role, but whose role it should be. 
Some study participants commented that all GPs are able to perform ABPIs due to its ease of 
use and relative simplicity, and should be using it themselves. This view has been reiterated in 
guidelines.52  
Others have stated that it could be more appropriate for nursing colleagues to perform ABPIs 
in general practice. Reasons included saving GP time, allowing more patients to be seen by  
GPs, prevent the risk that an urgent case is missed, and that nurses were sufficiently 
competent do perform this test independently. Previous studies have showed low levels of 
variability in results and accuracy between professionals making this a viable option in regards 
to accuracy and reliability of use.108, 109  
Some practitioners interviewed believed that the ABPI is a tool that an individual nurse or GP 
with a special interest could do for a practice or community. ABPIs were discussed by these 
practitioners as a special skill. Some GPs interviewed had little experience and little confidence 
in being able to perform and interpret the ABPI themselves, which could have contributed to 
this view. However, reasoning behind having a specialist clinician perform ABPIs in the 
community included the ability for GPs to refer to their specialist colleagues easily, mitigating 
barriers of Doppler costs, time and lack of patient need. One GP likened ABPIs to minor 
surgical procedures completed in general practice, as a specialised skill.   
Rearrangement of how the ABPI is used in a community setting could be an appropriate 
solution to maximise its benefits while mitigating barriers. Primary and secondary care 
professionals described a concept of having one individual (GP, nurse) being responsible for 
completing ABPIs for a wider group or community (depending on population sizes). Again, this 
clinician would gain more experience and efficiency in doing ABPIs with a larger patient load 
than one would normally expect. Further, other GPs’ time would be preserved, while not 
delaying the test unnecessarily, and there would be no further equipment costs to smaller 
practices because referral could be made to the ABPI specialist primary care professional 
instead. This solution allows for an integrated multi-centred and multidisciplinary approach to 
vascular care in general practice. This is similar to the case for Mosgiel and MHC currently, 
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with Dr Hywel Lloyd seeing more ABPI patients than normal due to having a special interest in 
this area. The disadvantage of this concept is that there is a risk that no practitioner would be 
interested, and so a community could lack the ability to complete the vascular assessment.  
Although no practitioners stated that there was no role for using the ABPI in general practice, 
several Dunedin GPs stated that it may not be a priority for GPs. This was because they were 
satisfied with existing vascular laboratory services in Dunedin and in turn may be because 
Dunedin has a relatively large university-owned vascular laboratory service at Dunedin Public 
Hospital. Other hospitals or regions in New Zealand may not offer a similar service (see 
Section 5.3.2 Limitations). Nevertheless, all interviewees believed that efforts to increase 
quality of patient management in primary care should be considered, and ABPIs in general 
practice could be a way to do so.   
 
5.3 Strengths and Limitations 
Both arms of the study had strengths and limitations that contribute to internal and external 
validity of the research.  
 
5.3.1 Strengths  
The quantitative arm of the study evaluated 379 ABPIs completed over 10 years, and this long 
time span allowed a large sample of ABPIs to be analysed as they are not done as often as 
other tests in general practice. On average, 3-4 ABPIs were completed per month. Having only 
one year of results would not have yielded enough results to merit proper analysis.  
Electronic patient records were used to harness a wealth of demographic information (see 
Section 5.1.1 Electronic Health Records), and there was minimal missing data for most 
enrolled patients at the MHC. Electronic data and minimal missing data allowed for more 
complete analysis of real world data of ABPIs conducted on patients with clinical need, rather 
than in an artificial research setting.  
Due to being able to analyse all 379 ABPIs completed in the practice, no sample size 
calculations needed to be completed, as all 100% of ABPIs were included in the study, and not 
just a proportion hoping to represent the entire sample.  
In regards to ABPI methodology, although the literature defines much variation, there was 
consistency in ABPI technique throughout the quantitative arm of the study.100 Electronic 
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records showed that 349 of the 379 ABPIs were completed by Dr Lloyd, and a minority (30, 
7.9%) completed by one of two nurses supervised by Dr Lloyd. Dr Lloyd based his techniques 
on NZ guidelines similar to that of international guidelines. The ABPI method followed is 
comparable to recommendations in international guidelines.  Further, for non-enrolled 
patients referred to the clinic, patient notes were read only after completion of the ABPI to 
decrease collection bias.  Therefore, consistency of methodology meant that risk of 
measurement bias would be reduced.  
The qualitative arm of the study used a similar interview structure for all interviewees, 
meaning consistency was applied. Interviews were recorded to minimise interview bias and 
memory difficulties during transcription phases (see Section 5.1.2 Semi-Structured 
Interviews).  
The setting of interviews encouraged maximum discussion and data collected. Interviews 
were completed in settings comfortable to interviewees, as the candidate travelled to most 
interviewees’ workplaces. Comfort encouraged maximum discussion when questions were 
asked. Interview techniques to encourage interviewee participation were used. Further, it 
allowed the candidate to observe the context in which statements were being made (e.g. sizes 
of individual practices, equipment available, vascular laboratory).  
Data saturation was achieved after nine general practice interviews as many GPs discussed 
similar advantages and barriers of using the ABPI. Though there were not many secondary 
care practitioners interviewed, they provided a valuable alternative perspective to 
supplement the primary care perspective.  
An external analyst was used to independently check and code transcribed interviews to 
reduce observer bias in the analysis period. A process of triangulation through discussion 
aided the candidate to code or recode certain aspects of interviews, as well as consider other 
points of view on how qualitative data was perceived and evaluated.  
The use of both a quantitative and qualitative approach together had a synergistic effect to 
assess the usefulness of ABPIs in general practice. The quantitative arm allowed for 
characterisation of the types of patients who are currently being evaluated using the ABPI, 
and evaluation of reasons or indications for ABPI use. Further, the real world data meant that 
outcomes could be measured to define the consequence of having ABPIs done. The qualitative 
arm allowed for an understanding of reasons practitioners gave for wanting to do the ABPI or 
not and challenges that inhibited use of the ABPI in this setting. Interviews helped to confirm 
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and place quantitative data into a meaningful social context, determining the situations in 
which the ABPI could be used.164 The quantitative and qualitative arms support one another in 
finding a more valid answer to the research question that each could have alone.   
No similar research to either the quantitative or qualitative arms has been completed in New 
Zealand before: it is the first of its kind in this setting. Therefore this research has bought new 
knowledge to the scientific community. Further, no quantitative research evaluating ABPI use 
clinically with patient follow-up over 10 years could be found during the research period- so 
this could be the longest retrospective ABPI group in general practice to have been analysed 
internationally.   
 
5.3.2 Limitations 
The quantitative arm of the study one evaluated data from one general practice, which limits 
generalisability to other practices although within the one practice there was consistency in 
technique and clinical judgement. The setting is one of an urban general practice in Dunedin, 
which has a different population to other regions in NZ and internationally. The findings can 
only be said to be applicable to this practice in this context and is not necessarily 
representative of the wider region or general practices in New Zealand, generally.  
Further, because this was an observational study of electronic records and not a controlled 
study, there was no comparison group for outcomes data. There is no group who were eligible 
for ABPIs who did not receive ABPIs. It can only be speculated what outcomes would have 
arisen for participants who did not receive ABPIs. This means that conclusions stated within 
the research may not be as strong as if there were a defined comparison group. 
There was a reliance on the electronic clinical notes and what was recorded in letters when 
determining indications and outcomes data for the ABPI group. Therefore any indications or 
outcomes were recorded in the study only if they had been previously recorded in the notes. 
This may have meant there is underreporting of some data, such as patients who received 
conservative treatment, as it was not recorded explicitly.  
Similarly, investigations and management delivered in secondary care may have been 
underreported as study data were restricted to documentation sent from the hospital to MHC.  
A further limitation was that because there was an arbitrary end-point for analysis of the MHC 
ABPI data, patients who were awaiting referral at 25/04/2015 did not necessarily have any 
outcomes recorded, and so no outcome was recorded for some ABPI patients. Therefore, 
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some patients may have had no further peripheral vascular management due to waiting for 
specialist consultation.    
The PAD definition by ABPI measurement in this study may have also limited findings. As the 
ABPI takes the higher of brachial and distal arterial pulses, disease in collateral circulation may 
have been missed, underestimating prevalence and severity of PAD in the MHC population. 
The getABI trial compared different methods of determining the ABPI, and found that PAD 
identification was doubled if the lowest ankle systolic pressure used in the calculation of ABPI 
compared to the highest.31  
Similarly, the definition for severe disease was <0.5, which was a numerical boundary between 
severe and moderate disease. This may not fairly reflect reality, as patients may have severe 
disease with ABPI values 0.52 for instance. Further, other research have used a definition of 
<0.4 as severe disease.16 Different definitions may have resulted in different results.  
The qualitative arm of the study also had limiting factors.  
Due to time constraints on the candidate to be able to finish both arms within the year, the 
number of the interviewees was limited to people who were able to be interviewed between 
June and September 2015. The sample size was relatively small, with nine GPs and four 
secondary care professionals. The recruitment protocol of snowball sampling put pressure on 
the time allocated for this arm of the study as existing participants were asked to recommend 
further participants following their interviews, which meant a pool of health care 
professionals could not be invited at the commencement of research. Nonetheless, saturation 
of data was reached for GPs for many of the topics discussed.  
Further, the time constraint meant that the demographic profile of interviewees was also 
limited to people who the candidate could interview face-to-face within the months 
mentioned. Only health professionals in the Dunedin region were interviewed, limiting the 
generalisability and context of findings to Dunedin, New Zealand. The research implies that 
more benefit may be gained if the ABPI was used in a setting further from a vascular 
laboratory or hospital such as in the rural GP setting because referral would entail patients 
travelling a larger distance. Interviews with GPs working in distance or rural settings would be 
useful to investigate potential ABPI utility. Participants in primary care were limited to urban 
GPs. There were no other primary care professions or allied health professionals represented 
in this arm of the study.  
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Interviews were all recorded and may have been seen as intrusive to participants. There was 
one instance when a participant wanted to mention other details and opinions after the 
recording was stopped. This was because they did not want to be identified discussing 
financial issues regarding ABPI use. It is possible the data were restricted to what participants 
were willing to share on tape to researchers, and could have limited the amount of 
contentious opinions gained.  
Subjectivity and interviewer bias was minimised by having a structured interview with open-
ended questions, as well as using an external analyst during analysis phases. However, 
subjectivity in the coding is still a possible limitation due to the nature of the study.  
 
5.4 Implications and Recommendations  
5.4.1 Implications 
This research suggests that there is a role for ABPIs to be used in primary care, which has 
implications for patients both on individual and population levels as well as primary and 
secondary care systems.119   
Practices that use ABPIs are able to gain an immediate answer to questions regarding patients 
have PAD or not. This may lead to the identification of appropriate cases needing referral. 
Moreover, it can convey level of severity and urgency to be seen by a secondary care vascular 
department without necessarily having to go through a lengthy waiting process, reducing 
morbidity for patients. Further, where disease is ruled out, unnecessary referrals are not sent, 
and patients are able to be reassured, treated using conservative management in primary care 
or investigated promptly for other diagnoses. Specifically, this means only patients with 
symptomatic or limiting PAD would be referred, and that compression bandaging would begin 
promptly for those with venous disease but without PAD in general practice. Doctors would be 
able to reinforce their clinical decisions to patients through ABPI results. These benefits are 
mirrored in both arms of the study (see Section 5.2 Key Findings).   
In regards to secondary care, using ABPIs in general practice may decrease some of the 
burden on vascular laboratories, outpatient clinics and wound care clinics as patients may be 
managed more appropriately with an ABPI result. Further, it may decrease the frequency of 
harms happening within the referral period (while waiting to be seen). 
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As the ageing population continues to rise in New Zealand, it is predicted that PVD and other 
cardiovascular disease prevalence will rise.54 Using the ABPI in primary care is one way to 
better manage patients and decrease unnecessary use of health resources.  
In order to implement ABPI testing more widely, practices may need to educate staff in using 
Doppler ultrasound, add another task to their lengthy list and incur additional expenses. 
Thoughts around whose role it is to do ABPIs should be discussed within or between practices 
of a community to mitigate and overcome the barriers identified in the study. Someone who is 
easily accessible to many practices and patients, who may have an interest or expertise in 
doing ABPIs, and who may be able to have access to an existing Doppler would be suitable. An 
adequate and accessible space would also be required to implement ABPIs in general practice.   
Another issue that should be considered includes what reimbursement is required for the 
extra service. Practices would need to charge patients, incur costs, or gain reimbursements 
from local PHOs or District Health Boards. More research around cost-effectiveness from a 
population standpoint and inter-professional collaboration may be needed to make this 
recommendation practical from a business point of view.  
There are potential issues of over-diagnosis and picking up PAD in asymptomatic individuals if 
the service is freely available to general practice. Clinicians with access to a primary care ABPI 
provider should discuss which patients should receive the test and clearly document this to 
provide guidelines to referring GPs for awareness. Clinical audits of recorded information 
using electronic data such as in this study, should be completed regularly to evaluate its 
effectiveness over time.  
 
5.4.2 Recommendations 
The findings have given scope for the following recommendations:  
Future avenues of research are recommended to extend this research, including;  
 Continuing the collection and analysis of ABPI data at MHC  
 Evaluating similar quantitative data in other practices that perform ABPIs regularly to 
be able to compare findings, both in Dunedin and across New Zealand 
 Conduct further interviews with more primary care health professionals in both urban 
and rural centres across New Zealand, comparing Dunedin to other centres 
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 Conduct further interviews with other primary care and allied health professionals to 
gain perspective 
 Completing a health economics cost analysis of the burden of PAD in New Zealand and 
how many DALYs would be reduced if ABPIs were done in primary care 
 Completing epidemiological research on the unmet need for ABPIs in primary care in 
different regions in New Zealand 
 Discussion into the possible reimbursement strategies for diagnostic tests such as the 
ABPI 
As suggested by the qualitative study, findings suggest that there could be a lack of knowledge 
and experience of ABPIs for GPs elsewhere. More information or education should be 
provided to GPs and GP trainees. For instance, an evening session provided by Departments of 
Primary Care in universities, or further publication of articles. Centres that train health 
professionals, practice educators or mentors should be encouraged to discuss the benefits, 
challenges and opportunity of using the ABPI in general practice to inform their decision of 
whether they should do them. This research recommends that GPs become cognizant of the 
capabilities and role of the ABPI.  
Further, medical schools should review whether the use of ABPIs is sufficiently integrated into 
the curriculum, and perhaps could be added to a list of core clinical skills which could be 
learnt. This would raise awareness of the value of ABPIs for all medical graduates.  
Results may be used in helping to influence guidance for primary care practitioners such as 
within clinical practice guidelines groups e.g. BPAC. Health professional associations, 
educational institutes or colleges should encourage those in primary care to perform ABPIs 
where there is a need. As suggested by the interviews with secondary care professionals, 
added commentary from secondary care vascular specialists to GPs via letters or articles may 
strengthen their recommendation of doing ABPI in general practice.   
Inter-professional collaboration within practices or communities is recommended to develop a 
system to recruit a local individual with an interest in vascular care to perform ABPIs for a 
population, as suggested by the research.  
This project has set a platform upon which other more focused research and discussion can 
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Appendix J: Interview Schedule for Interviews with Secondary Care Health Professionals 
 
 
